CATALYTIC, ASYMMETRIC ACYL HALIDE-ALDEHYDE CYCLOCONDENSATIONS IN COMPLEX MOLECULE SYNTHESIS AND APPLICATION TO THE INSTALLATION OF QUATERNARY CARBON STEREOCENTERS by Kassick, Andrew Jonathan
 
 
CATALYTIC, ASYMMETRIC ACYL HALIDE-ALDEHYDE CYCLOCONDENSATIONS IN 
COMPLEX MOLECULE SYNTHESIS AND APPLICATION TO THE INSTALLATION OF 
QUATERNARY CARBON STEREOCENTERS 
 
 
 
 
 
by 
 
Andrew J. Kassick 
 
 
B. S., The Pennsylvania State University, 1999 
 
 
 
 
 
 
 
Submitted to the Graduate Faculty of 
 
 
the Department of Chemistry in partial fulfillment 
 
 
of the requirements for the degree of 
 
 
Doctor of Philosophy 
 
 
 
 
 
 
 
 
University of Pittsburgh 
 
 
2004 
 
 
UNIVERSITY OF PITTSBURGH 
 
FACULTY OF ARTS AND SCIENCES  
 
The dissertation of Andrew J. Kassick is approved by: 
 
  Professor Scott G. Nelson 
Advisor       Date 
 
 
Professor Dennis P. Curran 
        Date 
 
 
Professor Craig S. Wilcox 
        Date 
 
 
Professor Billy W. Day 
                 Date 
 
University of Pittsburgh 
November 2004
 ii
CATALYTIC, ASYMMETRIC ACYL HALIDE-ALDEHYDE CYCLOCONDENSATIONS IN 
COMPLEX MOLECULE SYNTHESIS AND APPLICATION TO THE INSTALLATION OF 
QUATERNARY CARBON STEREOCENTERS 
 
 
Andrew J. Kassick, Ph. D. 
 
 
University of Pittsburgh, 2004 
 
 
 
The synthetic utility of recently developed catalytic, asymmetric acyl halide-aldehyde 
cyclocondensation (AAC) reactions has been successfully demonstrated in complex molecule 
total synthesis.  Extensive use of the enantiomerically enriched β-lactone products of AAC 
methodology has led to the enantioselective total synthesis of the potent microtubule-stabilizing 
agent, (–)-laulimalide (1).   Additional highlights of the synthesis include a diastereoselective 
aldol reaction that united major fragments 85 and 86 and a remarkably high-yielding modified 
Yamaguchi macrolactonization.  Novel methodology was also developed to effect both the one-
pot interconversion of β-lactones to dihydropyranones and the Lewis acid-mediated addition of 
allenylstannane reagents to glycal acetates. 
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 Asymmetric AAC reactions have also been instrumental in recent studies toward the total 
synthesis of the cytotoxic marine natural product, amphidinolide B1 (133).  By exploiting AAC 
methodology, several key stereochemical relationships present in major fragments 171 and 172 
were established.  A highly enantioselective installation of the C16 tertiary carbinol stereocenter 
was acheived through the application of Mukaiyama’s Sn(IV)-allylation protocol, and a rapid 
synthesis of sulfone subunit 174 was realized from commercially available γ-butyrolactone.  
Regioselective β-lactone ring opening by phosphonate anions was also documented. 
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 The enantiomerically enriched β-lactone products of AAC methodology have also been 
demonstrated to serve as useful templates for the installation of asymmetric quaternary carbon 
stereocenters.  Treatment of β-lactones with NaHMDS in the presence of an in situ electrophile 
at low temperature resulted in enolization and subsequent alkylation to afford to afford trans-3,4-
disubstituted lactones in moderate to good yield with good levels of diastereoselectivity.  
Resubjecting the monoalkylated products to the reaction conditions and a different electrophile 
resulted in the efficient production of α,α-disubstituted-β-lactones in high yield with high trans-
diastereoselectivity.  A more efficient route to α,α-disubstituted β-lactones was realized starting 
from the cis-3,4-disubstituted β-lactones products of the recently developed second generation 
 iv
AAC reaction.  Asymmetric quaternary carbon formation was accomplished in two steps 
affording the desired α,α-disubstituted-β-lactones in high yield with excellent 
diastereoselectivity. 
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 CHAPTER 1.  ENANTIOSELECTIVE TOTAL SYNTHESIS OF (–)-LAULIMALIDE 
 
 
1.1 BACKGROUND 
 
1.1.1 Isolation 
 
 
(–)-Laulimalide (1), originally known as fijianolide B, is a macrocyclic marine natural product 
that was first isolated in 1988 by Crews and coworkers from the Vanuatu chocolate sponge 
Cacospongia mycofijiensis (Figure 1).1  Independent efforts by a team of Hawaiian scientists led 
by Moore coincided with this discovery, culminating in the isolation of 1 from the Indonesian 
sponge Hyatella sp.2  The genesis of the name laulimalide is the Hawaiian word laulima, 
meaning “people working together,” and is reflective of the highly collaborative research effort 
that led to its isolation.  Laulimalide has since been found in the crude lipophilic extracts of 
several other species of marine sponge native to the Pacific region including Fasciospongia 
rimosa3 and most recently Dactylospongia sp.4  Structure elucidation and relative stereochemical 
assignments for 1 were achieved by NMR spectroscopy,1,2 while its absolute configuration was 
determined through X-ray diffraction studies by Higa and coworkers in 1996.3 
                                                 
1 Quiñoa, E.; Kakou, Y.; Crews, P.  J. Org. Chem. 1988, 53, 3642. 
2 Corley, D. G.; Herb, R.; Moore, R. E.; Scheuer, P. J.; Paul, V. J.  J. Org. Chem. 1988, 53, 3644. 
3 Jefford, C. W.; Bernardinelli, G.; Tanaka, J.; Higa, T. Tetrahedron Lett. 1996, 37, 159. 
4 Cutignano, A.; Bruno, I.; Bifulco, G.; Casapullo, A.; Debitus, C.; Gomez-Paloma, L.; Riccio, R. Eur. J. Org. 
Chem. 2001, 775. 
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Figure 1.  (–)-Laulimalide (1) 
 
 
As depicted in Figure 2, laulimalide is isolated along with its constitutional isomers, 
isolaulimalide (2) and neolaulimalide (3).  Isolaulimalide (fijianolide A) is a trisubstituted 
tetrahydrofuran-containing metabolite of 1 that arises from the SN2 ring opening of the 
laulimalide C16–C17 epoxide by the C20 hydroxyl function under weakly acidic conditions.5 
Neolaulimalide was obtained by Higa et al. from the Okinawan sponge Fasciospongia rimosa, 
and exists as a ring-expanded regioisomer of 1 resulting from lactonization onto the distal C20 
hydroxyl group of the syn diol moiety.6  It also appears to be less susceptible to acid-mediated 
cyclization than laulimalide (1), isomerizing to 2 only after several days.   
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Figure 2.  Isolaulimalide (2) and Neolaulimalide (3) 
                                                 
5 Upon treatment of 1 with 0.01 N HCl in acetone (4 h, ambient temperature), complete isomerization to 2 is 
observed.  See ref. 2. 
6 Tanaka, J.; Higa, T.; Bernardinelli, G.; Jefford, C. W. Chem. Lett, 1996, 255. 
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 1.1.2 Biological Activity 
 
 
Soon after its isolation, laulimalide (1) was found to be a highly cytotoxic chemical entity.1,2  It 
exhibits low nanomolar activity against the human epidermoid carcinoma KB cell line (IC50 = 15 
ng/mL), and has also proven to effectively inhibit growth in several other human tumor cell lines 
including A549 (human lung), HT29 (human colon), MEL28 (human skin), and MDA-MB-435 
(human breast) cell lines (IC50 = 10–50 ng/mL).2,3  Isolaulimalide exhibits substantially weaker 
levels of activity against the KB cell line (IC50 >200 ng/mL) as well as MDA-MB-435 cells (IC50 
= 2 µM) potentially owing to its lack of the C16–C17 epoxide moiety.  The ring-expanded 
neolaulimalide (3), however, displays commensurate levels of cytotoxicity as 1 against A549, 
HT29, and MEL28 cell lines (IC50 = 10–50 ng/mL).6
Recent studies have shown that the mechanism of action of laulimalide is similar to that 
of the popular anticancer agent paclitaxel (Taxol™).7  Both compounds promote the 
polymerization of tubulin and the stabilization of cellular microtubules, events that disrupt 
normal mitotic cell division and lead, ultimately, to premature apoptosis.7 As a result, 1 has been 
recognized as a new member of a limited collection of nontaxane microtubule-stabilizing natural 
products with high anticancer potential that includes discodermolide, elutherobin, and the 
epothilones.  However, a recent report strongly suggests that while laulimalide exhibits similar 
microtubule stabilizing activity as paclitaxel, it does not bind to the taxoid site on the αβ-tubulin 
dimer.8 Competitive binding assays by Hamel et al. have demonstrated the failure of (–)-
laulimalide to inhibit binding of either [3H]-paclitaxel or the fluorescent Taxol derivative, 7-O-
[N-(2,7-difluoro-4’-fluoresceincarbonyl)-L-alanyl]paclitaxel (Flutax 2), to the tubulin polymer.  
                                                 
7 Mooberry, S. L.; Hernandez, A. H.; Plubrukarn, A.; Davidson, B. S. Cancer Res. 1999, 59, 653. 
8 Pryor, D. E.; O’Brate, A.; Bilcer, G.; Diaz, J. F.; Wang, Yu; Wang, Yo; Kabaki, M.; Jing, M. K. ; Andreu, J. M.; 
Ghosh, A. K.; Giannakakou, P.; Hamel, E.  Biochemistry 2002, 41, 9109. 
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 Additionally, HPLC analysis of microtubule pellets formed in the presence of both laulimalide 
and paclitaxel revealed a near stoichiometric amount of both compounds.  This simultaneous 
binding of paclitaxel and laulimalide to tubulin provided further evidence for the existence of a 
binding site distinct from that recognized by the taxoids. Another notable difference between the 
two microtubule-stabilizing agents is the superior ability of laulimalide to inhibit cellular 
proliferation in multidrug-resistant cell lines overexpressing P-glycoprotein such as the human 
ovarian carcinoma SKVLB-1 cell line.6  Such impressive biological activity along with its 
limited natural abundance makes laulimalide an attractive synthetic target.   
 
1.1.3 Structural Features 
 
 
In addition to its intriguing and potentially useful biological activity, laulimalide displays a high 
degree of molecular complexity with many key structural features.  One of the most notable 
features is its highly functionalized 18-membered macrolide.  Located within laulimalide’s 
macrolactone is a trans-2, 6-disubstituted dihydropyran ring (C5–C9) along with some 
particularly sensitive functionality in the form of an acid-labile epoxide ring9 at C16–C17 and an 
easily isomerized Z-enoate ester linkage spanning C1–C4 (Figure 1).10  A second dihydropyran 
moiety is incorporated into a side chain that is tethered to the macrolide at C19.  Laulimalide 
possesses ten oxygenated carbons, nine stereogenic centers (eight hydroxyl-bearing stereocenters 
and an isolated methyl-bearing stereocenter at C11), as well as five C–C double bonds.  This 
                                                 
9 Isolaumalide can be easily prepared from 1 under acidic conditions (CSA, CDCl3). See Paterson, I.; Savi, C. D.; 
Tudge, M.  Org. Lett. 2001, 3, 213.   
10 Base-mediated scrambling of the (Z)-enoate ester was observed under traditional macrolactonization conditions.  
See (a) Paterson, I.; Savi, C. D.; Tudge, M.  Org. Lett. 2001, 3, 213. (b) Inanaga, J.; Hirata, K.; Saeki, H.; Katsuki, 
T.; Yamaguchi, M.  Bull. Chem. Soc. Jpn. 1979, 52, 1989.  Boden, E. P.; Keck, G. E. J. Org. Chem. 1985, 50, 2394. 
 4
 combination of structural complexity and potential chemotherapeutic utility has made 
laulimalide an extremely attractive target molecule for synthetic organic chemists.11,12
 
1.1.4 Previous Synthetic Work 
 
 
To date, ten total syntheses of (–)-laulimalide have been reported by seven different synthetic 
groups.  The first total synthesis of laulimalide was achieved in 2000 by Ghosh and Wang.11a 
Ghosh’s approach features two olefin forming reactions that unite the two major fragments 4 and 
5 to furnish the requisite macrocycle.  First, a Julia olefination between sulfone fragment 4 and 
aldehyde 5 affords the trans-alkene which is later fashioned into the C16–C17 epoxide 
functionality. An intramolecular Still-Gennari coupling between a C19 phosphonoacetate and C3 
aldehyde forms the requisite C2–C3 Z olefin (E/Z 2:1) and closes the macrocycle.13  Assembly of 
4 was accomplished through the nucleophilic addition of the organolithium species derived from 
vinyl dibromide 6 into α-alkoxyaldehyde 7.  Both dihydropyran rings were synthesized using 
Grubbs’ ring closing metathesis strategy,14 and the sensitive epoxide ring was installed in the 
final stages of the synthesis via the Sharpless asymmetric epoxidation (Figure 3). 
                                                 
11 (a) Ghosh, A. K.; Wang, Y.  J. Am. Chem. Soc. 2000, 122, 11027.  (b) Paterson, I.; Savi, C. D.; Tudge, M.  Org. 
Lett. 2001, 3, 3149.  (c) Enev, V. S.; Kaehlig, H.; Mulzer, J.  J. Am. Chem. Soc. 2001, 123, 10764.  (d) Mulzer, J.; 
Öhler, E. Angew. Chem., Int. Ed. 2001, 40, 3842.  (e) Mulzer, J.; Hanbauer, M. Tetrahedron Lett. 2002, 43, 3381.  
(f) Ahmed, A.; Hoegenauer, E. K.; Enev, V. E.; Hanbauer, J. Kahlig, H.; Öhler, E.; Mulzer, J. J. Org. Chem. 2003, 
68, 3026.  (g) Mulzer, J.; Öhler, E. Chem. Rev. 2003, 103, 3753.  (h) Ghosh, A. K.; Wang, Y.; Kim, J. J. Org. Chem. 
2001, 66, 8973.  (i) Wender, P. A.; Hedge, S. G.; Hubbard, R. D.; Zhang, L. J. Am. Chem. Soc. 2002, 124, 4956.  (j) 
Crimmins, M. T.; Stanton, M. G.; Allwein, S. P.  J. Am. Chem. Soc. 2002, 124, 5958.  (k) Williams, D. R.; Mi, L.; 
Mullins, R. J. Stites, R. E. Tetrahedron Lett. 2002, 43, 4841. 
12 (a)Shimizu, A.; Nishiyama, S. Tetrahedron Lett. 1997, 38, 6011.  (b) Shimizu, A.; Nishiyama, S.  Synlett. 1998, 
1209.  (c) Ghosh, A. K.; Mathivanan, P.; Cappiello, J. Tetrahedron Lett. 1997, 38, 2427.  (d) Ghosh, A. K.; Wang, 
Y. Tetrahedron Lett. 2000, 41, 2319.  (e) Mulzer, J; Hanbauer, M.  Tetrahedron Lett. 2000, 41, 33. (f) Dorling, E. 
K.; Öhler, E.; Mulzer, J.  Tetrahedron Lett. 2000, 41, 6323. (g) Dorling, E. K.; Öhler, E.; Mantouidis, A.; Mulzer, J.  
Synlett. 2001, 1105.    (h) Nadolski, G. T.; Davidson, B. S.  Tetrahedron Lett. 2001, 42, 797. (i) Messenger, B. T.; 
Davidson, B. S.  Tetrahedron Lett. 2001, 42, 801.   
13 Still, W. C.; Gennari, C.; Tetrahedron Lett. 1983, 24, 4405. 
14 Grubbs, R. H.; Chang, S.  Tetrahedron, 1998, 54, 4413, and references therein. 
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 Ghosh et al. later reported a modified approach to (–)-laulimalide that incorporated an 
improved method for macrocycle construction (Figure 4).15  Following the fragment uniting Julia 
olefination reaction between major subunits 4 and 5 employed in the original total synthesis of 1, 
Ghosh elected to pursue the Yamaguchi macrolactonization of hydroxy alkynoic acid 8 to close 
the 18-membered ring.  Subsequent Z-enoate ester installation was achieved by Lindlar reduction 
of the C2–C3 triple bond to furnish a highly functionalized laulimalide precursor. 
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Figure 3.  Retrosynthesis of (–)-laulimalide:  Ghosh approach 
 
                                                 
15 Ghosh, A. K.; Wang, Y.; Kim, J. T. J. Org. Chem. 2001, 66, 8973. 
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Figure 4.  Revised Ghosh Retrosynthesis 
 
 
Shortly after Ghosh and Wang published their first total synthesis of (–)-laulimalide, 
Paterson11b disclosed a second approach to the potent, microtubule-stabilizing natural product 
(Figure 5).  Paterson’s approach relied on his previously developed asymmetric aldol 
methodology employing chiral diisopinocampheyl-boron enolates.16  This methodology is used 
to achieve the C14–C15 bond formation between fragments 10 and 11 as well as in the preparation 
of the dihydropyran ring in fragment 11.17 The side chain dihydropyran fragment 12 was 
prepared in highly enantioenriched form via a hetero-Diels-Alder reaction using Jacobsen’s 
chiral tridentate Cr (III) catalyst 14.18  In the late stages of the synthesis, a Mitsunobu 
macrolactonization protocol was required to complete the macrolide in order to preserve the 
                                                 
16(a) Paterson, I.; Lister, M. A.; McClure, C. K.  Tetrahedron Lett. 1986, 27, 4787.  (b) Paterson, I; Goodman, J. M.; 
Lister, M. A.; Schumann, R. C.; McClure, C. K.; Norcross, R. D.  Tetrahedron Lett. 1990, 46, 4663. 
17 Paterson, I. and  Smith, J. D.  Tetrahedron Lett. 1993, 34, 5351. 
18Dossetter, A. G; Jamison, T.; Jacobsen, E. N.  Angew. Chem., Int. Ed. Engl. 1999, 38, 2398.  
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 integrity of the Z-enoate ester due to undesired scrambling of the olefin geometry at C2–C3 under 
traditional based-mediated macrolactonization conditions.6    
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Figure 5.  Retrosynthesis of (–)-Laulimalide:  Paterson Approach 
 
 
For Mulzer and coworkers, the total synthesis of (–)-laulimalide has been the subject of 
intense study since 1999.  A total of three different approaches to the synthesis of 1 have been 
achieved in the Mulzer laboratories.11c-e   In perhaps the most elegant of these strategies, a highly 
selective Still-Gennari coupling between the C3 aldehyde in fragment 15 and the C19 
phosphonoacetate in fragment 16 established the Z-enoate linkage.  Subsequent macrolide ring 
 8
 closure was accomplished with an unprecedented allylsilane addition into a chiral acetal moiety 
in 16 derived from (2R, 4R)-(–)-pentanediol.  This is reported as being the first example of 
macrocycle formation by an allyl transfer reaction.  As in Ghosh’s approach, dihydropyran ring 
formation in subunits 15 and 17 was achieved by ring-closing metathesis using Grubbs’ catalyst 
(Figure 6). 
 
 
O
O
OMOM
Me
H
CHOO
OTBDPS
O
Me
H
O
H H
O O
O
Me
HH
OH
O
OH
O
Me
H
O
O
O
O
P(O)(OCH2CF3)2
P
O
MeO
MeO
OTHP
H
TMS
Me
Allylsilane Addition
Still-Gennari Coupling
1 16
15
17
18
 
Figure 6.  Retrosynthesis of (–)-Laulimalide:  Mulzer Approach 
 
 
 In 2002, several total syntheses of (–)-laulimalide were completed in close succession 
beginning with a highly convergent route published by Wender (Figure 7).  Analysis of 
Wender’s synthesis reveals major fragments 19 and 20.  In the formation of the 18-membered 
macrolactone, Yamamoto’s (acyloxy)-borane 2119 was employed to effect an intermolecular 
asymmetric Sakurai reaction uniting allylsilane 20 and aldehyde 19 with concomitant 
establishment of the C15 stereocenter.  Wender then relied on a highly regioselective Yamaguchi 
                                                 
19 Ishihara, K.; Mouri, M.; Gao, Q.; Maruyama, T.; Furuta, K.; Yamamoto, H. J. Am. Chem. Soc. 1993, 115, 11490.  
 9
 macrolactonization of an alkynoic acid onto the unprotected C19, C20-diol to deliver the intact 
macrolide.  Desymmetrization of commercially available isopropylidene tartrate led to α-chiral 
aldehyde 22, while asymmetric hetero-Diels-Alder technology using Jacobsen’s (S, S)-Cr-salen 
catalyst 2420 and Mikami’s (S)-BINOL-TiCl2 system 2521 provided dihydropyran subunits 20 
and 23, respectively. 
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Figure 7.  Retrosynthesis of (–)-Laulimalide:  Wender Approach 
                                                 
20 Schaus, S. E.; Branalt, J.; Jacobsen, E. N. J. Org. Chem. 1998, 63, 403. 
21 Terada, M.; Mikami, K. J. Chem. Soc., Chem. Commun. 1995, 2391. 
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  Up to this point, the C16–C17 epoxide of (–)-laulimalide was viewed as an extremely 
sensitive functional group that warranted its installation very late, if not in the final step of all 
previously reported total syntheses.  This notion was challenged in Crimmins’ approach to 
laulimalide where the sensitive epoxide moiety was introduced at a much earlier stage in the 
synthesis.10f Fragment union and macrolide formation was accomplished with a 
diastereoselective allylstannane addition between the C1–C14 fragment 26 and the epoxide 
containing C15–C27 subunit 27, followed by a Mitsunobu macrolactonization of seco acid 28 to 
preserve the integrity of the (Z)-enoate ester linkage (Figure 8).  To establish elements of 
stereochemistry in each of the three major fragments 26, 29, and 30, Crimmins relied heavily on 
his previously developed asymmetric alkylation methodology employing chiral oxazolidinone 
glycolates.22
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Figure 8.  Retrosynthesis of (–)-Laulimalide:  Crimmins Approach 
 
                                                 
22 Crimmins, M. T.; Emmitte, K. A.; Katz, J. D. Org. Lett. 2000, 2, 2165. 
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 In the most recently reported total synthesis of (–)-laulimalide, Williams described a 
highly diastereoselective coupling of allylsilane fragment 31 and Crimmins’ epoxyaldehyde 27.  
Subunit 27 was constructed through a chelation-controlled addition of E-alkenyl zincate 32 to α-
alkoxyaldehyde 33 followed by Grubbs’ ring-closing metathesis to form the requisite 
dihydropyran side chain.   A novel allenylstannane Ferrier reaction between 34 and glycal 
acetate 35 was employed to directly install the C1–C4 propargylic sidearm necessary for the safe 
installation of the required C2–C3 Z-olefin via the Yamaguchi macrolactonization and subsequent 
Lindlar reduction protocol initially described by Ghosh and coworkers (Figure 9).  
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Figure 9.  Retrosynthesis of (–)-Laulimalide:  Williams Approach 
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 1.2 AAC REACTION TECHNOLOGY IN THE TOTAL SYNTHESIS OF (–)-
LAULIMALIDE 
 
Methodology developed recently in our research group encouraged our pursuit of the total 
synthesis of (–)-laulimalide.  Catalytic, asymmetric acyl halide-aldehyde cyclocondensation 
(AAC) reaction technology allows for the efficient preparation of masked aldol products in the 
form of β-lactones from a wide variety of aldehydes (Equation 1).  Employing substoichiometric 
amounts (10-15 mol %) of a chiral aluminum triamine catalyst 36, a variety of enantiomerically 
enriched β-lactones have been produced, making these synthons readily available and easily 
prepared for use in synthesis endeavors. 23
 
 
O
O
R
H R
O
Me Br
O
+ DIPEA, Catalyst, 36
CH2Cl2, -50 °C
74-93% yield
  89-92% ee
(1)
N
N
NAl
SO2CF3F3CSO2
Bn
Me
AAC Catalyst 36
 
 
Enantioenriched β-lactones are useful building blocks in organic synthesis due to their 
unique electrophilicity (Figure 10).24 By exploiting the reactivity of these β-lactone templates, 
synthetic and stereochemical challenges associated with the total synthesis of (–)-laulimalide can 
be addressed.  For example, the creation of hydroxyl-bearing stereocenters, a prominent 
architectural feature of laulimalide, can be accomplished by the addition of hard nucleophiles 
                                                 
23 (a) Nelson, S. G.; Peelen, T. J.; Wan, Z.  J. Am. Chem. Soc. 1999, 121, 9742. (b) Nelson, S. G.; Kim, B. K.; 
Peelen, T. J.  J. Am. Chem. Soc. 2000, 122, 9318.  (c) Wan, Z.; Nelson, S. G.  J. Am. Chem. Soc. 2000, 122, 10470. 
24 Pommier, A.; Pons, J.-M. Synthesis 1993, 441. 
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 such as alkoxides, alkyl Grignard reagents, and metal amide species into the carbonyl of the β-
lactone.25  Installing alkyl-bearing stereocenters, such as the methyl-bearing stereocenter at C11 
of laulimalide, can be achieved by utilizing soft nucleophiles.   Dialkylcuprate reagents undergo 
nucleophilic attack in an SN2 fashion at the C4 position of the lactone to generate optically active 
β-disubstituted carboxylic acids.26 Use of the asymmetric AAC reaction in an iterative fashion 
leads to the formation of 1,3-stereochemical relationships, yet another important structural 
feature in our planned total synthesis.  It was therefore speculated that the versatile reactivity 
demonstrated by enantiomerically enriched β-lactones would provide a novel and efficient 
approach to the total synthesis of (–)-laulimalide.    
                                                        
                                                                                                                     
Hard Nucleophiles
O
O
R
Nuc
Nuc R
O OH
Soft Nucleophiles
HO R
O Nuc
 (RMgX, R2NM, RO-)(R2CuLi, N3
-, RCOO-)
1,3 Stereochemical 
Relationships
H R
MeO
R
MeO
O
X R
O Me
Nuc
Acetate aldol adductsβ-Disubstituted carboxylic acids
AAC
X = Nuc, OH
 
Figure 10.  Accessible Structural Motifs from Enantiomerically Enriched β-Lactones 
                                                 
25 (a) Nelson, S. G.; Wan, Z.; Peelen, T. J.; Spencer, K. L. Tetrahedron Lett. 1999, 40, 6535.  (b) Stuckwisch, C. G.; 
Bailey, J. V. J. Org. Chem. 1963, 28, 2362.  (c) Gresham, T. L.; Jansen, J. E. Shaver, F. W.; Bankert, R. A. J. Am. 
Chem. Soc. 1949, 71, 2807. 
26 (a) Sato, T.; Kawara, T.; Kawashima, M.; Fujisawa, T.  Chem. Lett. 1980, 571.  (b) Sato, T.; Kawara, T.; 
Nishizawa, A.; Fujisawa, T. Tetrahedron Lett. 1980, 21, 3377. (c) Fujisawa, T.; Sato, T.; Kawara, T.; Ohashi, K. 
Tetrahedron Lett. 1981, 22, 4823.  (d) Sato, T.; Naruse, K.; Fujisawa, T. Tetrahedron Lett. 1982, 23, 3587.  (e) Sato, 
T.; Itoh, T.; Hattori, C.; Fujisawa, T. Chem. Lett. 1983, 1391.  (f) Kawashima, M.; Sato, T.; Fujisawa, T. 
Tetrahedron 1989, 45, 403. 
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 1.3 RETROSYNTHETIC ANALYSIS 
 
Our original retrosynthetic approach to (–)-laulimalide is outlined in Figure 11.  Removal of the 
C16–C17 epoxide followed by a disconnection at C20–C21 via a diastereoselective vinyl metal 
addition would deliver dihydropyran subunit 37 along with the highly functionalized macrocycle 
38.  Construction of 38 would be accomplished through propargylic acid esterification and 
subsequent intramolecular asymmetric allylsilane addition of the lower C1–C14 dihydropyran 
fragment 39 and the C15–C20 α,β-unsaturated aldehyde 40.  Stereoselective synthesis of 
fragments 39 and 40 was predicated on exploiting the unique reactivity demonstrated by the 
enantiomerically enriched β-lactone products of AAC reaction technology. 
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Figure 11.  Retrosynthesis of (–)-Laulimalide:  Nelson Approach 
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 1.4 THE C1–C14 DIHYDROPYRAN FRAGMENT 
 
1.4.1 Retrosynthetic Analysis 
 
 
Through further retrosynthetic analysis of the lower dihydropyran fragment 39, we recognized 
the potential for applying AAC-based reaction technology and developing new methods for 
addressing key synthetic challenges (Figure 12).  We had envisaged the novel stereoselective 
installation of the entire C1–C4 ynoate ester sidearm of 39 occurring via a Lewis acid-mediated 
allenylstannane addition of 41 to glycal acetate 42.27  Glycal 42 would be readily accessible 
through the typical 1,2-reduction and acylation sequence available to the corresponding 
dihydropyranone 43.  Preparation of 43 was then anticipated from the regioselective ring opening 
of β-lactone 44 with subsequent acid- mediated cyclization and elimination.  
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Figure 12.  Retrosynthetic Approach to the C1–C14 fragment of (–)-laulimalide 
 
                                                 
27 For a similar approach to this bond construction see ref 11k.  
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 1.4.2 First Generation Synthesis of the C1–C14 Fragment of (–)-Laulimalide 
 
 
The synthesis of the C1–C14 fragment of (–)-laulimalide (Scheme 1) began from the known 
aldehyde 45.28  Lactone 46 was prepared in 97% yield from aldehyde 45 under standard 
asymmetric AAC conditions (AcBr, iPr2NEt, CH2Cl2, –50 °C) employing 10 mol % of the S,S 
Al(III)-triamine catalyst 36 and was recrystallized to high enantiopurity (98% ee).  
Regioselective SN2 ring opening of 46 to the carboxylic acid via dimethylmagnesiocuprate 
addition (80% yield) efficiently set the requisite methyl-bearing C11 stereocenter.  Acid 47 was 
then converted to methyl ester 48 (DCC, DMAP, MeOH) in 86% yield.  Treating ester 48 with 
an excess of an organocerium reagent derived from CeCl3 and trimethylsilylmethylmagnesium 
chloride (TMSCH2MgCl) delivered the corresponding allylsilane 49.29  
 
Scheme 1.  Synthesis of Allylsilane 49a 
 
O
H
O
O
aConditions:  a) 10 mol% Catalyst 2, AcBr, DIPEA, CH2Cl2, –50 °C.  b) 
CuBr, MeMgBr, TMSCl, THF/DMS, –50 °C to rt. c) DCC, DMAP,
MeOH.  d) CeCl3, TMSCH2MgCl, THF, –78 °C to rt.
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28 Aldehyde 36 was prepared by ozonolysis of 3-(tert-butyldiphenylsilyloxy)-1-butene.  See Boeckman, R. K., Jr.; 
Charette, A. B.; Asberom, T.; Johnston, B. H.  J. Am. Chem. Soc. 1991, 113, 5337. 
29 Narayanan, B. A. and Bunnelle, W. H.  Tetrahedron Lett. 1987, 28, 6261. 
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 Further elaborating allylsilane 49 to the target molecule 39 required its transformation 
into lactone 44 (Eq 2).  The aldehyde 52 required for generating 44 was to be produced by silyl 
deprotection and oxidation of 49 (Scheme 2).  Treatment of silane 49 with tetra-n-
butylammonium fluoride (TBAF) resulted in the cleavage of the TBDPS ether in forming 
alcohol 51 (83% yield); however, oxidation with tetra-n-propylammonium perruthenate (TPAP, 
NMO, 4Å molecular sieves) afforded none of the desired aldehyde product 52.  Additional 
attempts to oxidize the primary alcohol employing Swern conditions30 and Dess-Martin 
periodinane31 were also unsuccessful. This problem was circumvented by removal of the 
trimethylsilyl (TMS) group with Amberlyst-15 resin in THF to form 53, although loss of the 
allylsilane at this stage now required a new approach for the coupling of major fragments 39 and 
40.  Silyl deprotection and subsequent TPAP oxidation provided the volatile aldehyde 50 in 79% 
yield from silyl ether 49.  
 
Scheme 2.  Preparation of AAC-Precursor 50a 
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30 (a) Swern, D.  J. Org. Chem. 1976, 41, 3329-3331. (b) Swern, D.  J. Org. Chem. 1978, 43, 2480.  (c) Swern, 
Synthesis. 1978, 297. 
31 (a) Dess, P. B.; Martin , J. C.  J. Am. Chem. Soc. 1978, 100, 300.  (b)   Dess, P. B.; Martin , J. C.  J. Am. Chem. 
Soc. 1979, 101, 5294.  (c) Dess, P. B.; Martin , J. C.  J. Org. Chem. 1983, 48, 4155. 
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 Aldehyde 50 was then used as the coupling partner in a second AAC reaction.   
Subjecting aldehyde 50 to standard AAC reaction conditions (AcBr, iPr2NEt, CH2Cl2, –50 °C) 
employing 10 mol% of the (R, R) aluminum-triamine catalyst ent-36 furnished lactone 55 as a 
91:9 mixture of (2′S,4R):(2′S,4S) diastereomers based on 1H NMR analysis (500 MHz).  
Unfortunately, intermediate 55 also proved to be very volatile and attempts to completely 
remove solvent from the product resulted in the substantial loss of material.  After separation of 
the lactone diastereomers by column chromatography, steps were taken to convert 55 to the 
requisite dihydropyranone. 
 
H Me
O Me O
O
Me
Me
50 55
dr  = 91:9
10 mol% Catalyst ent-36, 
AcBr, DIPEA
CH2Cl2, –50 °C.
(2)
 
 
 
We envisioned a possible synthetic route to dihydropyranones from simple 
enantiomerically enriched β-lactone precursors.  The initial strategy for arriving at these 
pyranone intermediates involved the direct nucleophilic addition of vinyl anions of type 56 into 
β-lactones (Figure 13).  These hard nucleophiles would preferentially add into the carbonyl of 
the lactone with subsequent ring opening to produce the corresponding enol ether 57. Under 
acidic conditions, this enol ether would hydrolyze to the β-ketoaldehyde 58 with probable 
cyclization to form hemiacetal 59.  Subsequent dehydration would then provide the desired 
dihydropyranone product 60. 
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Figure 13.  Pyranone Formation Via Direct Vinyl Anion Addition to β-Lactones 
 
 
 To explore the feasibility of this direct vinyl anion addition route, a model study was 
undertaken employing (4S)-4-phenethyloxetan-2-one 61 (Eq 3).23a Metallating (Z)-1-ethoxy-2-
tributylstannylethylene 6232 with n-butyllithium afforded vinyl anion 6333 which was then slowly 
treated with β-lactone 61. The desired product 64 was obtained as an approximately 3:1 mixture 
of cis/trans vinyl ether isomers in a combined 23% yield, along with many unidentifiable 
products.  Transmetallation of the reactive organolithium species 63 to the corresponding 
Grignard and organocerium reagents afforded similar mixtures of olefin isomers but in slightly 
lower yields (18%).  Forming the cuprate of the organolithium species provided compound 64 
again in low yield (15%).  Despite these low yields, it was discovered that, upon standing at 
ambient temperature, the enol ether intermediate does cyclize to the desired pyranone product 
65, proving the viability of the route; however, extensive optimization was necessary to achieve 
synthetically useful chemical yields.  
                                                 
32 Prepared by the hydrostannylation of ethyl ethynyl ether.  See:  Leusink, A. J.; Budding, A.; Marsman, J. W.  J. 
Organometal. Chem. 1967, 9, 285, 294. 
33 (a) Wollenberg, R. H.; Albizati, K. F.; Peries, R. J. Am. Chem. Soc. 1977, 99, 7365.  (b) Ficini, J.; Falou, S.; 
Touzin, A. M.; d’Angelo, J. Tetrahedron Lett. 1977, 3589.  
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 Due to the unsatisfactory results obtained from the direct addition of vinyl anions to β-
lactones, a modified strategy to achieve pyranone formation was devised (Scheme 3).  Prior ring 
opening of the β-lactone to a species more tolerant of the reaction conditions followed by vinyl 
anion addition was anticipated to result in higher yields.  To test this strategy, Weinreb amide 66 
was prepared from the corresponding β-lactone in 98% yield under conditions developed by 
Shimizu and Nakata.34  Protection of the resulting secondary alcohol with N,O-
bis(trimethylsilyl)acetamide (BSA) afforded the TMS-protected Weinreb amide 67 in 89% 
isolated yield.  Subjecting amide 67 to lithium anion 63 at –78 °C provided enol ether 68 as a 
mixture of cis/trans isomers (15:1) in a combined 65% yield.  In subsequent experiments, the 
enol ether was not isolated but, rather, was dissolved in tetrahydrofuran (THF), treated with 
Amberlyst-15 ion exchange resin (100 mass%), and maintained at ambient temperature overnight 
to effect the acid-mediated cyclization.  After purification, dihydropyran 65 was obtained in 76% 
overall yield from amide 67.   
 
 
 
 
 
 
 
 
                                                 
34 Shimizu, T.; Osako, K.; Nakata, T.  Tetrahedron Lett. 1997, 38, 2685. 
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 Scheme 3.  Lactone to Dihydropyranone Interconversiona 
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Using this strategy, lactone 55 was efficiently converted to Weinreb amide 69 by ring 
opening with the aluminum-amide species derived from N, O-dimethylhydroxylamine and 
dimethylaluminum chloride (Scheme 4).  Amide 69 was then treated with N, O-
bis(trimethylsilyl)acetamide (BSA) providing the corresponding TMS ether 70 in 90% yield.   
The resulting β-siloxyamide 70 was subjected to the cis-ethoxyvinyllithium-mediated protocol 
for pyranone synthesis and the resulting mixture of enones 71 was then treated with 100 mass % 
of Amberlyst-15 resin in THF at ambient temperature to effect the cyclization to pyranone 72 in 
good yield (72% from amide 70).  
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 Scheme 4.  Synthesis of Dihydropyranone 72a
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Having arrived at a working synthetic route to the desired dihydropyranone intermediate 
72, we next initiated model studies focused on installing the ynoate ester sidearm of the C1–C14 
fragment.  A Lewis acid-mediated allenylstannane addition of reagent 41 into glycal acetates 
derived from the corresponding pyranone intermediates was an intriguing possibility (Scheme 5).  
 
 
Scheme 5.  Proposed Lewis Acid Activated Allenylstannane Addition of C1–C4 laulimalide 
sidechain 
O
O
R O R
OAc
•
tBuO2C
Bu3Sn O R
tBuO2C
laulimalide
 sidechain
Lewis Acid
41
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 The requisite allenylstannane reagent 41 for exploring this strategy was previously unreported; 
however, there were several examples of similar compounds in the literature that instilled 
confidence in achieving the desired reactivity with glycal acetate intermediates.  For example, 
Danishefsky has demonstrated, under appropriately Lewis acidic conditions, that allylsilanes 
serve as good nucleophiles for the regio- and stereoselective addition into glycal acetates to 
provide 2,6-trans-disubstituted dihydropyran rings (Eq 4).35  Additionally, synthetic studies by 
Marshall have shown that allenylstannane reagents are capable of Lewis acid-mediated 
nucleophilic addition into aldehydes, affording the corresponding homopropargylic alcohol 
adducts (Eq 5).36  Based on these precedents, the successful nucleophilic addition of 
allenylstannane 41 to glycal acetates was anticipated. 
 
 
O R
OAc
TMS
Lewis Acid
O R
(4)
 
 
•
Bu3Sn
AcO
Lewis Acid
RCHO
AcO
OH
R
(5)
 
 
 
 
To examine the proposed nucleophilic allenylstannane addition, model glycal acetate 73 
as well as stannane reagent 41 was prepared.  Glycal acetate 73 was synthesized via a standard 
two step reaction sequence involving the reduction of pyranone 65 under Luche conditions37 
                                                 
35 Danishefsky, S.; Kerwin, J.  J. Org. Chem. 1982, 47, 3803. 
36 (a) Marshall, J.; Wang, X.  J. Org. Chem. 1990, 55, 6246.  (b) Marshall, J.; Wang, X.  J. Org. Chem. 1991, 56, 
3211.  (c) Marshall, J.  Chem. Rev. 1996, 96, 31. 
37 Gemal, A. L.; Luche, J. L.  J. Am. Chem. Soc. 1981, 103, 5454. 
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 (CeCl3•7H2O, NaBH4) with subsequent protection of the resulting allylic alcohol as the 
corresponding acetate to furnish glycal acetate 73 in 90-93% overall yield (Eq 6).38   
 
 
O
O
Ph
H 1)  CeCl3•7H2O
     NaBH4
O Ph
H
OAc
2)  Ac2O, Et3N, DMAP
65 73
(90-93%)
(6)
 
 
 
 
The synthesis of allenylstannane 41, as depicted in Scheme 6, commenced with the acid-
catalyzed esterification of commercially available 2-butynoic acid (H2SO4, isobutylene) to afford 
the desired tert-butyl ester 74 in good yield.  Deprotonation of 74 with LDA at –78 °C followed 
by quenching with nBu3SnCl then furnished allenylstannane 41 (25-38%).  These modest isolated 
yields have recently been attributed to the original preparation of 41 in which nBu3SnCl was 
added dropwise to a solution of enolate 75.    Under such reaction conditions, the potential 
Michael accepting product 41, was generated in the presence of excess nucleophile leading to an 
increased propensity for anionic polymerization.  Upon addition of the electrophile, the solution 
became deep red in color indicative of the presence of a highly conjugated species.  A reverse 
addition of enolate to electrophile at low temperature was envisioned to prevent the undesired 
Michael addition and increase the isolated yield of the allenylstannane 41.39  Indeed, reverse 
addition of nucleophile to electrophile proved to be the most effective method for enolate 
quenching as it cleanly afforded 41 in 75% yield. 
 
                                                 
38 Due to the high acid sensitivity of 73, purification was performed by flash chromatography on deactivated silica 
gel eluting with hexanes/Et3N (50:1).   
39 Optimization was performed by Dr. Junfa Fan (Postdoctoral fellow, Department of Chemistry, Univeristy of 
Pittsburgh). 
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 Scheme 6.  Synthesis of Allenylstannane 41a
•
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aConditions:  (a) isobutylene, H2SO4.  (b) i.  LDA, THF, –78 °C, 
ii. nBuSnCl.
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With model glycal acetate 73 and allenylstannane 41 in hand, a variety of Lewis acids 
were screened to establish the optimal reaction conditions for effecting the introduction of the 
requisite ynoate ester sidechain (Table 1).  Treatment of a –78 °C methylene chloride solution of 
acetate 73 and stannane 41 (2.2 equiv) with stoichiometric Lewis acids was envisioned to result 
in nucleophilic attack of 41 at C6 of glycal 73 with concomitant elimination of acetate to form 76 
(Eq 4).  Boron trifluoride diethyletherate provided the desired 2,6-dihydropyran product 76, but 
in modest yield (38%).  Montmorillonite K10 clay was also employed to mediate the reaction 
between glycal acetate 73 and allenylstannane 41; however, a yield of only 33% was achieved.  
Reactions with titanium-based Lewis acids afforded only moderate reactivity (entries c-e).  The 
low isolated yields of 76 obtained in these reactions prompted the investigation of other means of 
promoting this transformation 
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 Table 1.  Lewis Acid Activated Allenylstannane Additions to Glycal Acetates 
 
     Conditions
 
1.1 equiv, –78 °C
100 mass %, –78 °C 
1.1 equiv, –78 °C  
1.1 equiv, –78 °C 
1.1 equiv, –78 °C
Yield (%)a
38 
33
45
Lewis Acid
BF3•OEt2
Montmorillonite K10
TiCl4
entry
a
b
c
d
e
O
OAc
H
Ph
+
Lewis Acid O
H
Ph
H
•
tBuO2C
Bu3Sn
(2.2 equiv.)
CH2Cl2 76
)
35TiCl2(OiPr)2b
TiCl4(THF)2 40
f SnCl4b 201.1 equiv, –78 °C
BuO2Ct
 
aIsolated yields of purified products.  bAddition of glycal acetate to allene/Lewis acid. 
 
 
 
A similar reaction involving Lewis acid mediated allylstannane addition into glycal 
epoxides was recently described in Evans’ total synthesis of altohyrtin C (Eq 7).40  This 
nucleophilic addition sequence utilized various silyl and stannyl triflate Lewis acids for the 
introduction of propenyl sidechains into glycal epoxides in moderate to good yield (51-63%).  
These results led to the examination of silyl and stannyl triflate Lewis acids in the context of our 
allenylstannane addition reactions.   
                                                 
40 Evans, D. A.; Trotter, B. W.; Coleman, P. J.; Cote, B.; Dias, L. C.; Rajapakse, H. A.; Tyler, N. A.  Tetrahedron 
1999, 55, 8671. 
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OBn
OBn
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Initial attempts to promote the allenylstannane addition to glycal acetate 73 under the 
silyl triflate conditions afforded the desired product 76 in yields higher than those observed in 
previous investigations (Table 2).  Use of trimethylsilyl triflate generated propargyl ester 76 in 
56% yield while treatment with triethylsilyl triflate afforded the desired dihydropyran product in 
63% yield.  Additional trials with triisopropylsilyl triflate were comparable to earlier studies 
where titanium(IV)-based Lewis acids were employed (40%).  However, tributyltin triflate 
proved to be the optimal Lewis acid for the nucleophilic addition of allenylstannane 41 into 
glycal acetate 73, furnishing dihydropyran 76 in 65% yield.   
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 Table 2.  Lewis Acid Activated Allenylstannane Addition to Glycal Acetate 
 
     Conditions
 
1.1 equiv, –78 °C
1.1 equiv, –78 °C 
1.1 equiv, –78 °C  
1.1 equiv, –78 °C 
1.1 equiv, –78 °C
Yield (%)a
56 
63
40
65
75
a Isolated yields of purified products.  b Reaction was performed using 5.0 equiv of the 
allenylstannane reagent and warmed slowly to ambient temperature.
Lewis Acid
TMSOTf
TESOTf
TIPSOTf
nBu3SnOTfb
nBu3SnOTf
entry
a
b
c
d
e
O
OAc
H
Ph
+
Lewis Acid O
H
Ph
H
•
tBuO2C
Bu3Sn
(2.2 equiv)
CH2Cl2 tBuO2C 76
 
 
 
 
Due to the previously experienced acid sensitivity of glycal acetates,38 we hypothesized 
that the lower isolated yields of 76 resulted from the undesired decomposition of 73 prior to 
allenylstannane addition.  We envisioned that excess tin reagent would intercept the glycal 
acetate electrophile prior to its participation in destructive side reactions.  To test this hypothesis, 
a large excess (5.0 equiv) of the allenylstannane reagent 41 was employed in the nBuSnOTf-
mediated addition reaction.  The desired adduct 76 was now obtained as a single diastereomer in 
75% yield.  
We were now prepared to introduce the ynoate ester sidechain of the C1–C14 fragment of 
1 employing the optimized conditions for nucleophilic allenylstannane addition.  Glycal acetate 
77, prepared according to the reaction sequence outlined in Eq 6, and allenylstannane 41 were 
cooled to –78 °C and slowly treated with 1.1 equiv of nBu3SnOTf.  Upon warming the reaction to 
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 ambient temperature, the C1–C4 α, β-unsaturated ester sidearm of (–)-laulimalide was efficiently 
installed in one step in 71% yield completing fragment 78 (Eq 8).  The trans-substitution across 
the dihydropyran ring was confirmed by a 2D-NOESY spectrum (Figure 14) in which a cross-
peak between H9 and the C4 methylene was observed.  Additionally, the absence of a cross-peak 
between H5 and H9 provided further evidence for a 2,6-trans arrangement of ring substituents. 
 
 
O
H
OAc 77
+
O•
tBuO2C
Bu3Sn CH2Cl2 tBuO2C
(8)
H H
41
78
71%
Bu3SnOTf
Me Me
n
Me Me
 
 
 
 
1.5 FRAGMENT UNION AND MACROLIDE FORMATION 
 
According to the retrosynthetic strategy outlined in Figure 11, assembly of the asymmetric ene 
precursor 79 required first formatting dihydropyran subunit 78 as the corresponding carboxylic 
acid.  After a brief survey of reaction conditions for the deprotection of tert-butyl esters, 
TMSOTf and 2,6-lutidine was identified as a suitable reagent system, cleanly affording 
carboxylic acid 80 in 90% yield.  Acid 80 and alcohol 81 were then united through a 
carbodiimide coupling reaction (DCC, DMAP) to generate ester 82 in moderate yield (31%).  
Subjecting the coupled product 82 to 2% triflic acid (TfOH) in CHCl3/MeOH (7:3) resulted in 
trityl ether deprotection providing allylic alcohol 83 which was then oxidized to the requisite α, 
β-unsaturated aldehyde substrate for intramolecular ene macrocyclization (Scheme 7).  
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 Scheme 7.  Synthesis of Ene Substrate 79a 
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Figure 14.  1H 2D-NOESY NMR Spectrum of Dihydropyran 78 (500 MHz) 
 
 
 
 
 32
  The synthesis at this stage had arrived at the critical intramolecular ene macrocyclization 
event (Eq 9).  We sought to construct the C14–C15 bond and concomitantly establish the requisite 
C15 hydroxyl-bearing stereocenter under reaction conditions described by Mikami for the 
intermolecular ene reaction of olefins and activated glyoxylate electrophiles.41  Employing 
Mikami’s protocol, a –78 °C solution of Ti(IV)-(S)-(–)-BINOL catalyst was treated with the enal 
substrate 79.  No reaction was observed by TLC analysis after 2 h at –78 °C and, as a result, the 
reaction was allowed to warm slowly to ambient temperature while being carefully monitored by 
TLC.  Even after being maintained for several hours at ambient temperature, no product 
formation was observed.   Unfortunately, the electrophilic aldehyde portion of ene substrate 79 
proved to be insufficiently activated to achieve the desired bond construction.   
 
79
O
H H
MeO
O
OTBDPS
OH
O
H H
MeO
O
OTBDPS
CHO
Me
 (iPrO)2TiCl2
(S)-(–)-BINOL
4Å MS, CH2Cl2
(9)
84  
 
 
 
 Despite our inability to close the macrocycle through an intramolecular ene reaction, the 
previously described synthetic route provided a suitable arena for the evaluation of catalytic, 
asymmetric AAC reaction technology in complex molecule synthesis as well as the development 
of additional novel methodology aimed at addressing some of the key challenges in the synthesis 
of the lower C1–C14 fragment of (–)-laulimalide.  For example, a working synthetic route to 
useful dihydropyranone intermediates from enantiomerically enriched β-lactones was achieved.   
In addition, a novel, one-step installation of the C1–C4 ynoate ester sidechain of 78 was realized 
                                                 
41 Mikami, K.; Shimizu, M. Chem. Rev. 1992, 92, 1021, and references therein. 
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 via a Lewis acid-mediated allenylstannane addition to glycal acetate 73.  However, the present 
approach did suffer from several other problems.  Aldehyde 50 and lactone 55 were discovered 
to be rather volatile intermediates which hindered their preparation in large quantities.  
Additionally, although we had arrived at a route that accessed dihydropyranones from 
enantiomerically enriched β-lactone templates, we still desired a more direct strategy to 
streamline the current synthesis.  As a result, we elected to pursue an alternate route to the C1–
C14 fragment of (–)-laulimalide. 
 
 
1.6 REVISED RETROSYNTHETIC ANALYSIS 
 
Our revised retrosynthetic approach to (–)-laulimalide is illustrated in Figure 15.  Coupling of 
major fragments 85 and 86 was now envisioned to occur by an asymmetric aldol reaction 
between the C15 α,β-unsaturated aldehyde in fragment 85 and a suitable chiral enolate derived 
from the methyl ketone moiety in fragment 86.  To avoid the base- mediated scrambling of the 
Z-enoate ester linkage observed by Paterson, we would perform the requisite macrolactonization 
step on the corresponding propargylic carboxylic acid to close the 18-membered ring.  
Subsequent partial hydrogenation of the alkyne would unveil the sensitive Z-alkene.  As outlined 
in our initial strategy, the C1–C4 propargylic acid side arm would be installed via a Lewis acid-
mediated addition of allenylstannane 41 to glycal acetate 87 which in turn would be accessed 
through a dihydropyranone intermediate derived from the corresponding enantiomerically 
enriched β-lactone.  Completion of the upper fragment 85 and concomitant introduction of the 
C19,C20 syn-diol arrangment would be accomplished via a diastereoselective vinyl metal addition 
between an anion derived from dihydropyran subunit 88 and α-alkoxyaldehyde 89. 
 34
 O
OPMB
OTBS
Me
H
Me
O
H H
O
Me
CHO
BuO2Ct
85
86
O
OPMB
O
Me
H
H
O O
O
Me
HH
OH
O
OH
O
Me
H
Aldol
Macrolactonization
1
8988
OTr
I
O•
BuO2C
Bu3Sn
OAc
H
Me
41
87
Allenylstannane
Addition
Epoxidation
t
Me OTBDPS
Vinyl Metal Addition
 
Figure 15.  Revised Nelson Retrosynthesis 
 
 
 
1.7 SECOND GENERATION SYNTHESIS OF THE C1–C14 DIHYDROPYRAN 
FRAGMENT 
 
The synthesis of the lower C1–C14 dihydropyran subunit of (–)-laulimalide was initiated by an 
asymmetric AAC reaction with acetaldehyde (90) in the presence of tetrabutylammonium 
bromide at –78 °C to provide the known compound (S)-β-butyrolactone 91 in 86% yield and 
greater than 99% ee as determined by chiral GC analysis (Scheme 8).  Ring opening of 91 with 
N,O-dimethylhydroxylamine and dimethylaluminum chloride34 followed by protection of the 
resulting secondary alcohol as its tert-butyldiphenylsilyl ether furnished Weinreb amide 93 in 
77% overall yield from lactone 91.  Amide 93 was then efficiently reduced with 
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 diisobutylaluminum hydride (DIBAL-H) at –78 °C to deliver the corresponding β-
siloxyaldehyde 94 in excellent yield.   
 
Scheme 8.  Synthesis of β-Silyloxyaldehyde 94a 
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aConditions:  (a) Catalyst X, AcBr, DIPEA, Bu4NBr, 
CH2Cl2, –78 °C. (b) Me2AlCl, (MeO)MeNH·HCl, 
CH2Cl2.  (c) TBDPSCl, DIPEA, DMAP, CH2Cl2, rt. 
(d) DIBAL-H, Et2O, –78 °C.  
 
 
 
From our revised retrosynthesis, it can be seen that the silyl-protected secondary alcohol 
possessed by aldehyde 94 represents a latent C13 methyl ketone moiety anticipating the crucial 
asymmetric aldol reaction to unite major fragments 85 and 86.  Although this stereocenter would 
eventually be destroyed in the oxidative unmasking of the ketone, judicious choice of the 
absolute stereochemistry at this position is imperative as the iterative application of AAC 
reaction technology enters into the realm of double stereodifferentiation. 
 In double diastereodifferentiating reactions, both reacting partners (or one reacting 
partner and a catalyst) possess stereocontrolling elements. These chiral controllers can either 
interact favorably with one another in a “matched pair” to afford the desired product with 
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 enhanced selectivity or alternatively an unfavorable interaction can result leading to a 
“mismatched pair” and diminished levels of diastereoselectivity.42  Previous investigations from 
our group regarding the establishment of 1,3 stereochemical relationships via sequential AAC 
reactions have demonstrated the propensity of the chiral Al(III)-triamine catalyst 36 to exert a 
strong influence over the preexisting β-stereocenter in the aldehyde component of the reaction, 
leading to good to excellent levels of diastereoselectivity for both the “mismatched” and 
“matched” substrate/catalyst pairs, respectively.43  These observations have been rationalized by 
employing the following model (Figure 16).  In the matched AAC reaction of a β-chiral aldehdye 
containing an (S)-stereocenter and catalyst 36, the apically coordinated aldehyde adopts a 
conformation such that the β-methyl substituent orients itself away from the incoming ketene 
nucleophile.  This arrangment acts in concert with the stereocontrolling trifluoromethyl group 
present in the triamine backbone of 36 to further shield the Si diastereoface of the aldehyde 
resulting in excellent levels of diastereoselectivity (>94% de).  In contrast, when catalyst ent-36 
is employed, the corresponding mismatched case is obtained.  The methyl substituent of the β-
stereocenter is now directed toward the ketene nucleophile creating a more hindered approach to 
the Si face of the aldehyde electrophile.  Although the observed diastereoselection is lower in this 
case, it is still synthetically useful (>85% de). 
                                                 
42 Masamune, S.; Choy, W.; Petersen, J. S.; Sita, L. R. Angew. Chem. Int. Ed. Engl. 1985, 24, 1. 
43 For a more detailed discussion of double diastereodifferentiating AAC reactions, see Magdalena A. Stan Ph. D. 
thesis, University of Pittsburgh, 2003. 
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Figure 16.  Proposed Model for Observed Selectivity in Double Diastereodifferentiating AAC 
Reactions43
 
 
We sought to exploit this observation by establishing the C11 stereocenter in β-lactone 
intermediate 95 by iterative AAC application (Scheme 9). Unfortunately, subjecting aldehyde 94 
to standard AAC reaction conditions (AcBr, iPr2NEt, CH2Cl2, –50 °C) and employing 10 mol% 
of the necessary (R, R) aluminum-triamine catalyst ent-36 resulted in unexpectedly low levels of 
diastereoselection (60% de) along with poor yields, and undesirably long reaction times.   It 
appeared from this exceedingly apparent “mismatched” substrate/catalyst pairing that the 
sterically demanding tert-butyldiphenylsilyl protecting group was more capable of influencing 
the diastereoselectivity of the AAC reaction than in previously studied aldehydes.  Based on this 
outcome, we expected that performing the reaction with (S,S) catalyst 36 would result in much 
increased levels of diastereoselectivity and faster reaction time indicative of the matched pair.  
Indeed, this was the case as the combination of aldehyde 94 and 10 mol% of catalyst 36 at –50 
°C rapidly afforded syn-β-lactone 96 as a 97:3 mixture of (2′S,4S):(2′S:4R) diastereomers. 
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 Scheme 9.  Double Diastereodifferentiation in Iterative AAC Application 
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 Arriving at the desired 1,3-syn-β-lactone ent-96 necessary for (–)-laulimalide required 
the preparation of aldehyde ent-94 in the opposite enantiomeric series starting from (R)-β-
butyrolactone (Scheme 10).  Lactone ent-91 was obtained in identical yield as essentially a 
single enantiomer (99% ee), and application of the previously described three step sequence of 
ring-opening, protection, and reduction arrived at (3R)-3-(tert-butyldiphenylsilyloxy)-
butyraldehyde (ent-94). When subjected to the iterative AAC reaction with 10 mol % of the R,R-
Al(III)-triamine catalyst ent-36, lactone ent-96 was obtained in 86% isolated yield with excellent 
levels of diastereoselectivity [(2′R,4R):(2′R:4S) = 97:3] as determined by 500 MHz 1H NMR 
analysis. 
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 Scheme 10.  Synthesis of 1,3-syn β-lactone ent-96a 
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After generating β-lactone ent-96 with the correct absolute stereochemistry, we could 
then further elaborate this intermediate to the lower subunit of (–)-laulimalide (Scheme 11).  
Treating ent-96 with the soft nucleophile dimethylmagnesiocuprate resulted in the expected SN2 
ring opening to establish the requisite C11 methyl-bearing stereocenter in carboxylic acid 97.  
Acid 97 was then efficiently converted to the corresponding aldehyde 98 in high yield (86%) 
according to a one-pot reduction/oxidation sequence developed by Brown.44  Aldehyde 98 then 
served as the coupling partner in a third AAC reaction that afforded the anti, anti-β-lactone 99 in 
84% isolated yield with acceptable levels of diastereoselectivity (dr = 92:8). 
 
 
 
                                                 
44 Brown, H. C.; Rao, C. G.; Kulkarni, S. U. Synthesis 1979, 704. 
 40
 Scheme 11.  Preparation of anti,anti-β-lactone 99a 
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With lactone 99 in hand, attention was then focused on the preparation of pyranone 100.  
Although a synthetic route to dihydropyranones from β-lactones had been previously established, 
a more direct conversion was still desired.  Recently, a streamlined approach for the preparation 
of dihydropyranones via direct nucleophilic addition of hydrazone anions into β-lactones was 
described (Figure 17).45  The method involved lithiation of acetaldehyde N-piperidine hydrazone 
101 at   –78 °C, followed by treatment with a β-lactone electrophile which resulted in 
regioselective ring opening to the corresponding β-ketohydrazone.  Subjecting the crude 
hydrazones to Amberlyst-15 acidic ion exchange resin in refluxing THF then resulted in 
cyclization and subsequent dehydroamination to provide the desired dihydropyranone products 
in good yield (72-81%). 
                                                 
45 Zipp, G. G.; Hilfiker, M. A.; Nelson, S. G. Org. Lett. 2002, 4, 1823. 
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Figure 17.  Hydrazone Anion Mediated Dihydropyranone Formation from β-lactones 
 
Attempts to apply the hydrazone anion methodology to the more complex lactone 
intermediate 99 proved to be problematic.  Treating an excess of lithium anion derived from 
acetaldehyde N-piperidine hydrazone at –78 °C with lactone 99 cleanly generated the 
corresponding β-ketohydrazone 102; however, when 102 was subjected to the cyclization 
conditions (Amberlyst-15, THF, reflux) unexpected cleavage of the tert-butyldiphenylsilyl 
protecting group was observed.  The desired pyranone product was isolated in 26-38% yield 
along with considerable amounts of tert-butyldiphenylsilanol and other unidentified materials.    
By choosing a milder acid source to effect the cyclization, it was believed that this silyl 
deprotection/decomposition problem could be circumvented.    Treatment of 102 with CSA (5.0 
equiv) in THF at ambient temperature followed by gently warming to 60 °C resulted in 
cyclization of ketohydrazone 102 to the desired pyranone 100 in 62% yield from lactone 99 
without any observed loss of the TBDPS group (Scheme 12). 
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 Scheme 12.  One Pot β-Lactone to Dihdyropyranone Interconversion 
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Having adapted the acid-mediated cyclization conditions to arrive at the requisite 
dihydropyranone intermediate, attention was then focused on preparing 100 for ynoate ester 
sidearm installation.   Pyranone 100 was further elaborated into glycal acetate 87 according to 
the previously described sequence of Luche reduction followed by acylation of the resultant 
allylic alcohol to furnish acetate 87 in 90% overall yield.  Lewis acid-mediated allenylstannane 
addition with nBu3SnOTf then delivered the trans-2, 6-disubstituted dihydropyran 103 as a single 
diastereomer in 74% yield (Scheme 13). 
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 Scheme 13.  Synthesis of trans-2,6-Dihydropyran 103a
O
O
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aConditions:  a) CeCl3•7H2O, NaBH4.  b) Ac2O, Et3N, DMAP. c) 41, Bu3SnOTf, 
CH2Cl2, –78 °C
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Formatting subunit 103 for the fragment uniting aldol reaction required removal of the 
secondary silyl group at C13 followed by oxidation to the corresponding methyl ketone.  
However, these seemingly trivial functional group manipulations proved to be quite challenging 
as attempted deprotection of the TBDPS ether under standard fluoride- based reaction conditions 
(TBAF, THF) resulted in decomposition of the starting material.  This problematic 
decomposition may arise from either the deprotonation of a propargylic hydrogen at C4 or 
potential 1,4-addition of fluoride ion into the α,β-unsaturated ester.  Both pathways would lead 
to a reactive allene intermediate which could engage in unwanted side reactions.  As a result of 
this unexpected sensitivity of advanced intermediate 103 to TBAF deprotection conditions, a 
modification of the present scheme was required.  
Given the observed incompatibility of the α, β-unsaturated ester moiety in 103 with 
fluoride-based deprotection agents, it was decided to unveil the latent methyl ketone moiety at 
C13 prior to introducing the ynoate ester sidechain.  Compound 87 was treated with excess TBAF 
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 (5.0 equiv) at 0 °C to successfully effect silyl group deprotection, and the crude reaction product 
was then oxidized to methyl ketone 104 (80% overall yield from 87) employing pyridinium 
dichromate (PDC).   Exposing glycal acetate 104 to excess allenylstannane reagent 41 under the 
optimized conditions (Bu3SnOTf, –78 °C) resulted in the efficient installation of the C1–C4 
sidearm in one step (80%), thus completing the synthesis of the lower C1–C14 dihydropyran 
subunit 86 (Scheme 14). 
 
Scheme 14.  Completion of the C1–C14 Dihydropyran Fragment 86a 
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1.8 SYNTHESIS OF THE C15–C20 SUBUNIT46 
 
As illustrated in Scheme 15, construction of the C15–C20 α-alkoxyaldehyde subunit 89 again 
relied on the enantiomerically enriched β-lactone products of asymmetric AAC technology.   
                                                 
46 The synthetic work described in this section was performed by Dr. Wing S. Cheung. and Dr. Mark A. Hilfiker, 
University of Pittsburgh. 
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 Lactone 105 was prepared from aldehyde in 92% yield under the usual conditions (AcBr, 
iPr2NEt, 10 mol% Catalyst ent-36, CH2Cl2, –50 °C) efficiently setting the C19 hydroxyl-bearing 
stereocenter with an enantiomeric excess of 92% as determined by chiral HPLC analysis.  Ring 
opening of 105 with N, O-dimethylhydroxylamine and dimethylaluminum chloride34 to the 
corresponding Weinreb amide 106 followed by protection of the resulting secondary alcohol 
with p-methoxybenzyltrichloroacetimidate and triflic acid (TfOH) at 0 °C afforded amide 107 in 
77% yield from lactone 105.  Amide to aldehyde interconversion with DIBAL-H provided 
aldehyde 108 (80%) which was then subjected to the three step sequence of Wittig olefination, 
DIBAL-H reduction, and trityl protection to furnish the protected triol 109 in 60% yield.  
Deprotection of the tert-butyldiphenylsilyl ether (TBAF, THF) followed by alcohol oxidation 
with Dess-Martin periodinane then provided the α-alkoxyaldehyde subunit 89 in 87% overall 
yield from the fully protected triol 109. 
 
 
Scheme 15.  Synthesis of the C15–C20 Subunit 89a
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 1.9 SYNTHESIS OF THE C21–C28 DIHYDROPYRAN SIDECHAIN47 
 
Having arrived at the α-alkoxyaldehyde portion of the upper synthon 85, an efficient synthetic 
route to the corresponding dihydropyran coupling partner 88 was required.  The synthesis of the 
requisite C21–C28 dihydropyran subunit 88, depicted in Scheme 16, was initiated by an 
asymmetric Brown allylation48 of β-tributylstannyl acrolein with (–)-
diisopinocampheylallylborane 110 to afford the chiral homoallylic alcohol 111 in high yield with 
excellent levels of enantioselectivity (98% ee).  Etherification of alcohol 111 provided triene 112 
which was then exposed to 14 mol% of Schrock’s Mo(VI)-based ring closing metathesis catalyst 
113 to effect dihydropyran ring formation.49  Vinyl iodide 115 was then obtained upon treatment 
of stannane 114 with N-iodosuccinimide (NIS) at –20 °C. 
Scheme 16.  Synthesis of the C21–C28 Dihydropyran Sidechain 88a 
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47 All synthetic work described in this section was performed by Dr. Wing Cheung. 
48 Brown, H. C.; Jadhav, P. K.; Perumal, P. T. J. Tetrahedron Lett. 1984, 25, 5111. 
49 Schrock, R. R.; Murdzek, J. S.; Bazan, G. C.; Robbins, J.; DiMare, M.; O’Regan, M. J. Am. Chem. Soc. 1990, 
112, 3875. 
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 1.10 COMPLETION OF THE C15–C28 FRAGMENT 
 
The assembly of the intact C15–C28 fragment of (–)-laulimalide was predicated on the 
diastereoselective addition of a vinyl metal species derived from dihydropyran 115 into α-
alkoxyaldehyde 89.  It was postulated that metal chelation between the carbonyl oxygen and the 
neighboring p-methoxybenzyl substituent would serve to create an organized transition state 
capable of governing the formation of the desired C19–C20 syn diol relationship.  Preliminary 
experimentation revealed that the necessary Cram-chelate stereocontrol could be realized by 
employing vinyl Grignard 116 (Scheme 17).  Lithiation of iodide 115 at –78 °C with tBuLi (2 
equiv) followed by transmetallation with an ethereal solution of MgBr2 afforded the necessary 
vinyl Grignard species 116 which was then treated with α-alkoxyaldehyde 89.  Ensuing 
nucleophilic addition resulted in the formation of the C15–C28 fragment 117 in 89% yield as a 3:1 
mixture of syn:anti diastereomers favoring the desired syn-diol arrangement.50  Despite our 
arrival at the requisite C19–C20 syn-stereochemical relationship, the low levels of 
diastereoselectivity obtained in the vinyl Grignard addition prompted further optimization in 
order to be incorporated into the present total synthesis. 
 
 
 
 
 
 
 
 
 
                                                 
50 The (19R,20S) configurational assignment of 117 was confirmed by NOE analysis of the corresponding dimethyl 
acetal. 
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 Scheme 17.  Diastereoselective Vinyl Grignard Addition to α-Alkoxyaldehyde 89a 
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 Solvent polarity was believed to play a major role in the modest diastereoselectivity 
observed in the previously described vinyl Grignard addition.  It has been well documented that 
the use of Lewis basic solvents such as Et2O and THF in diastereoselective Grignard-aldehyde 
addition reactions disrupts chelate organization by coordination to the metal center leading, 
ultimately, to lower diastereoselectivity.   To avoid this undesired solvent effect, the diethyl ether 
was removed under reduced pressure at –78 °C after formation of the reactive Grignard species 
and was replaced with the noncoordinating solvent CH2Cl2.51,52  Treatment of the CH2Cl2 
solution of vinyl Grignard 116 with α-alkoxyaldehyde 89 then resulted in nucleophilic addition 
along the chelate-Cram trajectory depicted in Scheme 17 to afford exclusively the requisite C19–
C20 syn-diol diastereomer 117 in 98 % yield.  
                                                 
51 Keck, G. E.; Andrus, M. B.; Romer, D. R. J. Org. Chem. 1991, 56, 417. 
52 Evans, D. A.; Fitch, D. M.; Smith, T. E.; Cee, V. J. J. Am. Chem. Soc. 2000, 122, 10033. 
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  Completion of the upper C15–C28 synthon of laulimalide required only a few routine 
synthetic manipulations (Scheme 18).   Silylation of the newly formed C20 hydroxyl group with 
TBSCl and imidazole furnished the fully protected upper synthon 118 which was subsequently 
exposed to formic acid in nitromethane to effect trityl ether deprotection.  Treatment of allylic 
alcohol 119 with Dess-Martin periodinane then provided the completed α,β-unsaturated 
aldehyde fragment 85 in 84% overall yield from alcohol 117. 
 
Scheme 18.  Completion of the C15–C28 Fragment 85a 
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1.11 FRAGMENT UNION AND MACROLIDE FORMATION 
 
1.11.1 Asymmetric Aldol Reaction 
 
 
With sufficient quantities of both major fragments of laulimalide in hand, steps toward the union 
of the two halves were investigated.  Initial attempts at achieving the desired C14–C15 bond 
construction between aldehyde fragment 85 and methyl ketone 86 employed a chiral boron aldol 
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 protocol described by Paterson (Eq 10).53  Generation of the (+)-diisopinocampheyl boron 
enolate of methyl ketone 86 followed by treatment with aldehyde 85 at –78 °C afforded the 
desired aldol adduct 120 in 60% yield albeit as a 3:1 mixture of C15 (S:R) diastereomers. 
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The poor levels of diastereoselectivity obtained in the previously described aldol reaction 
forced us to evaluate other methods for achieving acceptable levels of stereocontrol.54  We 
recognized an attractive alternative to (+)-DIPCl in Corey’s chiral diazaborolidine 121.  In 1993, 
Corey described the aldol reaction of the chiral boron enolate derived from bromoborane 121 and 
tert-butyl acetate with benzaldehyde (Eq 11) that successfully delivered the desired β-
hydroxyester product in 73% yield and 80% ee.55  However, application of bromoborane reagent 
121 to the construction of the C14–C15 bond in laulimalide, did not increase diastereoselectivity 
from what was previously observed (3:1). 
                                                 
53 Paterson, I.; Norcross, R. D.; Ward, R. A.; Romea, P.; Lister, M. A. J. Am. Chem. Soc. 1994, 116, 11287. 
54 Further opitmization of the asymmetric aldol reaction described in this section was performed by Dr. Wing S. 
Cheung (Postdocoral Researcher, Department of Chemistry, University of Pittsburgh). 
55 Corey, E. J.; Lee, D.-H. Tetrahedron Lett. 1993, 34, 1737. 
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Further attempts at optimization of diastereoselectivity were made by modifying the 
structure of the Corey diazaborolidine reagent.  Reacting 1,2-diphenylethylenediamine with a 
variety of sulfonyl chlorides provided a range of bis-sulfonamide ligands that were evaluated in 
the asymmetric aldol reaction to stereoselectively unite fragments 85 and 86.  The results of this 
survey of modified Corey reagents are summarized in Table 3.  More sterically bulky 
sulfonamide groups (entries a and b) produced aldol adducts with higher levels of 
diastereoselection (~5:1) than previously observed.  Examining electron donating p-tolyl 
sulfonyl substituents on the diamine backbone (entry c) led to only marginally increased 
diastereoselectivity. The use of electron withdrawing substituents, however, proved to be much 
more effective.  While p-trifluoromethoxyphenyl groups resulted in commensurate levels of 
selectivity as previously observed, the bis-p-nitrophenyl-substituted diazaborolidine reagent 121e 
afforded the desired aldol adduct as an 8.7:1 (S):(R) mixture of diastereomers.  Scale-up and 
subsequent protection of the resulting secondary alcohol as the corresponding tert-
butyldimethylsilyl ether furnished aldol adduct 122 in 89% yield with a synthetically useful 
diastereomer ratio (C15 (S):(R) = 9:1). 
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 Table 3.  Asymmetric Aldol Reaction Employing Modified Corey Diazaborolidines  
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 1.11.2 Seco Acid Formation and Macrolactonization 
 
 
Once suitable conditions were established for uniting major fragments 85 and 86 with good 
levels of diastereoselectivity, we turned our attention to the critical macrocylcization event.  
According to our planned retrosynthesis, ring closure to form the 18-membered macrolide would 
occur via the Yamaguchi macrolactonization of propargylic seco acid 123 in order to prevent the 
undesired base-mediated scrambling of the C2–C3 (Z)-olefin observed previously by Paterson.10a 
Arriving at 123, however, required the sequential deprotection of the p-methoxybenzyl (PMB) 
ether and the tert-butyl ester in the fully protected aldol adduct 122.  Initial attempts aimed at 
removing the C19 PMB ether focused on traditional oxidative deprotection with 2,3-dichloro-5,6-
dicyano-1,4-benzoquinone (DDQ).  Treating 122 with 1.5 equiv of DDQ in a CH2Cl2/H2O 
mixture resulted in the cleavage of the desired PMB protecting group; however, the yield of 
alcohol 124 was not always reproducible (70-83%).   The varied isolated yields of 124 were 
attributed to the strongly acidic dihydroquinone by-product of the deprotection reaction. Under 
the reaction conditions, the acidic nature of the dihydroquinone may also to serve to deprotect 
the secondary TBS groups present in 124 resulting in an extremely polar triol species.  
Conducting the deprotection reaction under neutral conditions was viewed as a means of 
avoiding the unwanted cleavage of the silyl ether linkages.    Subjecting p-methoxybenzyl ether 
122 to DDQ in the presence of pH 7 phosphate buffer then provided alcohol 124 in quantitative 
yield (Scheme 19). 
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 Scheme 19.  Deprotection of C19 p-Methoxybenzyl Ether 122a
 
OPMB
O
O
Me
HH
OTBS
OTBS
O
Me
H
BuO2Ct
OH
O
O
Me
HH
OTBS
OTBS
O
Me
H
BuO2Ct
DDQ, CH2Cl2, 
pH 7 buffer
70-83
Conditions % Yield 124
DDQ, CH2Cl2/H2O
100
122 124
 
 
 
 Removal of the tert-butyl ester was next accomplished by adapting the previously 
described protocol in Scheme 7.  Ester 124 was treated with 2, 6-di-tert-butylpyridine and 
TMSOTf at –50 ºC followed by a pH 5 buffer solution at 0 ºC to effect silyl ester deprotection to 
obtain seco acid 123 in 90% yield after column chromatography (Eq 12).  With the requisite seco 
acid in hand, cyclization conditions for the construction of the 18-membered macrolactone could 
be explored.  
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  Pursuit of macrolactone 125 began by employing traditional Yamaguchi 
macrolactonization conditions (Scheme 20).  Seco acid 123 was first treated with Et3N and 2,4,6-
trichlorobenzoyl chloride in THF to generate the corresponding mixed anhydride 126.  
Following the removal of solvent, the crude reaction mixture was diluted with toluene (0.0006 
M) to attain the “high-dilution” conditions necessary to avoid intermolecular lactonization.  
Syringe pump addition of DMAP over the course of 2 h to a solution of mixed anhydride 126 at 
ambient temperature resulted in acyl-pyridinium formation and subsequent lactonization to 
afford the desired macrolactone 125 in 44 % yield.  Although preparation of the highly 
functionalized 18-membered macrolactone of (–)-laulimalide with the commonly used 
Yamaguchi protocol was successful, a more efficient macrolactonization method was still 
desired.  Additional reagent systems were investigated to achieve the desired propargylic acid 
macrolactonization.  Carbodiimide coupling reagents DCC56 and EDC57 as well diphenyl 
chlorophosphate,58 and p-nitrobenzoyl anhydride with Sc(OTf)359 were selected for activating the 
carboxylic acid moiety, unfortunately, the high reaction temperatures required by these 
macrolactonization protocols resulted in decomposition of the seco acid starting material. 
 
 
 
 
 
 
                                                 
56 Boden, E. P.; Keck, G. E. J. Org. Chem. 1985, 50, 2394. 
57 Chackalamannil, S.; Davies, R. J.; Wang, Y.; Asberan, T.; Doller, D.; Wong, J.; Leone, D. McPhail, A. T. J. Org. 
Chem. 1999, 64, 1932. 
58 Kaiho, T.; Masamune, S.; Toyoda, T. J. Org. Chem. 1982, 47, 1612. 
59 Ishihara, K.; Kubota, M.; Kurihara, H.; Yamamoto, H. J. Org. Chem. 1996, 61, 4560. 
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 Scheme 20. Yamaguchi Macrolactonization of Seco Acid 123a 
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 An interesting and highly efficient Yamaguchi macrolactonization was reported in 1990 
by Yonemitsu in the total synthesis of erythronolide A (Eq 13).60  The 14-membered 
erythronolide macrocycle was formed by treating a concentrated benzene solution (0.01 M) of 
the mixed anhydride of seco acid 127 with DMAP at ambient temperature.  The ensuing 
macrolactonization proceeded rapidly (1 h) to afford lactone 128 in near quantitative yield. 
Surprisingly, this reaction was successful even without the high dilution conditions which are 
                                                 
60 Hikota, M.; Sakurai, Y.; Horita, K.; Yonemitsu, O. Tetrahdron Lett. 1990, 31, 6367. 
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 generally required in the conventional Yamaguchi macrolactonization.  The success of this 
method has been attributed to the favorable conformation adopted by seco acid 127, which 
greatly enhances its propensity for cyclization.  
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Given the success enjoyed by Yonemitsu in the previously described Yamaguchi 
macrocyclization, we elected to incorporate similar lactonization conditions into our own 
synthetic strategy (Scheme 21).   Treating a benzene solution of seco acid 123, DMAP, and Et3N 
at ambient temperature with 2,4,6-trichlorobenzoyl chloride resulted in the complete 
consumption of starting material and the formation of two products as observed by TLC analysis.  
The major product, isolated in 56% yield, was determined to be the desired macrocycle 125 by 
1H NMR and high resolution ESI-MS analysis. The minor component of the reaction mixture 
was identified as the dimer 129 based on similar spectroscopic techniques and was obtained in 
15% yield.  While this result would suggest that seco acid 123 does not adopt an optimal 
conformation for macrolactonization, it was believed that the formation of dimer could be 
prevented by the commonly employed high dilution technique for traditional Yamaguchi 
macrolactonization.  
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 Scheme 21.  Synthesis of 125 via Yonemitsu Modified Yamaguchi Macrolactonization 
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To test this hypothesis, a series of macrolactonization reactions were performed at varying 
concentrations and the results are presented in Table 8.  Despite our attempts at lowering reaction 
concentration, we could not inhibit dimer formation.  Even at 0.001 M, the concentration 
typically employed in conventional Yamaguchi macrolactonizations, the undesired dimeric 
product 129 was still observed. 
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 Table 4.  Concentration Studies in Yamaguchi Macrolactonization 
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 Our inability to suppress the formation of dimer 129 led to the examination of several 
other variables.61  In our previous attempts at macrocyclization, the Yamaguchi reagent, 2,4,6-
trichlorobenzoyl chloride, was added to a solution of seco acid 123.  Under these reaction 
conditions, a small amount of the activated acyl pyridinium pecies would be generated in the 
presence of a relatively high concentration of hydroxy-acid thereby increasing the likelihood of 
dimer formation.  By reversing the order of addition, slow addition of 123 to a large excess of 
reagents, the effective concentration of seco acid would be minimized and the likelihood for 
dimer formation should be diminished.  In these modified macrolactonization reactions, a 
benzene suspension containing a large excess of 2,4,6-trichlorobenzoyl chloride (100 equiv), 
Et3N (500 equiv), and 4-pyrrolidinopyridine (30 equiv) was slowly treated with seco acid 123 in 
benzene via syringe pump.  Monitoring reaction progress by TLC revealed the complete 
                                                 
61 These optimization studies were the work of Dr. Wing S. Cheung (Postdocoral Researcher, Department of 
Chemistry, University of Pittsburgh). 
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 consumption of the starting acid 123 and the formation of three products:  the desired 
macrolactone 125, the dimer 129, although to a much lesser extent than previously observed, and 
a more polar, unidentified product.  Although another undesired by-product was formed during 
the course of the reaction, we were pleased to be able to suppress the formation of dimer 129. 
 The final variable to be explored in the optimization of our propargylic acid 
macrolactonization was reaction temperature.  All previous attempts at macrolactonization had 
been performed at ambient temperature, and determination of any temperature dependence on 
dimer/by-product formation was pursued.  Cyclization reactions were now conducted at 0 ºC in 
toluene employing the previously described slow addition of seco acid to excess reagents 
protocol.  Gratifyingly, dimer formation was completely eliminated at the lower temperature; 
however, the unidentified by-product still remained.  In an attempt to avoid this polar by-
product, the large excess of reagents was dramatically reduced.  Treating a 0 ºC toluene 
suspension of DIPEA (40 equiv), 4-pyrrolidinopyridine (20 equiv), and 2,4,6-trichlorobenzoyl 
chloride (20 equiv) with seco acid 123 via syringe pump now cleanly afforded the desired 18-
membered macrolactone 125 as the only observable product by TLC analysis.  The optimized 
Yamaguchi macrolactonization conditions provided macrolide 125 in 93% isolated yield 
(Scheme 22). 
Scheme 22.  Optimized Conditions for Modified Yamaguchi Macrolactonizationa
 
OH
O
O
Me
HH
OTBS
OTBS
O
Me
H
HO2C
O
O
O
Me
HH
OTBS
OTBS
O
Me
H
O
a
aConditions:  (a) 2,4,6-trichlorobenzoyl chloride (20 equiv), 4-pyrrolidinopyridine (20 equiv), 
DIPEA (40 equiv), PhCH3
123 125
 
 61
 1.12 COMPLETION OF THE TOTAL SYNTHESIS OF (–)-LAULIMALIDE 
 
Having prepared the highly functionalized macrolide 125, only a few additional functional group 
manipulations were necessary to complete the total synthesis of (–)-laulimalide (Scheme 23).   
Partial hydrogenation of the C2–C3 alkyne under Lindlar conditions (H2, BaSO4) successfully 
unveiled the requisite (Z)-enoate ester 130 as a single regioisomer in 88% yield.  Arriving at 
alkene 130, we had intercepted an intermediate previously described in Paterson’s laulimalide 
synthesis, and thus an equivalent approach was pursued.  Takai methylenation of the C13 ketone 
residue efficiently installed the desired exocyclic olefin (131), and subsequent silyl deprotection 
at 0 ºC with HF•py provided desepoxylaulimalide (132) in good yield.  The completion of our 
total synthesis of 1 was finally realized with a regio- and stereoselective Sharpless asymmetric 
epoxidation of the C16–C17 olefin employing (+)-diisopropyltartrate to afford synthetic (–)-
laulimalide (1) in 69% isolated yield.  All physical and spectroscopic data exhibited by 1 ([α]D = 
–198 (c 0.1, CHCl3), 1H, 13C, IR, HRMS) were in agreement with that previously reported in the 
literature by Ghosh, Paterson, and Mulzer.11   
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 Scheme 23.  Completion of the Total Synthesis of (–)-Laulimalide (1)a
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 1.13 CONCLUSIONS 
 
Catalytic, asymmetric acyl halide–aldehyde cyclocondensation methodology has been 
successfully applied to the total synthesis of the potent microtubule-stabilizing marine natural 
product (–)-laulimalide.   This achievement represents the first example of the application of 
AAC-based reaction technology to complex molecule synthesis.  The route encompassed 23 
steps along the longest linear sequence and afforded 1 in 5.1% overall yield from the inexpensive 
and readily available starting material acetaldehyde.  Asymmetric AAC reactions were 
instrumental in directly establishing the C9, C11, and C19 stereogenic centers in (–)-laulimalide.  
Highlights of the synthesis include a diastereoselective aldol reaction that united major fragments 
85 and 86 and a remarkably high-yielding modified Yamaguchi macrolactonization.  
Additionally, novel methodology was developed to effect both the one-pot interconversion of β-
lactones to dihydropyranones and the Lewis acid activated allenylstannane addition to glycal 
acetates which was employed to stereoselectively introduce the C1–C4 sidearm of laulimalide in 
one step.  A highly diastereoselective vinyl Grignard addition to α-alkoxyaldehyde 89 was also 
achieved which effectively generated the C19,C20-syn-diol arrangement. 
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 1.14 EXPERIMENTAL SECTION 
 
General Information: Optical rotations were measured on a Perkin-Elmer 241 digital 
polarimeter with a sodium lamp at ambient temperature and are reported as follows:  [α]D (c 
g/100mL, solvent) with units of degree•g•cm-3.  Infrared spectra were recorded on a Nicolet 
Avatar 360 FT-IR spectrometer.  1H NMR spectra were recorded on Bruker DPX 301 and DPX 
302 (300 MHz) spectrometers.  Chemical shifts are reported in ppm from tetramethylsilane with 
the solvent resonance as the internal standard (CHCl3: δ 7.27 ppm).  Data are reported as 
follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = broad, 
m = multiplet), coupling constants (Hz), integration.  13C NMR spectra were recorded on Bruker 
DPX 301 and DPX 302 spectrometers (75 MHz) with complete proton decoupling.  Chemical 
shifts are reported in ppm from tetramethylsilane with the solvent as the internal standard 
(deuterochloroform: δ 77.0 ppm).  Mass spectra were obtained on a VG-7070 or Fisons Autospec 
high resolution magnetic sector mass spectrometer.   
Analytical thin layer chromatography was performed on EM Reagent 0.25 mm silica gel 
60-F plates.  Flash chromatography was performed as previously described on EM silica gel 60 
(230-240 mesh).62  Analytical gas liquid chromatography (GLC) was performed on a Hewlet-
Packard 5890 Series II gas chromatograph with a flame ionization detector and split mode 
capillary injection system, using a Chiraldex™ G-TA column (20 m x 0.25 mm) (Advanced 
Separation Technologies Inc.).  Hydrogen was used as the carrier gas at the indicated pressures.  
Analytical high performance liquid chromatography (HPLC) was performed on a Hewlett 
Packard 1100 liquid chromatograph equipped with a variable wavelength UV detector 
(deuterium lamp, 190-600 nm), using either a Daicel Chiralcel™ OD-H column (250 × 4.6 mm) 
                                                 
62 Still, W.C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923. 
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 or a Daicel Chiralpak™ AS-H column (250 × 4.6 mm) (Daicel Inc.).  HPLC grade isopropanol 
and hexanes were used as the eluting solvents. 
All experiments were carried out under a nitrogen atmosphere in oven or flame-dried 
glassware using standard inert atmosphere techniques for introducing reagents and solvents.  
Tetrahydrofuran (THF) was distilled from potassium benzophenone ketyl. Diethyl ether (Et2O), 
toluene and benzene were distilled from sodium benzophone ketyl.  Dichloromethane (CH2Cl2), 
dimethylsulfide (DMS), N,N-diisopropylethylamine (DIPEA), and triethylamine (Et3N) were 
distilled from CaH2 under N2.   
 
(4S)-(tert-Butyldiphenylsilyloxyethyl)oxetan-2-one (46):  To a –50 °C 
solution of 0.745 g of aluminum triamine catalyst 36 (1.28 mmol) in 60 
mL of CH2Cl2 was added 3.8 mL of diisopropylethylamine (21.8 mmol) followed by 1.80 mL of 
acetyl bromide (24.3 mmol).  The resulting light yellow solution was maintained at –50 °C for 5-
10 min, then treated with 4.0 g of aldehyde 45 (12.8 mmol) in 5 mL of CH2Cl2 slowly dropwise.  
The reaction was maintained overnight at –50 °C, then poured into 400 mL of cold hexanes.  The 
mixture was filtered through silica gel, and the silica was washed with 30% EtOAc/hexanes.  
The combined filtrate was concentrated to afford 4.4 g (97%, crude) of lactone 46 as a white 
crystalline solid (88% ee).  Recrystallization from hexanes/CH2Cl2 mixtures provided the title 
compound in 98% ee: [α]D = –14.3 (c 4.0, CHCl3); IR (thin film) 3069, 3046, 2958, 2931, 2851, 
2883, 1830, 1735, 1426, 1117 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.59 (d, J = 6.9 Hz, 4H), 
7.48–7.20 (m, 6H), 4.71 (m, 1H), 4.76–4.60 (m, 2H), 3.74 (dd, J = 4.5, 11.5 Hz, 1H), 3.45 (dd, J 
= 5.9, 16.5 Hz, 1H), 2.12–1.85 (m, 2H), 1.00 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 168.7, 
135.7, 133.4, 130.1, 128.0, 69.3, 59.9, 43.4, 37.4, 27.0, 19.3; EI-MS m/z 297 (M+-tBu), 255, 241, 
O
O
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 225, 211, 199, 183, 117, 105; HRMS calcd for C21H26O3Si: 297.0947, found 297.0947; HPLC 
(95:5 hexanes/iPrOH, 1.0 mL/min) Tr (min) = 8.13 (S), 9.26 (R).   
 
(3R)-5-(tert-Butyldiphenylsilyloxy)-3-methylpentanoic acid (47): 
To a –50 °C solution of 1.82 g of CuBr (12.7 mmol) in 120 mL of 
THF and 13 mL of dimethylsulfide was added 8.5 mL of a 3 M ethereal solution of 
methylmagnesium bromide (25.4 mmol) slowly dropwise via syringe. The resulting 
heterogeneous mixture was stirred at –50 °C for 30 min then warmed to –30 °C for 30 min.  The 
reaction was then cooled to –50 °C and 3.0 g of lactone 46 (8.47 mmol) in 10 mL of THF was 
added via cannula.  The resulting mixture was maintained at –50 °C for 45 min, then 1.65 mL of 
TMSCl (12.7 mmol) was added and the reaction was allowed to warm to ambient temperature 
overnight.  Saturated aqueous NH4Cl (300 mL) and 1 M HCl (100 mL) was added and the 
mixture was extracted with Et2O (3 × 100 mL). The combined organics were washed with 
saturated aqueous NH4Cl and brine (100 mL), dried over Na2SO4, filtered, and concentrated.  
The crude product was purified by flash chromatography on silica gel (15% EtOAc/hexanes) to 
afford 2.5 g (80%) of 47 as a pale yellow viscous oil: [α]D = +3.7 (c 2.7, CHCl3); IR (thin film) 
3071, 2959, 2931, 2858, 1708, 1428, 1112, 909, 735, 702 cm-1; 1H NMR (300 MHz, CDCl3) 
δ 7.67 (dd, J = 1.6, 7.5 Hz, 4H), 7.47–7.28 (m, 6H), 3.74 (t, J = 6.2 Hz, 2H), 2.41 (dd, J = 4.1, 
8.1 Hz, 1H), 2.28–2.10 (m, 2H), 1.63 (m, 1H), 1.50 (m, 1H), 1.05 (s, 9H), 0.95 (d, J = 6.4 Hz, 
3H); 13C NMR (75 MHz, CDCl3) δ 180.0, 135.8, 134.0, 129.8, 127.9, 61.9, 41.7, 39.2, 27.2, 
27.0, 19.9, 19.4; HRMS calcd for C22H30O3Si: 353.1937, found 353.1934. 
HO OTBDPS
O Me
 
 67
 (3R)-5-(tert-Butyldiphenylsilyloxy)-3-methylpentanoic acid 
methyl ester (48): To a solution of 4.88 g of carboxylic acid 47 
(13.2 mmols) in 80 mL of CH2Cl2 was added 0.165 g of DMAP (1.35 mmol), 3.27 g of 
dicyclohexylcarbodiimide (15.8 mmols), and 2.7 mL of MeOH (65.4 mmol).  The reaction was 
maintained at ambient temperature for 3 h, then diluted with pentane and filtered through Celite.  
The filtrate was then concentrated and the crude material was purified by silica gel 
chromatography (5% EtOAc/hexanes) to provide 4.3 g of methyl ester 48 (86%) as a clear, 
colorless oil:   [α]D = +4.7 (c 2.3, CHCl3); IR (thin film) 3069, 3050, 2958, 2931, 2855, 1739, 
1426, 1386, 1358, 1295, 1259, 1220, 1168, 1109, 994, 820, 737, 705, 614 cm-1; 1H NMR (300 
MHz, CDCl3) δ 7.70 (dd, J = 1.3, 7.0 Hz, 4H), 7.45-7.37 (m, 6H), 3.73 (t, J = 6.3 Hz, 2H), 3.68 
(s, 3H), 2.37 (dd, J = 4.7, 8.7 Hz, 1H), 2.23–2.11 (m, 2H), 1.64 (m, 1H), 1.48 (m 1H), 1.08 (s, 
9H), 0.95 (d, J = 6.3 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 173.7, 135.7, 134.0, 129.7, 127.8, 
61.9, 51.5, 41.7, 39.3, 27.4, 27.0, 19.9, 19.3; EI-MS m/z 353 (M+-OMe), 327 (M+-tBu), 213, 197, 
183, 135; HRMS calcd for C23H32O3Si:   353.1937, found 353.1937. 
MeO OTBDPS
O Me
 
(3S)-tert-Butyldiphenylsilylmethyl-5-
(trimethylsilylmethyl)hex-5-ene ether (49):  To a –78 °C 
suspension of 6.26 g of CeCl3 (25.4 mmol) in 50 mL of dry THF was added 25 mL of a 1.0 M 
ethereal solution of TMSCH2MgCl (25.4 mmol).  The resulting beige suspension was stirred for 
1.5 h at –78 °C whereupon a solution of 1.95 g of methyl ester 48 (5.08 mmol) in 10 mL of THF 
was added slowly dropwise via cannula.  The reaction mixture was maintained at –78 °C for 2 h 
and then allowed to warm slowly to ambient temperature.  The reaction was quenched with 100 
mL of 1 M HCl and extracted with CH2Cl2 (3 × 100 mL).  The combined organics were dried 
TMS
Me
OTBDPS
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 over Na2SO4, filtered, and concentrated.  The crude residue was then dissolved in 60 mL of 
CH2Cl2 and 10 g of silica gel was added.  After stirring at ambient temperature for 1.5 h, the 
mixture was filtered and concentrated. Purification by flash chromatography on silica gel (2% 
EtOAc/hexanes) yielded 2.0 g (90%) of allylsilane 49 as a clear, colorless liquid: [α]D = +7.4 (c 
2.7, CHCl3); IR (thin film) 3069, 3053, 2951, 2931, 2855, 1628, 1430, 1259, 1113, 859 cm-1;1H 
NMR (300 MHz, CDCl3) δ 7.68 (d, J = 7.7 Hz, 4 H), 7.43–7.34 (m, 6 H), 4.55 (brs, 2 H), 3.72 
(d, J = 5.6, 6.8 Hz, 1 H), 3.65 (dd, J = 5.2, 7.1 Hz, 1 H), 1.90–1.63 (m, 2 H), 1.45–1.22 (m, 2 H), 
1.06 (s, 9 H), 0.81 (d, J = 6.1 Hz, 3 H), 0.041 (s, 9 H); 13C NMR (75 MHz, CDCl3) δ 146.4, 
135.8, 134.3, 129.7, 127.8, 108.8, 62.3, 46.5, 39.6, 27.0, 26.4, 19.8, –1.1; EI-MS m/z 423 (M+), 
381, 271, 231, 199, 135, 84, 73, 58; HRMS calcd for C27H42OSi2: 381.2068, found 381.2066. 
 
 (3S)-tert-Butyl-(3,5-dimethylhex-5-enyloxy)diphenyl-silane (53):  
To a solution of 4.4 g of allylsilane 49 (10.0 mmol) in 50 mL of THF 
was added 4.4 g of Amberlyst-15 ion exchange resin.  The reaction was maintained at ambient 
temperature for 16 h then filtered and concentrated to afford 3.4 g (92%) of 53 as a yellow oil:  
IR (thin film):  3071, 3050, 2959, 2930, 2858, 1472, 1428, 1111, 823 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 7.71–7.65 (m, 4H), 7.45–7.35 (m, 6H), 4.74 (s, 1H), 4.65 (s, 1H), 3.76–3.63 (m, 2H), 
2.01–1.96 (m, 1H), 1.88–1.78 (m, 2H), 1.69 (s, 3H), 1.65–1.59 (m, 1H), 1.37–1.25 (m, 1H), 1.05 
(s, 9H), 0.81 (d, J = 6.1 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 144.3, 135.5, 134.0, 129.5, 
127.6, 111.4, 68.0, 62.0, 46.0, 39.4, 26.9, 22.1, 19.5; EI-MS m/z 309 (M+-tBu), 271, 199, 183, 
84, 77; HRMS m/z calcd for C20H25OSi:  309.1675; found 309.1684. 
Me OTBDPS
Me
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  (3S)-3,5-Dimethylhex-5-en-1-ol (54):  To a 0 °C solution of 1.7 g of silyl 
ether 53 (4.64 mmol) in 22 mL of dry THF was added 5.6 mL of a 1.0 M 
THF solution of tetrabutylammonium fluoride (5.57 mmol).  The reaction was then warmed to 
ambient temperature and stirred for 1 h.  Saturated aqueous NaHCO3 (20 mL) was added, and the 
mixture was extracted with Et2O (3 × 20 mL).  The combined organics were washed with brine, 
dried over Na2SO4, filtered, and concentrated.  The crude product mixture was purified by flash 
chromatography on silica gel (30% Et2O/pentane) to afford 0.530 g (90%) of the title compound 
as a clear, colorless liquid. [α] D = –26 (c 2.24, CHCl3).  IR (thin film):  3343, 3074, 2961, 2928, 
1650, 1456, 1378, 1058, 887 cm-1.  1H NMR (300 MHz, CDCl3): δ 4.76 (s, 1H), 4.68 (s, 1H), 
3.80–3.65 (m, 2H), 2.02 (dd, J = 5.9, 13 Hz, 1H), 1.91–1.75 (m, 2H), 1.70 (s, 3H), 1.67–1.58 (m, 
1H), 1.45–1.30 (m, 1H), 1.19 (t, J = 5.3 Hz, 1H), 0.89 (d, J = 6.3 Hz, 3H); 13C NMR (75 MHz, 
CDCl3): δ 144.7, 111.9, 61.4, 46.3, 39.9, 27.5, 22.4, 19.7. EI-MS m/z 128 (M+), 110, 95, 86, 83, 
73, 59, 55; HRMS m/z calcd for C8H16O: 128.1201; found 128.1197. 
Me OH
Me
 
 (3S)-3,5-Dimethylhex-5-enal (50): To a suspension of 2.0 g of 4Å 
molecular sieves and 0.728 g of N-methylmorpholine N-oxide (6.21 mmol) 
in 15 mL of CH2Cl2 at ambient temperature was added 0.530 g of alcohol 54 (4.1 mmol) in 5 mL 
of CH2Cl2.  After several minutes, 0.075 g of tetrapropylammonium perruthenate (0.207 mmol) 
was added.  The resulting green-black suspension was stirred 30 min at ambient temperature, 
then filtered through a plug of silica gel.  The filtrate was concentrated to afford 0.460 g (88%) 
of the title compound as a clear, colorless liquid.  [α]D = –9.8 (c 3.43, CHCl3). IR (thin film): 
3425, 3069, 2962, 2926, 2871, 2827, 2720, 1726, 1651, 1453, 1378, 1263 cm-1; 1H NMR (300 
MHz, CDCl3): δ 9.77 (t, J = 2.3 Hz, 1H), 4.79 (s, 1H), 4.69 (s, 1H), 2.47–2.41 (m, 1H), 2.32–
Me H
Me O
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 2.15 (m, 2H), 2.01–1.97 (m, 2H), 1.71 (s, 3H), 0.96 (d, J = 6.5 Hz, 3H).  13C NMR (75 MHz, 
CDCl3): δ 202.7, 143.5, 112.1, 50.5, 45.6, 26.0, 25.6, 22.0, 20.0; EI-MS m/z 111 (M+-Me), 108, 
93, 82, 73, 61, 55; HRMS m/z calcd for C7H11O:  111.0809; found 1110808. 
   
(4R, 2′S)-4-(2,4-Dimethylpent-4-enyl)oxetan-2-one (55) To a –50 °C 
solution of 0.405 g of aluminum triamine catalyst ent-36 (0.697 mmol) in 
30 mL of CH2Cl2 was added 2.0 mL of diisopropylethylamine (11.8 mmol) followed by 0.98 mL 
of acetyl bromide (13.2 mmol).  The resulting light yellow solution was maintained at –50 °C for 
5-10 min, then treated with 0.878 g of aldehyde 50 (6.97 mmol) in 5 mL of CH2Cl2 slowly 
dropwise.  The reaction was stirred overnight at –50 °C and was poured into 150 mL of cold 
pentane, filtered through silica gel, and concentrated.  The residue was purified by flash 
chromatography on silica gel (20% ether/pentane) to afford the title compound as a colorless 
liquid: IR (thin film): 3073, 2966, 2919, 1830, 1647, 1457, 1374, 1124, 887 cm-1; 1H NMR (300 
MHz, CDCl3): δ 4.79–4.78 (m, 1H), 4.69–4.68 (m, 1H), 4.67–4.59 (m, 1H), 3.56 (dd, J = 5.7, 
16.0 Hz, 1H), 3.07 (dd, J = 4.3, 16.0 Hz, 1H), 2.06–1.93 (m, 2H), 1.92–1.84 (m, 2H), 1.70 (s, 
3H), 1.54–1.44 (m, 1H), 0.95 (d, J = 6.3 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 168.3, 143.5, 
112.2, 69.8, 46.0, 43.4, 41.5, 27.5, 22.0, 19.1; EI-MS m/z 168 (M+), 153, 135, 125, 109, 93, 82, 
71, 67, 55; HRMS m/z calcd for C10H16O2:  168.1150; found 168.1146. 
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 (3S)-3-Hydroxy-5-phenylpentanoic acid N-methoxy-N-
methylamide (66):,63 To a 0 °C suspension of 0.937 g of N,O-
dimethylhydroxylamine (9.66 mmol)  in 20 mL of CH2Cl2  was added 9.66 mL (9.66 mmol) of 
MeO
N
Me
O
Ph
OH
 
63 Evans, D. A.; Dart, M. J.; Duffy, J. L.; Yang, M. G.  J. Am. Chem. Soc. 1996, 118, 4322. 
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 dimethylaluminum chloride (1.0 M solution in hexanes).  The suspension was warmed to 
ambient temperature and stirred for 2 h.  To this suspension was added a solution of lactone 61 in 
5 mL of CH2Cl2 via cannula.  The reaction mixture was maintained overnight at ambient 
temperature and then quenched with 36 mL (3 mL/mmol Me2AlCl) of pH 8 phosphate buffer.  
The resulting suspension was stirred at ambient temperature for 15 min, filtered through Celite, 
and the filtrate was extracted with CHCl3 (3 × 20 mL).  The combined organics were washed 
with brine, dried over Na2SO4, filtered, and concentrated to afford 1.12 g (98%) of the title 
compound as a pale yellow liquid: [α]D = +28 (c 0.96, CHCl3); IR (thin film):  3437, 3058, 2940, 
1639, 1496, 1450, 1183, 1076, 994, 702 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.31–
7.16 (m, 5Η), 4.08–4.02 (m, 1H), 3.92 (brs, 1H), 3.68 (s, 3H), 3.19 (s, 3H), 2.85–2.75 (m, 1H), 
2.74–2.64 (m, 2H), 2.53–2.49 (m, 1H),  1.91–1.84 (m, 1H), 1.81–1.74 (m, 1H); 13C NMR (75 
MHz, CDCl3) δ 173.9, 142.1, 128.62, 128.58, 128.55, 128.48, 125.9, 67.3, 61.4, 60.2, 43.0, 38.3, 
31.9; LRMS (EI, 70 eV):  m/z 237. 
 
 (3S)-5-Phenyl-3-trimethylsilyloxypentanoic acid N-methoxy-N-
methylamide (67):  To a solution of 0.725 g (3.06 mmol) of amide 66 
in 25 mL of CH2Cl2 was added 1.2 mL (4.6 mmol) of N, O-bis(trimethylsilyl)acetamide at 
ambient temperature.  The reaction was maintained for 90 min, then concentrated and purified by 
flash chromatography on silica gel (20% EtOAc/hexanes) to yield 0.838 g (89%) of the title 
compound as a pale yellow oil:  [α]D = +17 (c 2.1, CHCl3); IR (thin film) 3062, 3027, 1662, 
1250, 1094, 842 cm-1; 1H NMR (300 MHz, CDCl3) δ  7.31–7.26 (m, 2H), 7.22–7.16 (m, 3H), 
4.31 (dddd, J =  5.1, 5.1, 7.3, 7.3 Hz, 1H), 3.67 (s, 3H), 3.17 (s, 3H), 2.84–2.71 (m, 2H), 2.66–
2.58 (m, 1H), 2.47 (dd, J = 5.2, 15 Hz, 1H), 1.95–1.72 (m, 2H), 0.14 (s, 9H); 13C NMR (75 MHz, 
MeO
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 CDCl3) δ 172.0, 142.0, 128.3 (4C), 125.6, 69.1, 61.1, 39.9, 39.5, 31.8, 0.81 (3C);  LRMS (EI, 70 
eV):  m/z 309; HRMS calcd for C16H27NO3Si:   309.1760, found 309.1754. 
 
                                                
 (2S)-2-Phenethyl-2,3-dihydropyran-4-one (65):64  To a –78 °C solution of 
0.390 g of cis-2-ethoxyvinylstannane 63 (1.08 mmol) in 8 mL of THF was 
slowly added 0.62 mL of a 1.6 M hexane solution of nBuLi.  The clear solution 
was stirred at –78 °C for 75 min and a solution of 0.160 g of amide 67 (0.52 mmol) in 2 mL of 
THF was added via cannula.  The reaction mixture was allowed to warm slowly to 0 °C.   
Saturated aqueous NaHCO3 (5 mL) was added, and the mixture was extracted with EtOAc (3 × 6 
mL).  The combined organics were dried over Na2SO4, filtered, and concentrated to afford 68 as 
a yellow oil.  The crude product mixture was dissolved in 2 mL of THF and Amberlyst-15 resin 
was added.  The reaction was stirred at ambient temperature overnight, filtered, and 
concentrated.  Purification by flash chromatography on silica gel (20% EtOAc/hexanes) afforded 
81 mg (76%) of 65 as a pale yellow oil:  [α]D = – 89 (c 1.0, CHCl3); IR (thin film) 1672, 1593 
cm-1; 1H NMR (300 MHz, CDCl3) δ  7.33 (d, J = 6.0 Hz, 1H), 7.28–7.22 (m, 2H), 7.21–7.10 (m, 
3H), 5.36 (dd, J = 1.1, 6.0 Hz, 1H), 4.35 (ddd, J = 4.3, 8.3, 13 Hz, 1H), 2.82–2.65 (m, 2H), 2.51 
(dd, J = 13, 17 Hz, 1H), 2.38 (ddd, J = 1.1, 4.0, 17 Hz, 1H), 2.11 (dtd, J = 5.8, 8.8, 17 Hz, 1H), 
1.90 (dddd, J = 4.6, 7.1, 9.4, 17 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 192.1, 162.9, 140.7, 
128.6, 128.3, 126.2, 107.1, 78.5, 41.9, 36.0, 31.0, 29.6; HRMS m/z calcd for C13H14O2:  
202.0994, found 202.0998. 
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64 Corey, E. J.; Cywin, C. L.; Roper, T. D.  Tetrahedron Lett. 1992, 33, 6907. 
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 (3R,5S)-3-Hydroxy-5,7-dimethyloct-7-enoic acid N-methoxy-
N-methyl-amide (69):  To a 0 °C  suspension of 1.15 g (11.9 
mmol) of  in 25 mL of CH2Cl2  was added 11.9 mL (11.9 mmol) of dimethylaluminum chloride 
(1.0 M solution in hexanes).  The suspension was warmed to ambient temperature and stirred for 
2 h.  To this suspension was added a solution of lactone 55 in 5 mL of CH2Cl2 via cannula.  The 
reaction mixture was allowed to stir overnight at ambient temperature and then quenched with 36 
mL (3 mL/mmol Me2AlCl) of pH 8 phosphate buffer.  The resulting suspension was stirred for 
15 min, filtered through Celite, and the filtrate was extracted with CHCl3 (3 × 10 mL).  The 
combined organics were washed with brine, dried over Na2SO4, filtered, and concentrated to 
afford 0.820 g of the title compound as a pale yellow liquid.  [α]D = –25 (c 2.3, CHCl3). IR (thin 
film): 3449, 3069, 2962, 2926, 1647, 1441, 1386, 1176, 887 cm-1; 1H NMR (300 MHz, CDCl3): 
δ 4.72 (m, 1H), 4.65 (m, 1H), 4.18–4.09 (m, 1H), 3.73 (brs, 1H), 3.67 (s, 3H), 3.18 (s, 3H), 2.61 
(brd, J = 16.0 Hz, 1H), 2.44 (dd, J = 9.4, 16.9 Hz, 1H), 2.03–1.84 (m, 3H), 1.67 (s, 3H), 1.59 
(ddd, J = 3.4, 9.9, 13.6 Hz, 1H), 1.04 (ddd, J = 3.1, 9.3, 12.5 Hz, 1H), 0.89 (d, J = 6.2 Hz, 3H);  
13C NMR (75 MHz, CDCl3): δ 173.9, 144.5, 111.5, 65.4, 61.2, 46.6, 43.5, 39.0, 31.8, 26.7, 22.1 
18.9.  HRMS m/z calcd for C12H23NO3:  229.1678; found 229.1678.  
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 (3R,5S)-5,7-Dimethyl-3-trimethylsilyloxyoct-7-enoic acid-N-
methoxy-N-methylamide (70): To a solution of 0.815 g (3.56 
mmol) of amide 69 in 25 mL of CH2Cl2 was added 1.5 mL (6.05 mmol) of N,O-
bis(trimethylsilyl)acetamide at ambient temperature.  The reaction was maintained for 90 min, 
then concentrated and purified by flash chromatography on silica gel (20% EtOAc/hexanes) to 
yield 0.960 g (90%) of the title compound as a pale yellow oil.  [α]D = +2.6 (c 2.4, CHCl3). IR 
MeO
N
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 (thin film): 3073, 2954, 2926, 1663, 1445, 1386, 1247, 1104 cm-1; 1H NMR (300 MHz, CDCl3): 
δ 4.74–4.73 (m, 1H), 4.66 (br s, 1H), 4.32 (m, 1H), 3.69 (s, 3H), 3.19 (s, 3H), 2.74 (dd, J = 7.4, 
15.0 Hz, 1H), 2.42 (dd, J = 5.3, 15.0 Hz, 1H), 1.69 (s, 3H), 1.56 (ddd, J = 3.1, 9.4, 12.8 Hz, 1H), 
1.19 (ddd, J = 3.1, 9.5, 12.8 Hz, 1H), 0.92 (d, J = 6.3 Hz, 3H), 0.15 (s, 9H); 13C NMR (75 MHz, 
CDCl3): δ 172.3, 144.4, 111.6, 67.5, 61.3, 46.5, 44.9, 40.8, 31.9, 26.7, 22.0, 19.2, 0.60.  HRMS 
m/z calcd for C15H31NO3Si:  301.2073; found 301.2073. 
 
(2R, 2′S)-(2,4-Dimethylpent-4-enyl)-2,3-dihydropyran-4-one (72):  To 
a –78 °C solution of 1.00 g of cis-2-ethoxyvinylstannane (2.79 mmol) 62 
in 8 mL of dry THF was slowly added 1.66 mL of a 1.6 M hexane 
solution of nBuLi.  The clear solution was stirred at –78 °C for 75 min and a solution of 0.400 g 
of amide 70 (1.33 mmol) in 2 mL of THF was added via cannula.  The reaction mixture was 
allowed to warm slowly to 0 °C.   Saturated aqueous NaHCO3 (10 mL) was added, and the 
mixture was extracted with EtOAc (3 × 10 mL).  The combined organics were dried over 
Na2SO4, filtered, and concentrated.  The crude product mixture was dissolved in 10 mL of THF 
and Amberlyst-15 resin was added.  The reaction was stirred at ambient temperature overnight. 
The reaction was filtered and the filtrate was concentrated.  Purification by flash chromatography 
on silica gel (15% EtOAc/hexanes) afforded 0.186 g (72%) of 72 a pale yellow oil:   [α]D = +120 
(c 2.6, CHCl3). IR (thin film):  3073, 2962, 2926, 1683, 1600, 1406, 1275, 1215, 1037, 895 cm-1; 
1H NMR (300 MHz, CDCl3): δ 7.35 (d, J = 6.0 Hz, 1H), 5.39 (d, J = 6.0 Hz, 1H), 4.76 (s, 1H), 
4.67 (s, 1H), 4.50 (ddt, J = 3.7, 7.4, 13.3 Hz, 1H),  2.51 (dd, J = 13.2, 16.8 Hz, 1H), 2.38 (dd, J = 
3.8, 17.0 Hz, 1H),  1.99–1.85 (m, 4H), 1.69 (s, 3H), 1.28–1.20 (m, 1H), 0.91 (d, J = 5.9 Hz, 3H); 
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 13C NMR (75 MHz, CDCl3): δ 192.7, 163.3, 143.8, 112.2, 107.0, 78.0, 46.1, 42.5, 41.4, 26.3, 
22.0, 19.1.  HRMS m/z calcd for C12H18O2:  194.1306; found 194.1300. 
 
                                                
 (2S, 4R)-2-Phenethyl-3, 4-dihydro-2H-pyran-4-yl acetate (73):  To a 0 °C 
solution of 75 mg of pyranone 72 (0.37 mmol) and 0.166 g of CeCl3●7H2O 
(0.445 mmol) in 2 mL of MeOH was added 15 mg of NaBH4 (0.39 mmol) in 
portions.  After 30 min at 0°C, the reaction was quenched by adding 3 mL of water.  The mixture 
was extracted with CH2Cl2 (4 × 10 mL) and the combined organics were dried over Na2SO4, 
filtered, and concentrated.  The crude alcohol (66 mg, 0.337 mmol) was then dissolved in 
CH2Cl2 and cooled to 0 °C.  To this solution was added 0.153 mL of Et3N (1.10 mmol), 4 mg of 
dimethylaminopyridine (DMAP) (0.037 mmol), and 0.052 mL of acetic anhydride (0.551 mmol).  
The resulting clear, colorless solution was then stirred 2 h at ambient temperature. The reaction 
was concentrated and purified by flash chromatography (3% EtOAc/hexanes, with 5% Et3N) to 
afford 85 mg (94%) of the title compound as a clear colorless oil:  [α]D = –5.6 (c 1.2, CHCl3); IR 
(thin film) 3064, 3027, 2931, 2864, 1731, 1645, 1232 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.34–
7.26 (m, 2H), 7.23–7.20 (m, 3H), 6.50 (d, J = 6.3 Hz, 1H), 5.41–5.36 (m, 1H), 4.78–4.75 (m, 
1H), 4.08–3.96 (m, 1H), 2.81–2.71 (m, 2H), 2.29–2.22 (m, 1H), 2.06–2.00 (m, 4H), 1.87–1.71 
(m, 2H); 13C NMR (75 MHz, CDCl3) δ 170.7, 146.6, 141.4, 128.4 (4C), 125.9, 100.9, 73.4, 65.6, 
36.3, 33.3, 31.3, 21.2; LRMS (EI, 70eV):  m/z 246; HRMS calcd for C15H18O3:   246.1256, found 
246.1247. 
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tert-Butyl but-2-ynoate (74):65  Into a pressure tube charged with 5.0 g of 
tetrolic acid (59.5 mmol) was condensed ~ 60 mL of isobutylene at –40 °C.  The mixture was 
Me CO2tBu
 
65 Otaka, A.; Mitsuyama, E.; Kinoshita, T.; Tamamura, H.; Fujii, N. J. Org. Chem. 2000, 65, 4888. 
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 then treated with 0.66 mL of H2SO4 dropwise via syringe and sealed.  The reaction was warmed 
to ambient temperature and maintained for 24 h.  Saturated aqueous K2CO3 (100 mL) was added 
and the mixture was extracted with Et2O (3 × 100 mL).  The combined organics were washed 
with brine, dried over Na2SO4, filtered, and concentrated.  The crude product was purified by 
flash chromatography (2% EtOAc/hexanes) to afford 6.2 g (75%) of the title compound 74 as a 
light yellow liquid:  IR (thin film):  2981, 2935, 2874, 2249, 1705, 1370, 1280, 1163, 1073; 1H 
NMR (300 MHz, CDCl3) δ 1.94 (s, 3H), 1.50 (s, 9H). 
 
tert-Butyl 2-(tributylstannyl)buta-2,3-dienoate (41):  To a 0 °C solution of 
1.40 mL of diisopropylamine (10.0 mmol) in 30 mL of THF was added 5.35 mL 
of a 1.6 M solution of nBuLi in hexanes dropwise via syringe.  The pale yellow solution was 
cooled to –78 °C then treated with 1.00 g of ester 74 (7.14 mmol) in THF (5mL).  The resulting 
orange-red solution was maintained at –78 °C for 1 h then 1.94 mL of nBu3SnCl (7.14 mmol) 
was added dropwise via syringe.  After maintaining for an additional 2 h at –78 °C, saturated 
aqueous NaHCO3 was added and the mixture was extracted with Et2O.  The combined organics 
were washed with brine, dried over anhydrous Na2SO4, filtered, and concentrated.  Purification 
of the crude product by flash chromatography (hexanes) afforded 1.16 g (38%) of the title 
compound as a clear, colorless liquid:  IR (thin film):  2957, 2928, 2872, 2854, 1920, 1709, 
1685, 1457, 1254, 1151, 801 cm-1;   1H NMR (300 MHz, CDCl3) δ 4.60 (s, 2H), 1.60–1.47 (m, 
6H), 1.47 (s, 9H), 1.34 (tq, J = 7.3, 7.3 Hz, 6H), 1.05 (m, 6H), 0.89 (t, J = 7.3 Hz, 9H); 13C NMR 
(75 MHz, CDCl3) δ 213.4, 167.7, 92.5, 80.7, 68.4, 28.8, 28.1, 27.1, 13.6, 10.9; LRMS (EI, 
70eV):  m/z 373 [M-tBu]+ ; HRMS calcd for C16H29O2120Sn:  373.1190, found 373.1187. 
•
tBuO2C
Bu3Sn
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  (6R,2S)-4-(6-Phenethyl-5,6-dihydro-2H-pyran-2-yl)but-2-
ynoic acid tert-butyl ester (76):  To a  –78 °C solution of 70 
mg of glycal acetate 73 (0.284 mmol) in 3 mL of CH2Cl2 was slowly added 0.610 g of 
allenylstannane 41 (1.42 mmol) and a solution of 0.150 mg of tributyltin 
trifluoromethanesulfonate (0.341 mmol) in 1 mL of CH2Cl2 via cannula.  The reaction was 
allowed to slowly warm to ambient temperature.  Saturated aqueous NaHCO3 (5 mL) was added, 
and the mixture was extracted with CH2Cl2 (4 × 12 mL).  The combined organics were dried 
over Na2SO4, filtered, and concentrated.  The crude product mixture was purified by flash 
chromatography (1% EtOAc/Hex) to afford 70 mg (75%) of the title compound as a clear 
colorless oil:  IR (thin film) 3028, 2979, 2928, 2239, 1706, 1603, 1455, 1369, 1279, 1161 cm-1; 
1H NMR (300 MHz, CDCl3) δ  7.32–7.19 (m, 5H), 5.92–5.87 (m, 1H), 5.85–5.80 (m, 1H), 4.47–
4.42 (m, 1H), 3.63 (tt, J = 4.2, 8.2 Hz, 1H), 2.86 (ddd, J = 5.3, 9.1, 14.0 Hz, 1H), 2.76–2.68 (m 
1H), 2.64 (dd, J = 7.1, 16.8 Hz, 1H), 2.50 (dd, J = 7.0, 16.8 Hz, 1H), 2.01–1.96 (m, 2H), 1.93– 
1.72 (m, 2H), 1.49 (s, 9H); LRMS (EI, 70 eV):  m/z 326, 270 [M-tBu]+; HRMS calcd for 
C21H26O3: 326.1882, found 326.1887. 
O Ph
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(2R, 2′S, 4S)-(2,4-Dimethylpent-4-enyl)-3,4-dihydro-2H-pyran-4-yl 
acetate (77): To a 0 °C solution of 66 mg of pyranone   72 (0.34 mmol) 
and 0.152 g of CeCl3●7H20 (0.408 mmol) in 2 mL of MeOH was added 14 
mg of NaBH4 (0.36 mmol) in portions.  After 30 min at 0°C, the reaction was quenched by 
adding 3 mL of water.  The mixture was extracted with CH2Cl2 (4 × 10 mL) and the combined 
organics were dried over Na2SO4, filtered, and concentrated to afford the corresponding allylic 
alcohol.  The crude alcohol (0.066 g, 0.337 mmol) was then dissolved in CH2Cl2 and cooled to 0 
O M
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 °C.  To this solution was added 0.140 mL of Et3N (1.01 mmol), 4 mg of dimethylaminopyridine 
(0.0337 mmol), and 0.048 mL of acetic anhydride (0.505 mmol).  The resulting clear, colorless 
solution was then stirred 2 h at ambient temperature. The reaction was concentrated and purified 
by flash chromatography (3% EtOAc/hexanes, with 5% Et3N) to afford 0.074 g (92%) of the title 
compound as a clear colorless residue.   [α]D = +6.8 (c 2.3, CHCl3). IR (thin film):  3069, 2958, 
2926, 2871, 1734, 1643, 1441, 1370, 1231, 1041, 891 cm-1; 1H NMR (300 MHz, CDCl3): δ 6.45 
(d, J = 6.2 Hz, 1H), 5.43–5.35 (m, 1H), 4.77–4.71 (m, 2H), 4.67 (brs, 1H), 4.14–4.04 (m, 1H), 
2.27–2.16 (m, 1H), 2.05 (s, 3H), 2.00–1.85 (m, 3H), 1.84–1.73 (m, 2H), 1.72 (s, 3H), 1.18–1.09 
(m, 1H), 0.89 (d, J = 5.9 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 171.0, 146.7, 144.3, 111.8, 
100.9, 72.3, 65.8, 46.5, 41.8, 34.2, 26.5, 22.2, 21.4, 19.1; EI-MS e/v 238 (M+), 178, 160, 145, 
121, 109, 91, 81, 66.     
 
 (2R,6R,2′S)-4-[6-(2,4-Dimethylpent-4-enyl)-5,6-
dihydro-2H-pyran-2-yl]but-2-ynoic acid tert-butyl 
ester (78):  To a  –78 °C solution of 42 mg of glycal acetate 77 (0.176 mmol) in 1 mL of CH2Cl2 
was slowly added 0.378 g of allenylstannane 41 (0.882 mmol) and a solution of 85 mg of 
tributyltin trifluoromethanesulfonate (0.194 mmol) in 1 mL of CH2Cl2 via cannula.  The reaction 
was allowed to slowly warm to ambient temperature.  Saturated aqueous NaHCO3 (4 mL) was 
added, and the mixture was extracted with CH2Cl2 (4 × 10 mL).  The combined organics were 
dried over Na2SO4, filtered, and concentrated.  The crude product mixture was purified by flash 
chromatography (1% EtOAc/Hex) to afford 0.040 g (71%) of the title compound as a clear 
colorless oil:  [α]D = –74 (c 2.1, CHCl3). IR (thin film):  3069, 3034, 2974, 2935, 2242, 1707, 
1457, 1370, 1275, 1164, 1073, 843 cm-1; 1H NMR (300 MHz, CDCl3): δ 5.95–5.89 (m, 1H), 
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 5.84–5.79 (m, 1H), 4.75–4.74 (m, 1H), 4.67 (br s, 1H), 4.43–4.38 (m, 1H), 3.82–3.76 (m, 1H), 
2.65 (dd, J = 7.1, 16.8 Hz, 1H), 2.54 (dd, J = 6.8, 16.8 Hz, 1H), 2.04–1.87 (m, 5H), 1.71 (s, 3H), 
1.62 (ddd, J = 3.5, 9.9, 13.6 Hz, 1H), 1.49 (s, 9H), 1.11 (ddd, J = 3.1, 9.2, 13.9 Hz, 1H), 0.89 (d, 
J = 6.4 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 152.7, 144.6, 127.6, 126.2, 111.7, 83.3, 83.1, 
75.9, 70.4, 66.0, 46.6, 42.4, 31.1, 28.0, 26.6, 24.7, 22.2, 19.2; EI-MS e/v 317 (M+-H), 261, 219, 
179, 161, 109, 95, 67, 57.   
 
 4-((2R,6R)-5,6-dihydro-6-((4S)-2,4-dimethylpent-4-enyl)-2H-
pyran-2-yl)but-2-ynoic acid (80):66  To a 0 °C solution of 0.026 g 
of ester 78 (0.082 mmol) in 2.0 mL of CH2Cl2 was added 0.095 
mL of 2,6-lutidine (0.82 mmol) followed by 0.075 mL of tert-butyldimethyltrifluoromethane 
sulfonate (0.41 mmol).  The resulting yellow solution was maintained at 0 °C for 1.5 h before 
being quenched with H2O.  The mixture was extracted with CH2Cl2 (3 × 10 mL) and the 
combined organics were subsequently washed with 0.1 M citric acid (20 mL) and brine (20 mL).  
The organics were then dried over Na2SO4, filtered, and concentrated to afford 0.020 g (95%) of 
a pale yellow oil:  1H NMR (300 MHz, CDCl3): δ 6.89 (br s, 1H), 5.96–5.89 (m, 1H), 5.85–5.75 
(m, 1H), 4.80–4.70 (m, 1H), 4.66 (br s, 1H), 4.48–4.35 (m, 1H), 3.79 (1H), 2.68 (dd, J = 7.0, 
16.9 Hz, 1H), 2.58 (dd, J = 6.9, 16.9 Hz, 1H), 2.10–1.80 (m, 5H), 1.70 (s, 3H), 1.62 (ddd, J = 
3.4, 9.8, 13.6 Hz, 1H), 1.12 (ddd, J = 3.2, 9.1, 13.8 Hz, 1H), 0.88 (d, J = 6.2, Hz, 3H); 13C NMR 
(75 MHz, CDCl3): δ 156.8, 144.9, 127.6, 126.5, 111.9, 87.0, 70.6, 66.5, 46.8, 42.6, 31.4, 26.9, 
25.0, 22.4, 19.5, 2.2. 
Me
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66 Full characterization was not obtained for compounds 80, 83, and 79 as they were a part of a failed route to 
macrocycle 84. 
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 1-(S)-(tert-Butyldiphenylsilyloxymethyl)-5-trityloxy-pent-3-
enyl-4-(2R,6R)-[6-(4S)-(2,4-dimethylpent-4-enyl)-5,6-dihydro-
2H-pyranyl]but-2-ynoate (82): To a 0 °C solution of 42 mg of 
alcohol 40 (68.7 µmol),  9 mg of acid 80 (34.3 µmol), and  2.7 
mg of DMAP (6.87 µmol) in 450 µL of CH2Cl2 was added 9 mg of DCC (41.2 µmol) in one 
portion.  The reaction was maintained at ambient temperature overnight.  After diluting with 
pentane, the reaction mixture was filtered through Celite and concentrated.  Purification by flash 
chromatography (2% EtOAc/hexanes) afforded 9 mg (31 %) of the title compound as a clear, 
colorless residue:  [α]D = –177 (c 0.9, CHCl3); IR (thin film):  3062, 3029, 2955, 2928, 2853, 
2238, 1709, 1488, 1446, 1246 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.67 (d, J = 7.3 Hz, 4H), 
7.50–7.20 (m, 21H), 5.95–5.85 (m, 1H), 5.85–5.77 (m, 1H), 5.75–5.55 (m, 2H), 5.10 (dddd, J = 
6.2, 6.2, 6.2, 6.2 Hz, 1H), 4.73 (br s, 1H), 4.66 (br s, 1H), 4.46–4.35 (m, 1H), 3.82–3.75 (m, 1H), 
3.74 (d, J = 7.0 Hz, 2H), 3.54 (d, J = 3.1 Hz, 2H), 2.68 (dd, J = 6.6, 16.8 Hz, 1H), 2.59 (dd, J = 
7.4, 16.8 Hz, 1H), 2.49–2.32 (m, 2H), 2.05–1.85 (m, 5H), 1.69 (s, 3H), 1.62 (ddd, J = 3.3, 9.9, 
13.6 Hz, 1H), 1.18–1.02 (s+m, 10H), 0.88 (d, J = 6.0 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 
153.4, 147.2, 144.8, 144.5 (2C), 135.9 (2C), 133.6, 131.0, 130.0, 129.0 (4C), 128.2, 128.1, 128.0, 
127.5, 127.2, 126.4, 111.9, 87.1, 86.2, 77.5, 75.7, 75.1, 70.5, 66.4, 64.9, 64.4, 46.8, 42.6, 33.8, 
31.4, 27.1 (3C), 27.0, 25.1, 22.5, 19.5; LRMS (EI, 70eV):  m/z 856.   
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 1-(S)-(tert-Butyldiphenylsilyloxymethyl)-5-hydroxy-pent-3-
enyl-4-(2R,6R)-[6-(4S)-(2,4-dimethylpent-4-enyl)-5,6-dihydro-
2H-pyranyl]but-2-ynoate (83): A solution of 13 mg of trityl 
ether 82 (15.2 µmol) in 200 µL of 2% TfOH in CHCl3/MeOH 
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 was maintained for 30 min at ambient temperature.  Saturated aqueous NaHCO3 was added (1 
mL) and the mixture was extracted with CH2Cl2 (3 × 10 mL). The combined organics were dried 
over Na2SO4, filtered, and concentrated.  Purification by flash chromatography on silica gel 
provided 7 mg (75%) of the title compound as a pale yellow residue:  IR (thin film):  3417, 2957, 
2925, 2855, 2237, 1712, 1463, 1248, 1186, 1080, 968 cm-1; 1H NMR (300 MHz, CDCl3): δ 
7.70–7.64 (m, 4H), 7.49–7.36 (m, 6H), 5.97–5.89 (m, 1H), 5.85–5.79 (m, 1H), 5.71 (dt, J = 5.5, 
15.4 Hz, 1H), 5.59 (dt, J = 6.7, 15.3 Hz, 1H), 5.08 (app quintet, J = 5.5 Hz, 1H), 4.73 (br s, 1H), 
4.66 (br s, 1H),  4.46–4.38 (m, 1H), 4.06 (br d, 2H), 3.82–3.73 (m, 1H), 3.72 (dd, J = 5.7, 11.0 
Hz, 1H), 3.67 (dd, J = 4.9, 11.0 Hz, 1H), 2.69 (dd, J = 6.7, 16.9 Hz, 1H), 2.60 (dd, J = 7.1, 16.8 
Hz, 1H), 2.51–2.32 (m, 2H), 2.04–1.85 (m, 5H), 1.69 (s, 3H), 1.62 (ddd, J = 3.4, 10.0, 13.7 Hz, 
1H), 1.12 (ddd, J = 3.1, 9.0, 12.3 Hz, 1H), 1.06 (s, 9H), 0.88 (d, J = 6.3 Hz, 3H); HRMS calcd 
for C38H50O5SiNa: 637.3325, found 637.3353. 
 
1-(S)-(tert-Butyldiphenylsilyloxymethyl)-5-oxo-pent-3-enyl-4-
(2R,6R)-[6-(2,4-dimethylpent-4-enyl)-5,6-dihydro-2H-
pyranyl]but-2-ynoate (79): To a mixture of 13 mg of allylic 
alcohol 83 (21.2 µmol), 4 mg of N-methylmorpholine N-oxide 
(31.8 µmol), and 11 mg of 4Å molecular sieves in 150 µL of CH2Cl2 at ambient temperature was 
added 1 mg of tetrapropylammonium perrhuthenate (1.06 µmol).  The reaction was maintained 
for 30 min, then filtered through silica gel (40% EtOAc/hexanes).  The filtrate was concentrated 
to afford 10 mg (77%) of the title compound 79 as a light yellow residue:  1H NMR (300 MHz, 
CDCl3):   δ 9.46 (d, J = 7.8 Hz, 1H), 7.67–7.61 (m, 4H), 7.46–7.35 (m, 6H), 6.71 (dt, J = 7.2, 
15.6 Hz, 1H), 6.14 (dd, J  = 7.8 Hz, 15.6 Hz, 1H), 5.95–5.89 (m, 1H), 5.83–5.74 (m, 1H), 5.16 
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 (dddd, J = 5.3, 5.3, 5.3, 5.3 Hz, 1H), 4.71 (br s, 1H), 4.65 (br s, 1H), 4.49–4.35 (m, 1H), 3.85–
3.69 (m, 3H), 2.75–2.50 (m, 3H), 2.05–1.84 (m, 5H), 1.66 (s, 3H), 1.05 (s, 9H), 0.96 (d, J = 6.6 
Hz, 3H). 
 
 (4R)-4-Methyloxetan-2-one (ent-91):  To a –78 °C solution of 1.3 g of aluminum 
triamine catalyst ent-36 (2.27 mmol) and 14.6 g of tetrabutylammonium bromide 
(45.4 mmol) in 91 mL of CH2Cl2 was added 6.72 mL of DIPEA (38.6 mmol) followed by 3.20 
mL of acetyl bromide (43.1 mmol).  The resulting yellow solution was stirred several minutes at 
–78 °C whereupon 1.27 mL of acetaldehyde (22.7 mmol) was added slowly dropwise via 
syringe.  The reaction was maintained at –78 °C overnight, and was quenched by pouring into 
cold hexanes (300 mL).  The resulting mixture was filtered through silica gel (40% EtOAc/Hex) 
and concentrated to yield 1.7 g (87%, crude) of ent-91 as a pale yellow liquid:  Separation of the 
enantiomers by chiral GC [Chiraldex G-TA column, flow rate 1.5 mL/min, method:  80 °C for 
5.0 min, ramp at 5.0 °C/min to 100 °C for 10.0 min, ramp at 5.0 °C to 130 °C for 5 min.  Tr  8.04 
min (R) and 9.05 min (S)] determined the enantiomeric excess to be 99%; 1H NMR (300 MHz, 
CDCl3): δ 4.61 (ddq, J = 4.2, 6.0, 12.0 Hz, 1H), 3.48 (dd, J = 5.7, 16.3 Hz, 1H), 2.98 (dd, J = 4.3, 
16.3 Hz, 1H), 1.47 (d, J = 8.2 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 168.0, 67.7, 44.0, 20.2. 
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 (3R)-3-Hydroxy-N-methoxy-N-methylbutyramide (ent-92): To a 0 °C 
solution containing 6.32 g of N,O-methoxymethylamine hydrochloride 
(65.1 mmol) in 30 mL CH2Cl2 was added 65 mL of dimethylaluminum chloride (65 mmol) as a 1 
M solution in hexanes.  The solution was allowed to warm to ambient temperature and stirred for 
2 h.  The resulting suspension was treated with a solution of ent-91 in 5 mL of CH2Cl2 via 
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 cannula.  The reaction mixture was maintained at ambient temperature overnight and then 
quenched with 36 mL (3 mL/mmol Me2AlCl) of pH 8 phosphate buffer.  The reaction was 
filtered through Celite to remove the solid aluminum salts.  The resulting mixture was separated, 
and the aqueous layer was washed with CH2Cl2 (3 × 100 mL).  The combined organics were 
dried over Na2SO4, filtered, and concentrated.  The crude oil was purified by silica gel 
chromatography (Et2O) to provide 3.8 g (81%) of the β-hydroxy amide ent-92 as a pale yellow 
oil: [α]D = –58 (c 3.0, CHCl3); IR (thin film): 3448, 3008, 2974, 2938, 1642, 1420, 1389, 1216, 
1002, 754 cm-1; 1H NMR (300 MHz, CDCl3): δ 4.21 (ddq, J = 2.6, 6.3, 9.0 Hz, 1H), 3.70 (s, 3H), 
3.20 (s, 3H), 2.67 (d, J = 16.7 Hz, 1H), 2.44 (dd, J = 9.5, 16.8 Hz, 1H), 1.24 (d, J = 6.3 Hz, 3H); 
13C NMR (75 MHz, CDCl3): δ 173.6, 64.0, 61.2, 39.7, 31.7, 22.2; HRMS calcd for C6H13NO3: 
147.0895, found 147.0895. 
 
(3R)-3-(tert-Butyldiphenylsilyloxy)-N-methoxy-N-methyl-
butyramide (ent-93): To a 0 °C solution of 0.730 g of the β-hydroxy 
amide ent-92 (4.96 mmol) in 8 mL of CH2Cl2 was added 1.73 mL of DIPEA (9.93 mmol), 1.42 
mL of TBDPSCl (5.46 mmol), and 0.607 g of DMAP (4.96 mmol).  The resulting solution was 
warmed to ambient temperature and maintained for 18 h.  Saturated aqueous NaHCO3 (20 mL) 
was added, and the mixture was extracted with CH2Cl2 (3 × 20 mL).  The combined organics 
were washed with 1 M HCl (50 mL) and brine (50 mL), dried over Na2SO4, filtered, and 
concentrated.  The crude product was purified by flash chromatography on silica gel (15% 
EtOAc/hexanes) to afford 1.8 g (94%) of ent-93 as a pale yellow oil: [α]D = –9.1 (c 3.8, CHCl3); 
IR (thin film): 3069, 3045, 2964, 2930, 2856, 1660, 1472, 1385, 1178, 1002, 940 cm-1; 1H NMR 
(300 MHz, CDCl3): δ 7.79–7.71 (m, 4H), 7.46–7.36 (m, 6H), 4.45 (sextet, J = 6.0 Hz, 1H), 3.61 
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 (s, 3H), 3.14 (s, 3H), 2.84 (dd, J = 6.0, 15.0 Hz, 1H), 2.44 (dd, J = 6.0, 15.0 Hz, 1H), 1.16 (d, J = 
6.0 Hz, 3H), 1.07 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 171.9, 135.8, 135.7, 134.5, 134.0, 
129.5, 129.4, 127.4, 127.3, 66.9, 61.1, 41.8, 31.4, 26.9, 23.7, 19.1; HRMS calcd for 
C22H30NO3Si: 384.1995, found 384.1976.  
 
  (3R)-3-(tert-Butyldiphenylsilyloxy)butyraldehyde (ent-94): To a –78 °C 
solution of 0.700 g of ent-93 (1.82 mmol) in 11 mL of dry Et2O was added a 
1.0 M hexanes solution of DIBAL-H (2.00 mmol) dropwise.  The resulting colorless solution 
was maintained at –78 °C for 30 min.  The reaction was quenched with 1 M HCl (20 mL) and 
extracted with Et2O (3 × 20 mL).  The combined organics were washed with brine (30 mL) and 
filtered through Celite.  The filtrate was then dried over Na2SO4, filtered, and concentrated.  
Purification by flash chromatography on silica gel (5% EtOAc/hexanes) afforded 0.569 g (95%) 
of the aldehyde as a clear, colorless liquid: [α]D = +7.5 (c 2.9, CHCl3); IR (thin film)  3069, 
3048, 2961, 2930, 2893, 2859, 2720, 1728, 1425, 1379, 1110, 823 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 9.78 (t, J = 2.6 Hz, 1H), 7.75–7.69 (m, 4H), 7.49–7.38 (m, 6H), 4.38 (sextet, J = 6.0 
Hz, 1H), 2.57 (ddd, J = 2.9, 6.0, 15.8 Hz, 1H), 2.49 (ddd, J = 2.2, 5.6, 15.8 Hz, 1H), 1.21 (d, J = 
6.0 Hz, 3H), 1.08 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 202.1, 136.1, 134.4, 134.0, 130.2, 
130.0, 128.0, 127.9, 66.0, 53.1, 27.2, 24.1, 19.5; HRMS calcd for C16H17O2Si: 269.0998, found 
269.0999. 
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 (4R,2′R)-4-[2-(tert-Butyldiphenylsilyloxy)propyl]oxetan-2-one (ent-96): 
To a –50 °C solution of 0.870 g of aluminum triamine catalyst ent-36 (1.50 
mmol) in 25 mL of CH2Cl2 was added 4.43 mL of DIPEA (25.4 mmol) followed by 2.10 mL of 
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 acetyl bromide (28.4 mmol).  The resulting yellow solution was stirred at –50 °C whereupon 
4.88 g of the aldehyde ent-94 (15.0 mmol) in 5 mL of CH2Cl2 was added dropwise via syringe.  
The reaction was maintained at –50 °C overnight, and was quenched by pouring into cold 
hexanes (150 mL).  The resulting mixture was filtered through silica gel (50% EtOAc/hexanes) 
and concentrated.  The crude product was then purified by flash chromatography on silica gel 
(3% EtOAc/hexanes) to afford 4.77 g (86%) of ent-96 as a viscous, colorless oil: [α]D = +17 (c 
2.6, CHCl3); IR (thin film): 3072, 3051, 2964, 2930, 2893, 2859, 1824, 1425, 1376, 1110, 909 
cm-1; 1H NMR (300 MHz, CDCl3): δ 7.70–7.66 (m, 4H), 7.45–7.38 (m, 6H), 4.69 (dq, J = 4.4, 
6.7 Hz, 1H), 4.04 (sextet, J = 6.1 Hz, 1H), 3.29 (dd, J = 5.8, 16.3 Hz, 1H), 2.95 (dd, J = 4.3, 16.3 
Hz, 1H), 2.13 (dt, J = 6.3, 14.0 Hz, 1H), 1.81 (ddd, J = 5.0, 7.0, 14.0 Hz, 1H), 1.19 (d, J = 6.2 
Hz, 3H), 1.09 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 168.4, 136.2, 136.1, 134.3, 134.0, 130.2, 
130.1, 128.1, 127.9, 68.8, 66.7, 44.0, 43.6, 27.3, 23.6, 19.5; HRMS calcd for C18H19O3Si: 
311.1103, found 311.1107. 
 
(3S,5R)-5-(tert-Butyldiphenylsilyloxy)-3-methylhexanoic acid (97): 
To a –50 °C solution of 2.69 g of CuBr (18.8 mmol) in 185 mL of THF 
and 20 mL of dimethylsulfide was added 12.5 mL of a 3.0 M ethereal solution of 
methylmagnesium bromide (37.5 mmol) slowly dropwise. The resulting clear, faint green 
solution was stirred at –50 °C for 30 min then warmed to –30 °C for 30 min.  The reaction was 
then cooled to –50 °C and 4.6 g of ent-96 (12.5 mmol) in 15 mL of THF was added via cannula.  
After maintaining the reaction at –50 °C for 45 min, 2.4 mL of TMSCl (18.8 mmol) was added 
and the reaction was allowed to warm to ambient temperature overnight.  A mixture of saturated 
NH4Cl (500 mL) and 1 M HCl (200 mL) was added and the mixture was extracted with Et2O (4 
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 × 150 mL). The combined organics were washed with saturated NH4Cl and brine (50 mL), dried 
over Na2SO4, filtered, and concentrated.  The crude product was purified by flash 
chromatography on silica gel (10% EtOAc/hexanes) to afford 3.85 g (80%) of 97 as a pale 
yellow viscous oil: [α]D = +6.7 (c 2.2, CHCl3); IR (thin film): 3070, 3045, 2961, 2928, 2853, 
1704, 1426, 1373, 1108, 909, 820 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.82–7.77 (m, 4H), 7.52–
7.41 (m, 6H), 4.02–3.92 (m, 1H), 2.32–2.20 (m, 2H), 2.15–2.06 (m, 1H), 1.69 (ddd, J = 5.1, 7.5, 
13.0 Hz, 1H), 1.32 (ddd, J = 4.6, 7.7, 13.0 Hz, 1H), 1.15-1.18 (m, 12H), 0.91 (d, J = 6.4 Hz, 3H); 
13C NMR (75 MHz, CDCl3): δ 179.6, 135.9, 134.8, 134.2, 129.6, 129.4, 127.5, 127.4, 67.5, 46.7, 
41.9, 27.0, 26.7, 24.0, 19.7, 19.3; HRMS calcd for C19H23O3Si: 327.1416, found 327.1419. 
  
(3S,5R)-5-(tert-Butyldiphenylsilyloxy)-3-methylhexanal (98): To a 
solution of 3.75 g of carboxylic acid 97 (9.76 mmol) in 50 mL of Et2O at 
ambient temperature was added 7.3 mL of a 2.0 M THF solution of H3B•SMe2 (14.6 mmol) 
slowly dropwise.  The resulting clear, colorless solution was heated to reflux and maintained 1 h.  
After cooling to ambient temperature, the solvent was removed, and the remaining viscous 
residue was dissolved in 50 mL of CH2Cl2.  To this colorless solution was added 5.26 g of 
pyridinium chlorochromate (24.4 mmol), and the resulting brown suspension was heated to 
reflux and maintained for 2.5 h.  The reaction was then cooled to ambient temperature, diluted 
with Et2O, filtered through Celite, and concentrated.  The crude product was purified by flash 
chromatography on silica gel (5% EtOAc/hexanes) to afford 3.05 g (85%) of 98 as a pale yellow 
oil:  [α]D = –1.0 (c 2.6, CHCl3); IR (thin film): 3067, 3048, 2959, 2928, 2853, 2708, 1726, 1426, 
1373, 1111, 1067, 823 cm-1; 1H NMR (300 MHz, CDCl3): δ 9.63 (t, J = 2.5 Hz, 1H), 7.72–7.67 
(m, 4H), 7.44–7.36 (m, 6H), 3.91–3.81 (m, 1H), 2.23–2.07 (m, 2H), 1.55 (ddd, J = 5.0, 7.7, 13.0 
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 Hz, 1H), 1.23 (ddd, J = 4.7, 8.2, 13.4 Hz, 1H), 1.09 (d, J = 6.0 Hz, 3H), 1.06 (s, 9H), 0.78 (d, J = 
6.4 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 202.6, 135.9, 134.7, 134.2, 129.6, 129.5, 127.6, 
127.4, 67.5, 51.3, 47.1, 27.1, 24.9, 24.0, 20.0, 19.3. 
 
(4R,2′S,4′R)-4-[4′-(tert-Butyldiphenylsilyloxy)-2-methyl-
pentyl]oxetan-2-one (99):  To a –50 °C solution of 0.704 g of 
aluminum triamine catalyst ent-36 (1.21 mmol) in 16 mL of CH2Cl2 was added 2.40 mL of 
DIPEA (13.7 mmol) followed by 1.13 mL of acetyl bromide (15.3 mmol).  The resulting yellow 
solution was stirred at –50 °C whereupon 2.97 g of the aldehyde 98 (8.07 mmol) in 5 mL of 
CH2Cl2 was added slowly dropwise via syringe.  The reaction was maintained at –50 °C 
overnight, and was quenched by pouring into cold hexanes (100 mL).  The resulting mixture was 
filtered through silica gel (50% EtOAc/Hex) and concentrated.  The crude product was then 
purified by flash chromatography on silica gel (11% hexanes/benzene) to afford 2.76 g (84%) of 
99 as a white solid: [α]D = +21 (c 2.3, CHCl3); IR (thin film): 3070, 3048, 2965, 2931, 2853, 
1828, 1426, 1376, 1200, 1111, 1061, 820 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.72–7.66 (m, 
4H), 7.47–7.35 (m, 6H), 4.45 (dtd, J = 4.5, 5.6, 8.0 Hz, 1H), 3.90–3.80 (m, 1H), 3.45 (dd, J = 
5.7, 16.2 Hz, 1H), 2.95 (dd, J = 4.3, 16.2 Hz, 1H), 1.84-1.73 (m, 1H), 1.67 (ddd, J = 5.2, 7.8, 
13.7 Hz, 1H), 1.54 (ddd, J = 5.2, 7.6, 13.4 Hz, 1H), 1.37 (ddd, J = 5.3, 7.9, 13.6 Hz, 1H), 1.20 
(ddd, J = 4.9, 8.2, 12.7 Hz, 1H), 1.10 (d, J = 6.0 Hz, 3H), 1.05 (s, 9H), 0.76 (d, J = 6.5 Hz, 3H); 
13C NMR (75 MHz, CDCl3): δ 168.2, 135.9, 134.7, 134.3, 129.6, 129.5, 127.6, 127.4, 69.7, 67.4, 
47.2, 43.4, 42.2, 27.0, 26.7, 24.1, 19.6, 19.3; HRMS calcd for C21H25O3Si: 353.1572, found 
353.1559. 
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 (2R,2′S,4′R)-2-[4-(tert-Butyldiphenylsilyloxy)-2-methyl-pentyl]-2,3-
dihydropyran-4-one (100): To a 0 °C solution of 0.690 mL of 
diisopropylamine (4.93 mmol) in 20 mL of THF was added 2.95 mL of 
a 1.6 M solution of nBuLi in hexanes (4.68 mmol) slowly dropwise.  The solution was 
maintained at 0 °C for 30 min, then treated with 0.590 mL of acetaldehyde N-piperidine 
hydrazone (4.93 mmol).  The resulting heterogeneous mixture was stirred at 0 °C for 1 h, then 
cooled to –78 °C whereupon 1.01 g of 99 (2.46 mmol) in 2 mL of THF was added via cannula.  
The resultant yellow solution was maintained at –78 °C overnight.  The reaction was quenched 
with saturated NaHCO3 and extracted with EtOAc (3 × 20 mL).  The combined organics were 
washed with brine, dried over Na2SO4, filtered, and concentrated.  The remaining residue was 
dissolved in THF and treated with 2.8 g of camphorsulfonic acid (12.1 mmol).  The reaction was 
warmed to 60 °C over the course of 1 h and then allowed to cool to ambient temperature. The 
reaction was quenched with with saturated NaHCO3 and extracted with EtOAc.  The combined 
organics were washed with brine, dried over Na2SO4, filtered, and concentrated. Purification by 
flash chromatography on silica gel (8% EtOAc/hexanes) afforded 0.665 g (62%) of 100 as a 
yellow oil:  [α]D = +68 (c 2.1, CHCl3);  IR (thin film): 3073, 3051, 2962, 2931, 2860, 1673, 
1593, 1429, 1274, 1114, 909 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.73–7.68 (m, 4H), 7.47–7.35 
(m, 6H), 7.29 (d, J = 6.0 Hz, 1H), 5.39 (dd, J = 1.0, 6.0 Hz, 1H), 4.40 (ddt, J = 4.0, 8.3, 13.2 Hz, 
1H), 3.94-3.84 (m, 1H), 2.43 (dd, J = 12.5, 16.8 Hz, 2H), 1.97-1.81 (m, 1H), 1.67 (ddd, J = 4.5, 
9.5, 14.2 Hz, 1H), 1.52 (ddd, J = 5.7, 7.3, 13.4 Hz, 1H), 1.12 (d, J = 6.0 Hz, 3H),  1.06 (s, 9H), 
0.76 (d, J = 6.6 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 192.5, 163.0, 135.9, 134.7, 134.3, 129.5, 
129.4, 127.5, 127.4, 106.9, 67.5, 47.6, 47.1, 42.4, 41.9, 27.0, 25.3, 24.0, 19.4, 19.2; HRMS calcd 
for C23H27O3Si: 379.1729, found 379.1729. 
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  (2R,2′S,4′R, 4S)-2-[4-(tert-Butyldiphenylsilyloxy)-2-methylpentyl]-
3,4-dihydro-2H-pyran-4-yl acetate (87):  To a 0 °C solution of 0.408 
g of 100 (0.936 mmol) and 0.418 g of CeCl3●7H20 (1.12 mmol) in 10 
mL of MeOH was added 0.039 g of NaBH4 (1.03 mmol) portionwise.  After 40 min at 0 °C, the 
reaction was quenched by adding 10 mL of water.  The mixture was extracted with CH2Cl2 (4 
× 20 mL) and the combined organics were dried over Na2SO4, filtered, and concentrated to 
afford the corresponding allylic alcohol.  The crude alcohol (0.410 g, 0.936 mmol) was then 
dissolved in 8 mL of CH2Cl2 and cooled to 0 °C.  To this solution was added 0.391 mL of Et3N 
(2.81 mmol), 0.011 g of DMAP (0.0936 mmol), and 0.135 mL of acetic anhydride (1.40 mmol).  
The resulting clear, colorless solution was then maintained at ambient temperature for 2 h.  The 
reaction was concentrated and purified by flash chromatography (hexanes/ Et3N 50:1) to afford 
0.404 g (90%) of the allylic acetate as a clear colorless oil: [α]D = +17.1 (c 2.0, CHCl3); IR (thin 
film): 3070, 3048, 2961, 2931, 2856, 1729, 1645, 1429, 1370, 1231, 1108, 1040, 912 cm-1; 1H 
NMR (300 MHz, CDCl3): δ 7.73–7.68 (m, 4H), 7.43–7.35 (m, 6H), 6.41 (d, J = 6.2 Hz, 1H), 
5.38 (tq J = 1.5, 6.6 Hz, 1H), 4.72 (ddd, J = 2.2, 3.8, 6.2 Hz, 1H), 4.03–3.95 (m, 1H), 3.94–3.83 
(m, 1H), 2.16–2.10 (m, 1H), 2.05 (s, 3H), 1.95–1.78 (m, 1H), 1.69–1.57 (m, 1H), 1.56–1.47 (m, 
1H), 1.19 (ddd, J = 5.3, 8.0, 13.5 Hz, 1H), 1.10–1.06 (m, 12H), 0.75 (d, J = 6.5 Hz, 3H); 13C 
NMR (75 MHz, CDCl3): δ 171.8, 146.7, 135.9, 134.9, 134.4, 129.5, 129.4, 127.5, 127.3, 100.8, 
72.2, 67.6, 65.7, 47.7, 42.2, 34.0, 27.0, 25.5, 24.0, 21.2, 19.5, 19.2; EI-MS m/z 423 (M+-tBu), 
363 (M+-tBu-AcOH), 253, 199, 147; HRMS calcd for C23H27O2Si: 363.1780, found 363.1765. 
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   (2R,4R,2′S,4′R)-tert-Butyl 4-{6-[4-(tert-
butyldiphenylsiloxy)-2-methylpentyl]-5,6-dihydro-
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 2H-pyran-2-yl}but-2-ynoate (103):  To a  –78 °C solution of 0.065 g of 87 (0.135 mmol) in 1 
mL of dry CH2Cl2 was slowly added 0.290 g of 41 (0.677 mmol) in 0.5 mL of CH2Cl2 followed 
by a solution of 0.065 g of tributyltin trifluoromethanesulfonate (0.149 mmol) in 1 mL of CH2Cl2 
via cannula.  The reaction was maintained at –78 °C for 2 h, then allowed to slowly warm to 
ambient temperature.  Saturated aqueous NaHCO3 (5 mL) was added, and the mixture was 
extracted with CH2Cl2 (4 × 10 mL).  The combined organics were washed with brine, dried over 
Na2SO4, filtered, and concentrated.  The crude product mixture was purified by flash 
chromatography (1% EtOAc/hexanes) to afford 0.056 g (74%) of 103 as a clear colorless oil: 
[α]D = –25 (c 1.2, CHCl3); IR (thin film):  3071, 3045, 2963, 2930, 2857, 2240, 1708, 1427, 
1369, 1279, 1160, 1074, 702 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.80–7.60 (m, 4H), 7.50–7.32 
(m, 6H), 5.95–5.80 (m, 2H), 4.40–4.29 (m, 1H), 3.75–3.20 (m, 1H), 3.88 (dq, J = 6.0, 12.0 Hz, 
1H), 2.58 (dd, J = 6.6, 16.7 Hz, 1H), (dd, J = 6.0, 16.5 Hz, 1H) 2.00–1.70 (m, 4H), 1.60 (s, 3H), 
1.49 (s, 9H), 1.38 (ddd, J = 4.5, 9.1, 13.9 Hz, 1H), 1.25–1.14 (m, 1H), 1.08 (d, J = 6.0 Hz, 1H), 
1.05 (s, 9H), 0.75 (d, J = 6.5 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 152.7, 135.9, 134.9, 134.4, 
129.4, 129.3, 127.5, 127.4, 127.3, 126.0, 83.2, 83.0, 76.0, 70.1, 67.6, 66.0, 47.7, 42.4, 31.6, 30.8, 
29.7, 28.0 (3C), 27.0 (3C), 25.4, 24.7, 24.0, 22.6, 19.7, 19.3, 14.1; HRMS m/z calcd for 
C35H48O4Si [M+Na]+: 583.3220, found 583.3203. 
 
  (2R,4S,2′S)-(2-methyl-4-oxopentyl)-3,4-dihydro-2H-pyran-4-yl 
acetate (104): To a 0 °C solution of 0.400 g of allylic acetate 87 (0.833 
mmol) in 0.25 mL of THF was added 1.95 mL of a 1.0 M THF solution of 
tetrabutylammonium fluoride (1.95 mmol) slowly dropwise.  The reaction was warmed to 
ambient temperature, maintained for 6 h, then diluted with EtOAc (100 mL).  The solution was 
washed with brine, dried over Na2SO4, filtered, and concentrated. The crude alcohol was 
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 dissolved in 6 mL of CH2Cl2 and 1.0 g of 4 Å molecular sieves was added followed by 0.784 g 
of pyridinium dichromate (2.08 mmol).  The resulting brown suspension was maintained at 
ambient temperature for 1.5 h before being diluted with Et2O (100 mL) and filtered through 
Celite.   The filtrate was concentrated and the crude product mixture was purified by flash 
chromatography on silica gel (hexanes/Et3N 50:1) to afford 0.160 g (80%) of 104 as a clear, 
colorless residue: [α]D = +9.8 (c 2.5, CHCl3); IR (thin film):  3067, 2960, 2930, 1729, 1644, 
1372, 1232, 1042, 1023, 805 cm-1; 1H NMR (300 MHz, CDCl3): δ 6.40 (d, J = 6.2 Hz, 1H), 
5.38–5.33 (m, 1H), 4.72–4.69 (m, 1H), 4.05–3.97 (m, 1H), 2.50–2.22 (m, 3H), 2.20–2.13 (m, 
1H), 2.10 (s, 3H), 2.02 (s, 3H), 1.73–1.61 (m, 2H), 1.27 (ddd, J = 3.3, 8.4, 14.0 Hz, 1H), 0.92 (d, 
J = 6.1 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 208.1, 170.7, 146.4, 100.9, 72.2, 65.5, 51.4, 
41.7, 34.0, 30.2, 25.7, 21.1, 19.6. 
 
(2R,6R,2′S)-4-[6-(2-Methyl-4-oxo-pentyl)-5,6-
dihydro-2H-pyran-2-yl]but-2-ynoic acid tert-butyl 
ester (86): To a  –78 °C solution of 0.064 g of 104 (0.267 mmol) in 1 mL of dry CH2Cl2 was 
slowly added 0.457 g of 41 (1.07 mmol) in 0.5 mL of CH2Cl2 followed by a solution of 0.129 g 
of tributyltin trifluoromethanesulfonate (0.293 mmol) in 1 mL of CH2Cl2 via cannula.  The 
reaction was maintained at –78 °C for 2 h, then allowed to slowly warm to ambient temperature.  
Saturated aqueous NaHCO3 (5 mL) was added, and the mixture was extracted with CH2Cl2 (4 × 
6 mL).  The combined organics were washed with brine, dried over Na2SO4, filtered, and 
concentrated.  The crude product mixture was purified by flash chromatography (2% 
EtOAc/hexanes) to afford 0.068 g (80%) of 86 as a clear colorless oil: [α]D = –72 (c 1.5, CHCl3); 
IR (thin film): 3039, 2980, 2931, 2241, 1706, 1369, 1282, 1160, 1074, 912, 732 cm-1; 1H NMR 
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 (300 MHz, CDCl3): δ 5.92–5.85 (m, 1H), 5.79–5.74 (m, 1H), 4.46–4.34 (m, 1H), 3.74 (dtd, J = 
3.6, 8.5, 12.5 Hz, 1H), 2.61 (dd, J = 7.0, 16.9 Hz, 1H), 2.50 (dd, J = 6.9, 17.0 Hz, 1H), 2.44 (dd, 
J = 6.9, 17.0 Hz, 1H), 2.33–2.22 (m, 2H), 2.11 (s, 3H), 2.02–1.82 (m, 3H), 1.53 (ddd, J = 4.5, 
9.7, 14.0 Hz, 1H), 1.45 (s, 9H), 1.22 (ddd, J = 3.1, 8.3, 12.9 Hz, 1H), 0.92 (d, J = 6.2 Hz, 3H); 
13C NMR (75 MHz, CDCl3): δ 208.6, 152.5, 127.4, 125.9, 83.3, 82.9, 75.9, 70.1, 66.1, 51.6, 
42.1, 30.8, 30.0, 28.0, 26.0, 24.6, 19.6; EI-MS m/z 321 (M++H), 265, 181, 163, 123, 105, 57; 
HRMS calcd for C19H28O4 [M+Na]+: 343.1885, found 343. 1900. 
 
(4S)-(tert-Butyldiphenylsiloxymethyl)oxetan-2-one (105):23a  To  a  –50 
°C solution of 58 mg of aluminum triamine catalyst ent-36 (0.10 mmol) in 
5.7 mL of CH2Cl2 was added 0.30 mL of DIPEA (1.7 mmol) followed by 0.14 mL of acetyl 
bromide (1.9 mmol).  The resulting yellow solution was stirred at –50 °C whereupon 0.298 g of 
2-tert-butyldiphenylsilyloxyacetaldehyde (1.0 mmol) was added dropwise via syringe.  After 
maintaining at –50 °C for 12 h, the reaction mixture was diluted with 10 mL of pentane, filtered 
through silica gel (30% EtOAc/hexanes), and concentrated.  The resulting residue was purified 
by silica gel chromatography (10% EtOAc/hexanes) to provide 0.30 g of 105 (92%) as a white 
crystalline solid:  1H NMR (300 MHz, CDCl3): δ 7.69–7.66 (m, 4H), 7.45–7.38 (m, 6H), 4.64–
4.57 (m, 1H), 4.05 (dd, J = 2.6, 12.4 Hz. 1H), 3.84 (dd, J = 3.1, 12.4 Hz, 1H), 1.08 (s, 9H).  
Separation of the enantiomers by chiral HPLC (90/10 hexanes/iPrOH, 1.0 mL/min) Tr (min) = 7.63 
(R), 13.27 (S) determined the enantiomeric excess to be 89%. 
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4-(tert-Butyldiphenylsilanyloxy)-(3S)-hydroxy-N-methoxy-N-
methylbutyramide (106): To a 0 °C solution of 1.36 g of N, O-
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 methoxymethylamine hydrochloride (14 mmol) in 30 mL of CH2Cl2 was added 14 mL of 
dimethylaluminum chloride (14 mmol) as a 1 M solution in hexanes.  The solution was allowed 
to warm to ambient temperature and maintained for 1 h.  To this suspension was added a solution 
of 2.39 g of 105 (7.0 mmol) in 5 mL of CH2Cl2 via cannula.  The reaction mixture was 
maintained for 2 h at ambient temperature, and then quenched with 42 mL of pH 8 hydrogen 
phosphate buffer.  The reaction was filtered through a pad of Celite to remove the solid 
aluminum salts.  The resulting biphasic solution was separated, and the aqueous layer was 
washed with CH2Cl2 (2 × 10 mL).  The combined organics were dried over Na2SO4, filtered, and 
concentrated.  The crude oil was purified by silica gel chromatography (30% EtOAc/hexanes) to 
provide 2.64 g (94%) of the β-hydroxy amide as a white solid: [α]D = –16 (c 1.1, CHCl3); IR 
(thin film): 3441.6, 3069, 3046, 2954, 2931, 2891, 2855, 1640, 1465, 1426, 1386, 1184, 1109, 
998, 828, 741, 705, 610 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.72 (dd, J = 1.8, 5.0 Hz, 4H), 
7.44–7.36 (m, 6H), 4.24 (m, 1H), 3.85 (d, J = 3.2 Hz, 1H), 3.80 (dd, J = 4.7, 10.1 Hz, 1H), 3.72 
(dd, J = 5.0, 10.0 Hz, 1H), 3.64 (s, 3H), 3.16 (s, 3H), 2.78 (d, J = 15.6 Hz, 1H), 2.67 (dd, J = 8.3, 
15.2 Hz, 1H), 1.11 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 173.1, 135.4, 133.2, 129.7, 127.7, 
68.6, 67.0, 61.1, 53.4, 34.9, 31.7, 26.8, 19.2; HRMS calcd for C22H31NO4Si: 344.1322, found 
344.1318. 
 
4-(tert-Butyldiphenylsilanyloxy)-N-methoxy-(3S)-(4-
methoxybenzyloxy)-N-methylbutyramide (107): To a solution 
of 0.511 g of β-hydroxy amide 106 (1.27 mmol) in 2.5 mL of diethyl ether at ambient 
temperature was added 0.790 mL of p-methoxybenzyltrichloroacetimidate (3.82 mmol) and 
0.010 mL of trifluoromethanesulfonic acid via syringe.  After stirring for 30 min, saturated 
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 aqueous NaHCO3 (5 mL) was added to the reaction.  The layers were separated, and the aqueous 
layer was extracted with diethyl ether (2 ×  10 mL).  The combined organic layers were dried 
over MgSO4, filtered, and concentrated.  The crude product was purified by silica gel 
chromatography (20% EtOAc/hexane).  Elution of the title compound from the silica column 
was coincident with trichloroacetamide.  The product was triturated from the white solid using 
pentane (5 × 10 mL).  The combined pentane washings were concentrated to provide 107 as a 
clear, colorless oil in 77% yield: [α]D = –9.5 (c 1.1, CHCl3); IR (thin film): 3006, 2954, 2931, 
2851, 1707, 1655, 1509, 1461, 1422, 1244, 1109, 820, 756, 701 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 7.68 (dd, J = 1.1, 7.5 Hz, 4H), 7.46–7.35 (m, 6H), 7.21 (d, J = 8.6 Hz, 2H), 6.83 (d, J 
= 8.6 Hz, 2H), 4.53 (dd, J = 5.7, 16.5 Hz, 2H), 4.12 (m, 1H), 3.79 (s, 3H), 3.76 (dd, J = 5.2, 7.2 
Hz, 1H), 3.68 (dd, J = 5.2, 8.8 Hz, 1H), 3.61 (s, 3H), 3.20 (s, 3H), 2.95–2.55 (m, 2H), 1.06 (s, 
9H); 13C NMR (75 MHz, CDCl3): δ 172.4, 156.8, 135.6, 133.3, 130.9, 129.7, 129.4, 127.7, 
113.6, 76.5, 72.3, 65.6, 61.2, 55.2, 34.7, 32.0, 26.8, 19.2; HRMS calcd for C30H39NO5Si: 
464.1893, found 464.1893. 
 
4-(tert-Butyldiphenylsilanyloxy)-(3S)-(4-methoxybenzyloxy)  
butyraldehyde (108): To a –78 °C solution of 61 mg of 107 (0.117 
mmol) in 1.0 mL of THF was added 0.129 mL of DIBAL-H (0.129 mmol) as a 1 M solution in 
hexanes.  After stirring at –78 °C for 45 min, the reaction was poured into 5 mL of a 0 °C 
mixture of 1:1 diethyl ether and 1 M HCl.  The resulting biphasic mixture was stirred at ambient 
temperature for 30 min and the organic layer was separated and washed with brine (1 × 5 mL).  
The ether layer was dried over MgSO4, filtered, and concentrated.  Purification of the crude 
product by silica gel chromatography (20% EtOAc/hexanes) provided 0.044 g (80%) of the 
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 aldehyde as a clear, colorless oil: [α]D = –20 (c 0.7, CHCl3); IR (thin film): 3065, 3050, 2994, 
2954, 2931, 2855, 2725, 1723, 1608, 1584, 1513, 1469, 1422, 1248, 1113, 1034, 820, 737, 705 
cm-1; 1H NMR (300 MHz, CDCl3): δ 9.78 (t, J = 2.0 Hz, 1H), 7.67 (dd, J = 1.7, 6.1 Hz, 4H), 
7.43–7.37 (m, 6H), 7.19 (d, J = 8.6 Hz, 2H), 6.85 (d, J = 8.6 Hz, 2H), 4.48 (dd, J = 11.1, 34.1 
Hz, 2H), 4.03 (m, J = 5.5 Hz, 1H), 3.80 (s, 3H), 3.77 (dd, J = 4.9, 10.6 Hz, 1H), 3.67 (dd, J = 5.7, 
10.5 Hz, 1H), 2.70 (dd, J = 1.9, 6.1 Hz, 2H), 1.06 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 201.4, 
159.4, 135.7, 133.2, 130.3, 130.0, 129.5, 127.9, 113.9, 74.6, 71.9, 65.3, 55.3, 46.4, 26.9, 19.3; 
EI-MS (70 eV) 419 (M+-CH2CHO), 405 (M+-tBu), 391, 333, 327, 309, 267, 241, 199, 181, 163, 
135, 121, 105. 
 
6-(tert-Butyldiphenylsilanyloxy)-(5S)-(4-methoxybenzyloxy)hex-
2-enoic acid ethyl ester: To a 0 °C suspension containing 1.06 g of 
methyltriphenylphosphonium bromide (3.0 mmol) in 5 mL of THF was added 4.53 mL of 
KHMDS (2.27 mmol) as a 0.5 M solution in toluene dropwise via syringe.  A solution of 0.700 g 
of the aldehyde 108 (1.5 mmol) in 5 mL of THF was transferred via cannula to the orange Wittig 
reagent at 0 °C.  The reaction mixture was warmed to ambient temperature and maintained for 1 
h.  The reaction was then concentrated and purified by silica gel chromatography (25% 
EtOAc/hexanes) to provide 0.758 g (95%) of the E-enoate ester as a colorless oil: [α]D = –16 (c 
2.5, CHCl3); IR (thin film): 3069, 3050, 2954, 2931, 2851, 1719, 1655, 1612, 1584, 1513, 1469, 
1430, 1362, 1299, 1248, 1172, 1113, 1034, 820, 741, 705, 610 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 7.67 (d, J = 6.8 Hz, 4H), 7.56–7.40 (m, 6H), 7.20 (d, J = 8.6 Hz, 2H), 6.95 (dt, J = 7.9, 
15.6 Hz, 1H), 6.85 (d, J = 8.6 Hz, 2H), 5.87 (d, J = 15.6 Hz, 1H), 4.46 (dd, J = 11.4, 31.2 Hz, 
2H), 4.20 (q, J = 7.0 Hz, 2H), 3.81 (s, 3H), 3.74 (m, 1H), 3.60 (dd, J = 5.2, 6.0 Hz, 2H), 2.49 (dd, 
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 J = 6.9, 14.3 Hz, 2H), 1.35 (t, J = 7.2 Hz, 3H), 1.06 (s, 9H); 13C NMR (75 MHz, CDCl3): 
δ 166.5, 159.3, 145.5, 135.7, 133.4, 133.3, 130.5, 129.9, 129.5, 127.9, 123.6, 113.8, 78.1, 71.8, 
65.4, 60.3, 55.3, 34.8, 26.9, 19.3, 14.4; EI-MS (70 eV) 475 (M+-tBu), 429, 337 (475-OPMB), 
309, 267, 241, 227, 223, 199, 121 (PMB). 
 
6-(tert-Butyldiphenylsiloxy)-(5S)-(4-methoxybenzyloxy)hex-2-en-
1-ol: To a –78 °C solution of 0.328 g of the E-enoate ester (0.617 
mmol) in 3.1 mL of THF was added 1.3 mL of a 1.0 M solution of DIBAL-H in hexanes (1.29 
mmol).  The reaction was allowed to warm slowly to 0 °C over a 90 min period.  The reaction 
mixture was poured into a 0 °C mixture containing 10 mL of diethyl ether and 10 mL of 1 M 
HCl and was maintained for 15 min.  The organic and aqueous layers were separated, and the 
aqueous layer was saturated with brine and washed with diethyl ether (3 × 10 mL).  The 
combined organics were dried over MgSO4, filtered, and concentrated.  The crude product was 
purified by silica gel chromatography (15% EtOAc/hexanes) to provide 0.267 g (89%) of the 
allylic alcohol as a colorless oil: [α]D = –13 (c 1.1, CHCl3); IR (thin film): 3418, 3065, 3046, 
2954, 2931, 2851, 1612, 1509, 1461, 1422, 1244, 1109, 1030, 820, 741, 701 cm-1; 1H NMR (300 
MHz, CDCl3): δ 7.68 (d, J = 6.2 Hz, 4H), 7.44–7.36 (m, 6H), 7.23 (d, J = 8.5 Hz, 2H), 6.86 (d, J 
= 8.5Hz, 2H), 5.66–5.63 (m, 2H), 4.51 (dd, J = 11.3, 34.1 Hz, 2H), 4.04 (dd, J = 4.3, 9.4 Hz, 
2H), 3.81 (s, 3H), 3.72 (dd, J = 5.7, 10.7 Hz, 1H), 3.64 (dd, J = 5.1, 10.5 Hz, 1H), 3.53 (m, J = 
5.9 Hz, 1H), 2.34 (ddd, J = 6.6, 9.2, 9.9 Hz, 2H), 1.07 (s, 9H); 13C NMR (75 MHz, CDCl3): 
δ 159.2, 135.8, 135.7, 133.6, 133.5, 131.7, 130.9, 129.9, 129.8, 129.6, 129.5, 128.7, 127.8, 113.8, 
79.0, 71.6, 65.5, 63.6, 55.3, 34.4, 27.0, 19.3; EI-MS (70 eV) 433 (M+-tBu), 415 (433-H2O), 333, 
295, 279, 241, 223, 211, 199, 181, 163, 135, 121, 105. 
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6-tert-Butyldiphenylsiloxy-(5S)-(4-methoxybenzyloxy)-hex-2-
enyl triphenylmethyl ether (109): To a solution containing 0.181 
mL of 2,6-lutidine (1.56 mmol), 0.289 g of chlorotriphenylmethane (1.04 mmol), and 0.383 g of 
tetra-n-butylammonium iodide (1.04 mmol) in 2 mL of CH2Cl2 was added a 1 mL methylene 
chloride solution containing 0.508 g of the allylic alcohol (1.04 mmol) via syringe at ambient 
temperature.  The golden-brown reaction solution was maintained at ambient temperature for 5.5 
h.  The reaction mixture was then concentrated and purified by silica gel chromatography (10% 
EtOAc/hexanes) to provide 0.678 g (92%) of 109 as a clear, colorless oil: IR (thin film): 3057, 
3026, 2955, 2927, 2856, 1960, 1881, 1818, 1616, 1509, 1450, 1426, 1386, 1362, 1299, 1248, 
1176, 1109, 1054, 1034, 820, 760, 744, 700 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.74 (d, J = 6.5 
Hz, 4H), 7.53 (d, J = 7.3 Hz, 6H), 7.48–7.28 (m, 15H), 6.86 (d, J = 8.5 Hz, 2H), 5.88–5.65 (m, 
2H), 4.58 (dd, J = 11.3, 26.5 Hz, 2H), 3.87–3.65 (m, 3H), 3.83 (s, 3H), 3.60 (d, J = 4.6 Hz, 2H), 
2.43 (ddd, J = 6.4, 9.63, 10.0 Hz, 2H), 1.13 (s, 9H); 13CNMR (75 MHz, CDCl3): δ 159.2, 144.6, 
135.8, 133.7, 131.1, 130.0, 129.8, 129.5, 129.4, 128.8, 128.6, 128.0, 127.9, 127.1, 113.9, 86.9, 
79.3, 71.8, 65.7, 65.0, 55.4, 34.9, 27.0, 19.4;  
OTBDPS
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 (2S)-(4-Methoxybenzyloxy)-6-(triphenylmethyloxy)hex-4-en-1-ol: To a 
solution of 0.100 g of 109 (0.137 mmols) in 1.4 mL of THF was added 0.164 mL of TBAF 
(0.164 mmol) as a 1 M solution in THF via syringe at ambient temperature.  The reaction was 
maintained for 2 h, then added directly to a silica gel column and eluted with 30% 
EtOAc/hexanes.  The alcohol was isolated as a colorless oil in 99% yield: [α]D = +8.0 (0.8, 
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 CHCl3); IR (thin film): 3434, 3081, 3061, 3030, 2931, 2867, 1640, 1612, 1513, 1446, 1244, 
1172, 1030, 824, 745, 709 cm-1;  1H NMR (300 MHz, CDCl3): δ 7.48 (d, J = 7.2 Hz, 6H), 7.35–
7.23 (m, 11H), 6.89 (d, J = 6.6 Hz, 2H), 5.95–5.65 (m, 2H), 4.57 (dd, J = 11.1, 41.0 Hz, 2H), 
3.80 (s, 3H), 3.74–3.40 (m, 3H), 2.39 (ddd, J = 6.5, 9.8, 13.0 Hz, 2H), 1.95 (m, 1H); 13C NMR 
(75 MHz, CDCl3): δ 159.4, 144.3, 130.5, 129.9, 129.6, 128.8, 128.0, 127.6, 127.1, 114.1, 86.9, 
79.1, 71.5, 64.8, 64.3, 55.4, 34.2; HRMS calcd for C33H34O4: 493.2373, found 493.2379. 
 
(2S)-(4-methoxybenzyloxy)-6-(triphenylmethyloxy)hex-4-en-1-al (89): 
To a solution of 0.133 g of alcohol (0.19 mmol) in 15 mL of CH2Cl2 at 
ambient temperature was added 0.094 g of Dess-Martin periodinane (0.22 mmol) portionwise.  
The resulting turbid white mixture was stirred 30 min. Saturated aqueous NaHCO3 (5 mL) was 
added and the mixture was extracted with CH2Cl2 (3 × 15 mL).  The combined organics were 
washed with brine (15 mL), dried over MgSO4, filtered, and concentrated.  The crude product 
was purified by flash chromatography on silica gel (20% EtOAc/hexanes) to afford 0.124 g 
(94%) of 89 as a colorless oil: [α]D = –8.3 (0.8, CHCl3); IR (thin film): 3550, 3085, 3058, 3032, 
2932, 2860, 1732, 1612, 1513, 1490, 1448, 1248, 1174, 1035, 763, 738, 706 cm-1; 1H NMR (300 
MHz, CDCl3): δ 9.67 (d, J = 1.9 Hz, 1H), 7.49 (d, J = 7.2 Hz, 6H), 7.42–7.18 (m, 11H), 6.89 (d, 
J = 8.5 Hz, 2H), 5.90–5.71 (m, 2H), 4.62 (dd, J = 11.3, 21.7 Hz, 2H), 3.88–3.73 (m, 4H), 3.61 (d, 
J = 4.2 Hz, 2H), 2.51 (m, 2H); 13C NMR (75 MHz, CDCl3): δ 203.5, 144.3, 134.9, 130.8, 129.9, 
129.7, 128.8, 128.0, 128.0, 127.3, 127.1, 125.9, 114.1, 87.0, 82.8, 72.4, 64.7, 55.4, 33.6, 29.9.  
FAB-MS m/z 515 [M+Na]+. 
H
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 (1E)-(3S)-5-Methyl-1-tributylstannylhexa-1,5-dien-3-ol (111): To a –
78 ºC solution of 0.119 g of allyl-(–)-Ipc2B 110 (0.348 mmol) in 1.5 mL 
of Et2O was added 0.100 g of β-tributylstannyl acrolein (0.290 mmol) 
slowly dropwise.  The resulting colorless solution was maintained for 1 h at –78 ºC and then 
slowly warmed to 0 ºC.  An aqueous solution of 3 N NaOH (0.3 mL) and 30% H2O2 (0.3 mL) 
were added, the colorless, biphasic solution was then stirred for 2 h at ambient temperature.  The 
mixture was extracted with Et2O (3 × 10 mL).  The combined organics were washed with brine 
(10 mL), dried over MgSO4, filtered, and concentrated.  The crude product was purified by flash 
chromatography on silica gel (2% EtOAc/hexanes) to afford 0.112 g (96%) of the homoallylic 
alcohol as a colorless oil: [α]D = –9.3 (c 1.1, CHCl3); IR (thin film): 3365, 2957, 2926, 2871, 
2853, 1460, 1376, 1073, 989, 889 cm-1; 1H NMR (300 MHz, CDCl3): δ 6.12 (dd, J = 1.1, 19.1 
Hz, 1H), 6.04 (dd, J = 5.1, 19.1 Hz, 1H), 4.86 (dd, J = 1.2, 79.5 Hz, 1H), 4.24–4.23 (m, 1H), 
2.28–2.24 (m, 2H), 1.93 (d, J = 3.4 Hz, 1H), 1.80 (s, 3H), 1.55–1.47 (m, 6H), 1.36–1.34 (m, 6H), 
0.94–0.89 (m, 14H); 13C NMR (75 MHz, CDCl3): δ 150.1, 142.2, 127.6, 113.6, 72.4, 46.0, 30.0, 
27.2, 22.4, 13.6, 9.4; HRMS calcd for C15H29OSn [M-nBu]+: 345.1240, found 345.1251. 
Me
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(1E)-(3S)-Benzoic acid 3-methyl-1-(2-tributylstannylvinyl)-but-3-enyl 
ester (111a): To a 25 ºC solution of 0.092 g of the homoallylic alcohol 
111 (0.23 mmol) in 0.1 mL pyridine was added 0.03 mL of benzoyl 
chloride (0.28 mmol) and 0.001 g of DMAP (0.01 mmol) sequentially.  The resulting white 
suspension was maintained for 20 min at ambient temperature.  The reaction mixture was 
quenched with saturated NaHCO3 (2 mL), and the aqueous layer was extracted with Et2O (3 × 6 
mL).  The combined organics were washed with brine (4 mL), dried over MgSO4, filtered, and 
concentrated.  The crude product was purified by flash chromatography on silica gel (2% 
Me
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 EtOAc/Hex) to afford 0.113g (97%) of the ester as a colorless oil: [α]D = –9.2 (c 7.1, CHCl3); IR 
(thin film): 2956, 2926, 2871, 2853, 1721, 1271, 1111, 710 cm-1; 1H NMR (300 MHz, CDCl3): δ 
8.11 (d, J = 8.5 Hz, 2H), 7.59 ( m, 1H), 7.50–7.45 (m, 2H), 6.32 (d, J = 18.9 Hz, 1H), 6.07 (dd, J 
= 5.5, 19.1 Hz, 1H), 5.70–5.68 (m, 1H), 4.83 (s, 1H), 2.57–2.48 (m, 2H), 1.84 (s, 1H), 1.53 (m, 
6H), 1.33 (m, 7H), 0.91 (m, 14H); 13C NMR (75 MHz, CDCl3): δ 165.7, 145.3, 141.1, 132.7, 
130.6, 129.6, 128.3, 113.6, 75.3, 43.1, 29.0, 27.6, 27.2, 22.6, 13.7, 9.4; HRMS calcd for 
C22H33O2Sn [M-nBu]+: 449.1503, found 449.1484.  Separation of the enantiomers by chiral 
HPLC [Daicel Chiracel™ OD-H colume, flow rate 0.5 mL/min, 0.5% iPrOH, 99.5% hexane, Tr: 
9.7 min (R), 10.8 min (S)] provided the enantiomer ratio: S : R = 98 : 1 (98% ee). 
 
(1E, 3S)-3-Allyloxy-5-methylhexa-1,5-dienyltributylstannane (112):  
To a –78 ºC solution of 0.662 g of the homoallylic alcohol 111 (1.65 
mmol) in 10 mL of THF was added 7.90 mL of 0.5 M toluene solution of 
KHMDS (1.82 mmol) slowly dropwise.  After 15 min, 0.94 mL of allyl bromide (4.95 mmol) 
was added into the pale yellow reaction mixture.  The resulting solution was slowly warmed to 
ambient temperature and maintained for 2 h.  The reaction was quenched with brine and the 
aqueous layer was extracted with Et2O (3 × 12 mL).  The combined organics were dried over 
MgSO4, filtered, and concentrated. Purification by flash chromatography on silica gel (2% 
EtOAc/hexanes) afforded 0.699 g (97%) of  the title compound 112 as a colorless oil: [α]D = –38 
(c 2.3, CHCl3); IR (thin film): 3077, 2957, 2926, 2871, 2852, 1460, 1077, 992, 920, 888 cm-1; 1H 
NMR (300 MHz, CDCl3): δ 6.10 (d, J = 9.5 Hz, 1H), 5.96-5.87 (m, 1H), 5.79 (dd, J = 7.2, 19.0 
Hz, 1H), 5.25 (dd, J = 1.6, 17.1 Hz, 1H), 5.15 (d, J = 10.4 Hz, 2H), 4.75 (d, J = 10.8 Hz, 1H), 
4.06 (dd, J = 5.2, 12.8 Hz, 1H), 3.87–3.79 (m, 2H), 2.39 (dd J = 7.1, 13.9 Hz, 1H), 2.21 (dd, J = 
Me
SnBu3
O
 101
 6.3, 13.9 Hz, 1H), 1.75 (s, 3H), 1.56–1.46 (m, 6H), 1.37–1.25 (m, 7H), 0.96–0.82 (m, 14H); 13C 
NMR (75 MHz, CDCl3): δ 148.4, 142.2, 135.1, 131.2, 116.5, 112.6, 82.0, 69.1, 44.0, 29.1, 27.2, 
22.9, 13.7, 9.4; HRMS calcd for C18H33OSn [M-nBu]+: 377.1580, found 377.1597. 
 
Tributyl[(E)-2-[(2S)-4-methyl-3,6-dihydro-2H-pyran-2-yl]-
vinyl]stannane (114): To a brown solution of 0.081 g of freshly prepared 
Schrock’s catalyst (0.11 mmol) in 11 mL of degassed toluene was added 0.661 g of 112 (1.5 
mmol) at ambient temperature.  After maintaining the reaction for 25 min, the resulting dark 
solution was added another portion of 0.081 g of Schrock’s catalyst (0.11 mmol).  After 30 min, 
the reaction was exposed to air for 2 h.  The reaction mixture was concentrated to provide the 
crude product, which was purified by flash chromatography on silica gel (0.6% EtOAc/hexanes) 
to afford 0.465 g (81%) of 114 as a brown oil: [α]D = –73 (c 1.1, CHCl3); IR (thin film): 2957, 
2926, 2872, 2851, 1460, 1378, 1123, 988 cm-1; 1H NMR (300 MHz, CDCl3): δ 6.25 (d, J = 19.2 
Hz, 1H), 6.09 (dd, J = 4.8, 19.2 Hz, 1H), 5.43 (s, 1H), 4.22 (s, 2H), 4.00 (m, 1H), 2.10–1.91 (m, 
2H), 1.73 (s, 3H), 1.61–1.47 (m, 6H), 1.39–1.27 (m, 6H), 0.94–0.86 (m, 15H); 13C NMR (75 
MHz, CDCl3): δ 148.3, 131.5, 128.5, 119.6, 76.4, 65.6, 35.5, 29.0, 27.2, 22.9, 13.6, 9.3; HRMS 
calcd for C16H29OSn [M-nBu]+: 357.1240, found 357.1248. 
SnBu3O
Me
 
(2S)-2-[(E)-2-Iodovinyl]-4-methyl-3,6-dihydro-2H-pyran (115): To a  –20 ºC 
solution of 0.226 g of 114 (0.55 mmol) in 10 mL of THF was added a mixture of 
(0.55 mmol) and 0.8 mL of THF slowly dropwise.  The resulting yellow solution 
was maintained for 30 min at –20 ºC, at which point brine was added (6 mL) and the mixture 
was extracted with Et
0.123 g of NIS 
2O (3 × 15 mL).  The combined organics were washed with saturated 
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 Na2S2O3 (8 mL), dried over MgSO4, filtered, and concentrated.  The crude product was purified 
by flash chromatography on silica gel (10% CH2Cl2/pentane) to afford 0.131 g (96%) of the title 
compound 115 as a yellow oil: [α]D = –107 (c 0.76, CHCl3); IR (thin film): 3026, 2963, 2908, 
2823, 1381, 1368, 1124, 1059, 1013, 667, 682 cm-1; 1H NMR (300 MHz, CDCl3): δ 6.61 (dd, J = 
5.5, 14.5 Hz, 1H), 6.39 (dd, J = 0.9, 14.6 Hz, 1H), 5.39 (s, 1H), 4.16 (s, 2H), 3.97 (m, 1H), 2.04-
1.87 (m, 2H), 1.68 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 145.9, 131.0, 119.7, 78.0, 75.5, 65.6, 
35.0, 23.0; HRMS calcd for C8H11OI: 249.9855, found 249.9860. 
 
(1E,6E)(3S,4S)-4-(4-Methoxybenzyloxy)-1-((2S)-4-methyl-
3,6-dihydro-2H-pyran-2-yl)-8-trityloxy-octa-1,6-dien-3-ol 
(117): To a mixture of 0.173 g of magnesium powder (7.1 
mmol) in 5 mL of Et2O at ambient temperature was added 0.57 mL of 1,2-dibromoethane (6.7 
mmol) in 1.70 mL of benzene slowly dropwise.  After heat generation and gas evolution ceased, 
the slightly turbid gray solution was maintained for an additional 30 min then allowed to stand 
for 1.5 h without stirring.  The molarity of magnesium bromide in Et2O was approximately 1.0 
M. 
O
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To a –78 ºC solution of 0.104 g of 115 (0.42 mmol) in 3.5 mL of Et2O was added 0.60 
mL of 1.39 M pentane solution of tBuLi (0.83 mmol) slowly dropwise.  After maintaining the 
pale yellow reaction at –78 ºC for 1h, 1.00 mL of 1.0 M ethereal magnesium bromide (1.0 mmol) 
was added dropwise.  The diethyl ether was pumped off completely under reduced pressure at –
78 ºC and 6.0 mL of precooled (–78 ºC) CH2Cl2 was added via cannula to dissolve the white 
residue (116).  To this clear colorless solution, 0.158 g of 89 (0.33 mmol) in 0.7 mL of CH2Cl2 
was added dropwise.  After stirring for 20 min at –78 ºC, water (1.5 mL) and brine (2.5 mL) 
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 were added to quench the reaction.  The aqueous layer was extracted with CH2Cl2 (3 × 10 mL).  
The combined organics was dried over MgSO4, filtered, and concentrated.  The crude product 
was purified by flash chromatography on silica gel (35% EtOAc/hexanes) to afford 1.91 g (96%) 
of 117 as a colorless oil: [α]D = –32 (c 3.0, CHCl3); IR (thin film): 3436, 3013, 2928, 2856, 
1513, 1249, 1216, 1034, 757, 705 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.58–7.56 (m, 6H), 7.38–
7.26 (m, 11H), 6.91 (d, J = 8.4 Hz, 2H), 5.97–5.78 (m, 4H), 5.48 (s, 1H), 4.65 (dd, J = 10.9, 44.7 
Hz, 2H), 4.25 (s, 3H), 4.14 (m, 1H), 3.78 (s, 3H), 3.69 (d, J = 4.4 Hz, 2H), 3.52 (m, 1H), 2.93 (s, 
1H), 2.56 (m, 1H), 2.43 (s, 1H), 2.16 (m, 1H), 2.08 (s, .6H),  1.99 (m, 1H), 1.77 (s, 3H); 13C 
NMR (75 MHz, CDCl3): δ 159.1, 144.1, 133.1, 131.2, 130.0, 129.7, 129.6, 129.4, 128.4, 127.6, 
127.5, 126.8, 119.5, 113.7, 86.6, 81.2, 73.1, 72.1, 65.4, 64.5, 60.2, 55.0, 35.5, 33.4, 22.8, 20.9, 
14.0; FAB-MS e/ν 639 [M+Na]+.  Separation of the diastereomers by HPLC [Zorbax column, 
flow rate 0.3 mL/min, 3.5 % iPrOH, 96.5% hexane, Tr: 65.2 (S), 67.8 (R)] provided the 
diastereomer ratio: S:R = 9:1. 
 
tert-Butyl-{(4E)(1S, 2S)-2-(4-methoxy-benzyloxy)-1-[(1E)-
2-((2S)-4-methyl-3,6-dihydro-2H-pyran-2-yl)-vinyl]-6-
trityloxyhex-4-enyloxy}dimethylsilane (118): To a 0 ºC 
solution of 0.682 g of 117 (1.1 mmol) and 0.238 g of imidazole (3.4 mmol) in 5 mL of DMF was 
added 0.513 g of TBSCl (3.4 mmol).  After maintaining the reaction at 25 ºC for 4.5 h, the 
resulting yellow solution was treated with saturated NaHCO3 (15 mL) and EtOAc (20 mL).  The 
aqueous layer was extracted with EtOAc (3 × 15 mL).  The combined organics were washed 
with brine (20 mL), dried over MgSO4, filtered, and concentrated.  The crude product was 
purified by flash chromatography on silica gel (10% EtOAc/Hex) to afford 0.799 g (98%) of the 
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 silyl ether 118 as a yellow oil: [α]D = –52 (c 2.1, CHCl3); IR (thin film): 3058, 3005, 2954, 2929, 
2855, 1513, 1448, 1249, 1105, 1036, 836, 775, 758, 706, 632 cm-1; 1H NMR (300 MHz, CDCl3): 
δ 7.65–7.62 (m, 6H), 7.49–7.37 (m, 11H), 6.96 (d, J = 8.6 Hz, 2H), 6.05–5.77 (m, 4H), 5.58 (s, 
1H), 4.73 (dd, J = 11.3, 19.0 Hz, 2H), 4.47 (t, J = 4.6 Hz, 1H), 4.30 (s, 2H), 4.20 (m, 1H), 3.90 
(s, 3H), 3.71 (d, J = 4.9 Hz, 2H), 3.54 (m, 1H), 2.52 (m,1H), 2.32–2.21 (m, 2H), 2.07 (m,1H), 
1.06 (s, 9H), 0.2 (s, 3H), 0.19 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 159.1, 144.3, 131.6, 131.4, 
130.8, 130.2 129.6, 129.4 128.6, 127.7, 126.8, 119.7, 113.7, 86.6, 82.1, 73.6, 73.1, 72.5, 65.5, 
64.8, 55.2, 35.7, 33.2, 25.9, 25.6, 23.0, 18.1, –4.5, –4.9; FAB-MS e/ν  753 [M+Na]+. 
 
(2E,7E)(5S,6S)-6-(tert-Butyldimethylsilyloxy)-5-(4-
methoxybenzyloxy)-8-((2S)-4-methyl-3,6-dihydro-2H-
pyran-2-yl)octa-2,7-dien-1-ol (119): To a 0 ºC solution of 
0.440 g of the silyl ether 118 (0.61 mmol) in 28.0 mL of nitromethane was added 3.9 mL of 
formic acid slowly dropwise.  The resulting yellow solution was stirred for another 20 min after 
the completed addition.  40 mL of cold saturated NaHCO3 and then 30 mL of EtOAc were 
added.  The aqueous layer was extracted with EtOAc (3 × 40 mL). The combined organics were 
washed with brine (40 mL), dried over MgSO4, filtered, and concentrated.  The crude product 
was purified by flash chromatography on silica gel (35% EtOAc/Hex) to afford 0.250 g (86%) of 
the allylic alcohol 119 as a yellow oil: [α]D = –83 (c 4.0, CHCl3); IR (thin film): 3442, 2999, 
2929, 2856, 1513, 1249, 1098, 1037, 972, 836, 777 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.34 (d, 
J = 8.4 Hz, 2H), 6.95 (d, J = 8.5 Hz, 2H), 5.87 (m, 2H), 5.72 (m, 2H), 5.50 (s, 1H), 4.62 (dd, J = 
11.5, 29.6 Hz, 2H), 4.37 (t, J = 4.5 Hz, 1H), 4.26 (s, 2H), 4.13 (s, 3H), 3.89 (s, 3H), 3.44 (m, 
1H), 2.37 (m, 1H), 2.16–2.11 (m, 2H), 1.79 (m, 1H), 0.98 (s, 9H), 0.11 (s, 6H); 13C NMR (75 
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 MHz, CDCl3): δ 159.2, 131.5, 131.4, 130.9, 130.8, 130.2, 130.1, 129.5, 119.7, 113.6, 81.8, 73.5, 
73.1, 72.3, 65.6, 63.8, 55.3, 35.7, 32.8, 25.9, 23.0, 18.1, -4.5, -4.9; HRMS calcd for C24H35O5Si 
[M-tBu]+: 431.2253, found 431.2275. 
 
(2E,7E)(5S,6S)-6-(tert-Butyldimethylsilyloxy)-5-(4-
methoxybenzyloxy)-8-((2S)-4-methyl-3,6-dihydro-2H-pyran-
2-yl)octa-2,7-dienal (85): To a solution of 0.117 g of the allylic 
alcohol (0.16 mmol) in 10 mL of CH2Cl2 was added 0.139 g of Dess-Martin periodinane (0.33 
mmol) portionwise at ambient temperature.  The resulting turbid white mixture was stirred 30 
min, then quenched with 8 mL of saturated NaHCO3.  The mixture was extracted with CH2Cl2 (3 
× 15 mL) and the combined organics were washed with brine (15 mL), dried over MgSO4, 
filtered, and concentrated.  The crude product was purified by flash chromatography on silica gel 
(15% EtOAc/hexanes) to afford 0.117 g (100%) of 85 as a pale yellow oil: [α]D = –86 (c 3.9, 
CHCl3); IR (thin film): 2955, 2930, 2887, 2856, 1692, 1513, 1250, 1111, 1036, 837, 778 cm-1; 
1H NMR (300 MHz, CDCl3): δ 9.55 (d, J = 7.9 Hz, 1H), 7.39 (d, J = 8.7 Hz, 2H), 7.02 (d, J = 6.2 
Hz, 2H), 6.89 (dt, J = 7.3, 15.6 Hz, 1H), 6.22 (dd, J = 7.9, 15.6 Hz, 1H), 5.96 (t, J = 3.0 Hz, 2H), 
5.56 (s, 1H), 4.68 (dd, J = 11.5, 41.5 Hz, 2H), 4.32 (m, 1H), 4.19 (m, 1H), 3.95 (s, 3H), 3.26 (m, 
1H), 2.68 (m, 1H), 2.48 (m, 1H), 2.19 (m, 1H), 2.04 (m, 1H), 1.84 (s, 3H); 13C NMR (75 MHz, 
CDCl3): δ 194.0, 159.4, 156.6, 134.1, 132.2, 131.3, 130.0, 129.7, 129.0, 119.7, 113.8, 80.5, 73.3, 
72.4, 65.6, 55.3, 35.7, 33.4, 25.8, 22.9, 18.1, –4.6, –5.0; HRMS calcd for C24H33O5Si [M-tBu]+: 
429.2097, found 429.2077. 
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 4-{(2R, 6R)-6-[(7E, 12E)(2R, 6S, 10S, 11S)-6,11-Bis-
(tert-butyldimethylsilyloxy)-10-(4-
methoxybenzyloxy)-2-methyl-13-((2S)-4-methyl-
3,6-dihydro-2H-pyran-2-yl)-4-oxo-trideca-7,12-
dienyl]-5,6-dihydro-2H-pyran-2-yl}but-2-ynoic acid tert-butyl ester (122): To a white 
suspension of 0.800g of disulfonamide (1.4 mmol) in 71 mL of 1,2-dichloroethane at 0 ºC was 
added 2.75 mL of a 1.0 M CH2Cl2 solution of boron tribromide (2.8 mmol) slowly dropwise via 
syringe.  After 5 min, the reaction mixture was warmed to 50 ºC and maintained for 8 h.  The 
resulting clear yellow solution was evaporated under reduced pressure.  The yellow residue was 
dissolved in toluene (50 mL) and then the clear yellow solution was evaporated again.  A 
procedure of dissolution and subsequent evaporation repeated two times until the white powder 
formed. 
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To a –78 ºC solution of 0.117 g of the prepared boron reagent 121f (0.17 mmol) in 4 mL 
of CH2Cl2 was added 0.056 g of 86 (0.17 mmol) dissolved in 0.5 mL of CH2Cl2 was added 
slowly.  After maintaining the resulting colorless solution at –78 ºC for 2 h, 0.072 g of 85 (0.15 
mmol) dissolved in 0.5 mL of CH2Cl2 was added slowly.  After 1 h, 1 mL of MeOH and 5 mL of 
phosphate buffer (pH 7) were injected sequentially.  The reaction mixture was allowed to warm 
to ambient temperature and maintained for an additional 30 min.  The separated aqueous layer 
was extracted with CH2Cl2 (3 × 9 mL).  The combined organics were dried over MgSO4, filtered, 
and concentrated to provide the crude alcohol 120. 
To a 0 ºC solution of the resulting yellow residue 120 and 0.059 g of imidazole (1.1 
mmol) in 4 mL of DMF was added 0.126 g of TBSCl (1.0 mmol).  After stirring the reaction for 
7 h at ambient temperature, the resulting yellow solution was added 10 mL of saturated NaHCO3 
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 and 20 mL of CH2Cl2.  The separated aqueous layer was extracted with CH2Cl2 (3 × 20 mL).  
The combined organics were washed with brine (20 mL), dried over MgSO4, filtered, and 
concentrated.  The crude product was purified by flash chromatography on silica gel (15% 
EtOAc/hexanes) to afford 0.141 g (89%) of the silyl protected aldol adduct 122 as a yellow oil: 
[α]D = –82 (c 2.1, CHCl3); IR (thin film): 2955, 2929, 2856, 2239, 1708, 1253, 1704, 837, 777 
cm-1; 1H NMR (300 MHz, CDCl3): δ 7.25 (d, J = 8.6 Hz, 2H), 6.86 (d, J = 8.6 Hz, 2H), 5.93–
5.61 (m, 5H), 5.48–5.41 (m, 2H), 4.56–4.44 (m, 3H), 4.39 (bt, 1H), 4.27 (t, J = 4.3 Hz, 1H), 4.17 
(s, 2H), 4.06–4.00 (m, 1H), 3.79 (s, 3H), 3.79–3.76 (m, 1H), 3.30 (m, 1H), 2.63–2.55 (m, 3H), 
2.38–2.28 (m, 5.5H), 2.03–1.92 (m, 6.5H), 1.70 (s, 3H), 1.48 (s, 9H), 0.93 (d, J = 6.1 Hz, 3H), 
0.88 (s, 9H), 0.84 (s, 9H), 0.01 (m, 12H); 13C NMR (75 MHz, CDCl3): δ 208.7, 159.2, 152.7, 
134.3, 131.6, 131.5, 130.9, 130.1, 129.5, 128.1, 127.5, 125.9, 119.8, 113.8, 83.2, 82.4, 76.2, 73.6, 
72.8, 72.5, 70.2, 70.0, 66.2, 65.7, 55.4, 52.4, 51.5, 42.1, 35.8, 32.7, 30.9, 28.1, 26.0, 25.3, 24.8, 
23.1, 19.7, 18.7, 18.3, 18.2, –4.1, –4.4, –4.8, –4.8; HRMS calcd for C53H84O9Si2 [M+Na]+: 
943.5552, found 943.5579. 
 
4-{(2R,6R)-6-[(7E,12E)(2R,6S,10S,11S)-6,11-
Bis(tert-butyldimethylsilyloxy)-10-hydroxy-2-
methyl-13-((2S)-4-methyl-3,6-dihydro-2H-pyran-2-
yl)-4-oxotrideca-7,12-dienyl]-5,6-dihydro-2H-
pyran-2-yl}but-2-ynoic acid (123): To a solution of 0.063 g of the silyl protected aldol adduct 
122 (0.069 mmol) in 12 mL of CH2Cl2 at ambient temperature was added 6 mL of a pH 7 
phosphate buffer followed by 0.134 g of DDQ (0.48 mmol) portionwise.  The reaction was 
maintained for 4 h then diluted with CH2Cl2 (20 mL).  The separated organic layer was washed 
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 with saturated NaHCO3 (2 × 15 mL) until it was colorless.  The extract was dried over Na2SO4, 
filtered, and concentrated to give yellow oil, which was then dissolved in 8 mL of CH2Cl2.  To 
this yellow solution, 0.34 mL of 2, 6-di-tert-butylpyridine (1.4 mmol) and 0.15 mL of 
trimethylsilyl trifluoromethanesulfonate (0.7 mmol) were added sequentially at –50 ºC.  The 
reaction mixture was then warmed up to 0 ºC and stirred for 2.5 h.  A pH 5 buffer solution (2 
mL) was added at 0 ºC and the reaction was stirred vigorously for an additional 1 h.  The 
separated aqueous layer was extracted with CH2Cl2 (3 × 30 mL).  The combined organics were 
washed with brine (30 mL), dried over MgSO4, filtered, and concentrated.  The crude product 
was purified by flash chromatography on silica gel (20% EtOAc/Hex to 15% EtOH/EtOAc) to 
afford 0.050 g (94%) of 123 as a yellow oil: [α]D = –70 (c 2.5, CHCl3); IR (thin film): 3395, 
3035, 2953, 2929, 2852, 2237, 1713, 1470, 1359, 1252, 1091, 837, 778 cm-1; 1H NMR (300 
MHz, CDCl3):  δ 5.95–5.85 (m, 1H), 5.80–5.46 (m, 5H), 5.42 (brs, 1H), 4.62 (m, 1H), 4.42 (m, 
1H), 4.19 (brs, 2H), 4.13–3.95 (m, 3H), 3.74 (m, 1H), 3.55 (m, 1H), 2.80–2.55 (m, 2H), 2.54–
2.37 (m, 2H), 2.35–2.20 (m, 2H), 2.13–1.88 (m, 6H), 1.71 (s, 3H), 1.65–1.50 (m, 1H), 1.36–1.20 
(m, 2H), 0.95 (d, J = 5.7 Hz, 3H), 0.90 (s, 9H), 0.86 (s, 9H), 0.12 (s, 3H), 0.08 (s, 3H), 0.04 (brs, 
6H); 13C NMR (75 MHz, CDCl3):  δ 209.5, 154.8, 135.3, 134.3, 133.6, 131.2, 130.5, 127.4, 
126.3, 125.6, 119.5, 86.3, 75.7, 74.5, 73.4, 70.4, 69.4, 66.0, 65.4, 52.3, 50.3, 42.3, 35.4, 35.1, 
31.0, 25.9, 24.3, 22.9, 20.0, 18.1, 0.44, –3.9, –4.3, –4.8, –5.0; HRMS calcd for C41H68O8Si2 
[M+Na]+: 767.4370, found 767.4345. 
 
 (9E,19Z)(1R, 7S, 11S, 15R, 17R)-11-(tert-
Butyldimethylsilyloxy)-7-[(1S)-1-(tert-butyl-
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 dimethylsilyloxy)-3-((2S)-4-methyl-3,6-dihydro-2H-pyran-2-yl)allyl]-15-methyl-6,21-
dioxabicyclo[15.3.1]henicosa-9,19-dien-3-yne-5,13-dione (125): To a 0 ºC solution of 0.0228 g 
of 4-pyrrolidinopyridine (0.15 mmol) and 0.050 mL of DIPEA (0.30 mmol) in 5.8 mL of toluene 
was added 0.024 mL of 2,4,6-trichlorobenzoyl chloride (0.15 mmol) slowly dropwise.  The 
resulting pale yellow suspension was stirred for 15 min at 0 ºC then  slowly treated with 0.0056 g 
of seco acid 123 (0.077 mmol) in 2.4 mL of toluene via syringe pump over 2 h.  The pale yellow 
suspension was maintained for 16 h.  The reaction was quenched with brine (5 mL) and the 
separated aqueous layer was extracted with Et2O (3 × 10 mL).  The combined organics were 
washed with brine (10 mL), dried over MgSO4, filtered, and concentrated.  Purification by flash 
chromatography on silica gel (15% EtOAc/hexanes) afforded 0.0051 g (93%) of the title 
compound 125 as a yellow oil: [α]D = – 67 (c 2.2, CHCl3); IR (thin film): 3033, 2956, 2929, 
2856, 2237, 1713, 1471, 1361, 1250, 1094, 1067, 964, 837 cm-1; 1H NMR (300 MHz, CDCl3): δ 
5.91–5.79 (m, 2H), 5.70 (dd, J = 6.0, 15.6 Hz, 1H), 5.65–5.51 (m, 3H), 5.43 (brs, 1H), 4.95 (ddd, 
J = 2.4, 6.8, 9.3 Hz, 1H), 4.66 (brd, J = 9.0 Hz, 1H), 4.43 (brd, J = 9.0 Hz, 1H), 4.20-4.16 (m, 
3H), 4.07 (ddd, J = 3.0, 9.1 Hz, 1H), 3.61–3.53 (m, 1H), 2.67 (dd, J = 11.1, 17.6 Hz, 2H), 2.45–
2.25 (m, 5H), 2.20–2.02 (m, 4H), 1.72 (s, 3H), 1.95–1.89 (m, 2H), 1.39 (dd, J = 10.1, 12.5 Hz, 
1H), 1.14 (dd, J = 7.6, 13.5 Hz, 1H), 1.01 (d, J = 6.2 Hz, 3H), 0.89 (s, 9H), 0.85 (s, 9H), 0.10 (s, 
3H), 0.06 (s, 3H), 0.00 (s, 6H); 13C NMR (75 MHz, CDCl3): δ 209.9, 153.2, 137.1, 133.6, 131.3, 
128.9, 127.5, 126.7, 123.6, 119.8, 86.7, 73.8, 73.6, 73.2, 71.4, 68.4, 65.9, 65.5, 54.1, 49.8, 41.8, 
35.7, 31.6, 26.8, 25.9, 25.8, 23.9, 22.9, 22.6, 21.4, 18.1, 18.0, 14.1, 4.4, –4.4, –4.9, –5.2;  ESI-
MS: 749.3 (M+Na)+;  HRMS calcd for C41H66O7Si2 [M+Na]+: 749.4245, found 749.4279. 
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 (3Z, 9E, 19Z)(1R, 7S, 11S, 15R, 17R) - 11-(tert-
Butyldimethylsilyloxy)-7-[(1S)-(tert-
butyldimethylsilyloxy)-3-((2S)-4-methyl-3,6-
dihydro-2H-pyran-2-yl)allyl]-15-methyl-6, 21-
dioxa-bicyclo[15.3.1]henicosa-3, 9, 19-triene-5, 13-dione (130): To a solution of 8.5 mg of 29 
(11.7 µmol) in EtOAc (3 mL) and 1-hexene (3 mL) under H2 was added 0.014 mL of quinoline 
followed by 15 mg of Lindlar catalyst (5% Pd by wt.).  The resulting black suspension was 
maintained for 1 h at ambient temperature, then filtered through Celite and concentrated.  
Purification by flash chromatography on silica gel (2% EtOAc/hexanes) afforded 7.5 mg (88%) 
of 130 as a clear, colorless oil: [α]D = –155 (c 1.2, CHCl3); IR (thin film): 2955, 2927, 2855, 
1720, 1651, 1419, 1111, 837 cm-1; 1H NMR (300 MHz, CDCl3): δ 6.35 (ddd, J = 4.1, 9.6, 11.4 
Hz, 1H), 5.90–5.77 (m, 3H), 5.73–5.49 (m, 4H), 5.43 (brs, 1H), 4.86 (ddd, J = 2.1, 6.0, 11.1 Hz, 
1H), 4.59 (app q, J = 6.0 Hz, 1H), 4.31,(brd, J = 9.8 Hz, 1H), 4.23–4.19 (m, 3H), 4.06 (ddd, J = 
4.4, 9.3 Hz, 1H), 3.79–3.65 (m, 2H), 2.61 (dd, J = 6.2, 16.2 Hz, 1H), 2.46 (dd, J = 6.6, 16.3 Hz, 
1H), 2.41–2.31 (m, 2H), 2.25 (app dq, J = 2.6, 16.6 Hz, 1H), 2.16–2.01 (m, 5H), 1.95–1.85 (m, 
2H), 1.72 (s, 3H), 1.51 (pentet, J = 7.7 Hz, 1H), 1.27 (ddd, J = 3.6, 6.1, 9.9 Hz, 1H), 0.91 (d, J = 
6.4 Hz, 3H), 0.89 (s, 9H), 0.87 (s, 9H), 0.07 (s, 3H), 0.05 (s, 3H), 0.02 (s, 3H), 0.01 (s, 3H); 13C 
NMR (75 MHz, CDCl3): δ 209.2, 165.3, 148.4, 135.8, 132.9, 131.3, 129.0, 128.8, 125.7, 124.9, 
121.4, 119.8, 75.1, 73.3, 73.2, 73.0, 68.6, 66.9, 65.5, 51.8, 51.3, 42.5, 35.7, 33.6, 31.6, 31.3, 28.7, 
25.8, 25.7, 22.9, 21.0, 18.1, 18.0, –4.5 (2C), –4.9, –5.0; HRMS m/z calcd for C41H68O7Si2 
[M+K]+: 767.4141, found 767.4158. 
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 (3Z, 9E, 19Z)(1R, 7S, 11S, 15R, 17R) - 11-(tert-
Butyldimethylsilyloxy)-7-[(1S)-(tert-
butyldimethylsilyloxy)-3-((2S)-4-methyl-3,6-
dihydro-2H-pyran-2-yl-)-allyl]-15-methyl-13-
methylene-6, 21-dioxa-bicyclo[15.3.1]-henicosa-3,9,19-trien-5-one (131): To a suspension of 
0.365 g of zinc (5.58 mmol) and 0.025 g of lead (II) iodide (0.054 mmol) in THF (5 mL) was 
added 0.250 mL of CH2I2 (3.10 mmol).  The resulting pale yellow suspension was maintained for 
30 min at ambient temperature, cooled to 0 ºC, then treated with 0.25 mL of a 1.0 M solution of 
TiCl4 in CH2Cl2 (0.25 mmol).  The resulting dark brown suspension was warmed to ambient 
temperature and maintained for an additional 30 min.  A 0 ºC solution of 130 in THF (1 mL) was 
then treated with the previously described suspension until the starting ketone was completely 
consumed as observed by TLC.  The reaction was quenched with a 1:1 mixture of saturated 
aqueous NaHCO3 and brine.  The mixture was extracted with Et2O (3 × 10 mL) and the 
combined organics were washed with brine, dried over NaSO4, filtered, and concentrated.  
Purification by flash chromatography on silica gel (5% EtOAc/hexanes) afforded 9.1 mg (85%) 
of 131 as a clear, colorless oil: [α]D = –118 (c 1.4, CHCl3); IR (thin film): 2955, 2928, 2856, 
1723, 1074, 836, 776 cm-1; 1H NMR (300 MHz, CDCl3): δ 6.32 (ddd, J = 4.8, 10.2 Hz, 1H), 
5.91-5.82 (m, 2H), 5.80–5.67 (m, 3H), 5.53–5.49 (m, 2H), 5.43 (brs, 1H), 4.89 (ddd, J = 2.4, 6.1, 
10.4 Hz, 1H), 4.77 (brs, 1H), 4.75 (brs, 1H), 4.30–4.15 (m, 5H), 4.06 (ddd, J = 4.3, 9.2 Hz, 1H), 
3.80 (m, 1H), 3.68 (ddd, J = 10.0, 15.2 Hz, 1H), 2.37–2.22 (m, 3H), 2.19–2.02 (m, 6H), 1.94–
1.82 (m, 3H), 1.71 (s, 3H), 1.62–1.54 (m, 1H), 1.17 (ddd, J = 4.9, 6.8, 12.0 Hz, 1H), 0.88 (brs, 
21H), 0.07 (s, 3H), 0.04 (s, 3H), 0.02 (s, 3H), 0.01 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 165.3, 
147.0, 144.7, 136.3, 132.8, 131.3, 129.0, 128.6, 125.3, 124.9, 121.6, 119.7, 113.4, 75.6, 73.3, 
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 73.1, 72.2, 72.1, 67.0, 65.5, 45.0, 44.7, 43.1, 35.7, 33.8, 31.6, 31.4, 28.8, 25.9, 25.7, 22.9, 20.3, 
18.2, 18.0, –4.3, –4.5, –4.8, –4.9; HRMS m/z calcd for C42H70O6Si2 [M+Na]+: 749.4609, found 
749.4586. 
 
Desepoxylaulimalide (132): To a 0 ºC solution of 13 
mg of silyl ether 131 (17.9 µmol) in THF (2 mL) was 
added 1.0 mL of HF•pyridine complex dropwise via 
syringe.  The reaction was maintained for 1 h at 
ambient temperature, then poured into a 0 ºC mixture of saturated aqueous NaHCO3 (50 mL) and 
EtOAc (30 mL).  The mixture was extracted with EtOAc (3 × 20 mL).  The combined organics 
were washed with brine, dried over NaSO4, filtered, and concentrated.  Purification of the crude 
product by flash chromatography on silica gel (40% EtOAc/hexanes) afforded 8.0 mg (90%) of 
desepoxylaulimalide 132 as a pale yellow oil: [α]D = –171 (c 0.7, CHCl3); IR (thin film): 3415, 
2924, 2853, 1720, 1415, 1165 cm-1; 1H NMR (300 MHz, CDCl3) δ 6.36 (ddd, J = 5.3, 9.9, 11.4 
Hz, 1H), 5.94–5.82 (m, 3H), 5.79–5.69 (m, 2H), 5.64–5.61 (m, 2H), 5.42 (brs, 1H), 5.00 (app q, 
J = 6.6 Hz, 1H), 4.87 (brs, 2H), 4.23–4.12 (m, 5H), 4.05 (ddd, J = 4.4, 9.1 Hz, 1H), 3.92–3.84 
(m, 1H), 3.56 (dddd, J = 1.3, 8.0, 9.9, 18 Hz, 1H), 2.39–2.32 (m, 2H), 2.31–2.22 (m, 2H), 2.20–
2.08 (m, 3H), 2.07–1.97 (m, 1H), 1.96–1.84 (m, 3H), 1.83–1.74 (m, 3H), 1.70 (s, 3H), 1.67–1.61 
(m, 1H), 1.14 (ddd, J = 4.0, 7.5, 11.7 Hz, 1H), 0.87 (d, J = 6.0 Hz, 3H); 13C NMR (75 MHz, 
CDCl3): δ 165.6, 147.3, 144.9, 135.4, 133.9, 131.3, 129.0, 128.3, 126.5, 124.8, 121.2, 119.7, 
114.3, 75.3, 73.7, 73.1, 71.3, 69.8, 67.6, 65.6, 44.8, 43.3, 42.3, 35.7, 34.4, 33.6, 30.9, 28.3, 22.9, 
19.7; HRMS m/z calcd for C30H42O6 [M+Na]+: 512.2879, found 521.2880. 
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 (–)-Laulimalide (1): To a –20 ºC suspension of 0.130 
g of powdered 4 Å molecular sieves in 4 mL of 
CH2Cl2 was added 5 µl of (+)-DIPT (22.5 µmol) 
followed by 5 µL of titanium tetraisopropoxide (16.1 
µmol).  The reaction mixture was maintained at –20 ºC for 30 min, then treated with a 4.3 M 
solution of tBuOOH in toluene.  The reaction was maintained for an additional 30 min at –20 ºC, 
then a solution of 7.8 mg of desepoxylaulimalide 132 (15.7 µmol) in CH2Cl2 (2 mL) was added 
dropwise via syringe.  The reaction was maintained for 2 h.  A mixture of 4 N NaOH (0.5 mL) 
and brine (1.5 mL) was added, and the reaction was maintained for 90 min at 0 ºC.  The mixture 
was then extracted with CH2Cl2 (3 × 10 mL).  The combined organic layers were washed with 
brine and filtered through Celite.  The filtrate was dried over Na2SO4, filtered and concentrated.  
The crude product was purified by flash chromatography on silica gel to provide a pale yellow 
oil that was then triturated with 5% iPrOH/hexanes to afford 5.5 mg (69%) of (–)-laulimalide (1) 
as a white solid: [α]D = –198 (c 0.1, CHCl3); IR (thin film): 3423, 3071, 3032, 2917, 2846, 1719, 
1642, 1422, 1383, 1213, 1169, 894 cm-1; 1H NMR (600 MHz, CDCl3): δ 6.45 (ddd, J = 3.8, 10.1, 
11.4 Hz, 1H), 5.94–5.83 (m, 3H), 5.77 (dd, J = 5.7, 15.7 Hz, 1H), 5.72–5.69 (m, 2H), 5.43 (brs, 
1H), 5.17 (ddd, J = 1.6, 5.2, 11.2 Hz, 1H), 4.88 (brs, 1H), 4.86 (br s, 1H), 4.32 (br d, J = 9.4 Hz, 
1H), 4.24 (app q, J = 5.5 Hz, 1H), 4.19 (m, 2H), 4.07 (m, 1H), 4.04 (ddd, J = 4.5, 9.7 Hz, 1H), 
3.79–3.72 (m, 2H), 3.08 (ddd, J  = 3.3, 9.1 Hz, 1H), 2.91 (t, J = 2.6 Hz, 1H), 2.40–2.37 (m, 2H), 
2.22 (app dq, J =  2.7, 16.8 Hz, 1H), 2.13 (brd, J = 15.3 Hz, 1H), 2.07–1.85 (m, 7H), 1.79 (dd, J 
= 10.0, 12.8 Hz, 1H), 1.70 (brs, 3H), 1.54–1.43 (m, 2H), 1.37–1.31 (m, 1H), 0.84 (d, J = 6.5 Hz, 
3H); 13C NMR (125 MHz, CDCl3): δ 166.0, 150.3, 144.8, 133.9, 131.2, 128.7, 128.5, 125.2, 
120.5, 119.7, 112.5, 73.4, 73.2, 73.1, 72.3, 67.9, 66.5, 65.6, 60.7, 52.1, 45.5, 43.4, 37.1, 35.6, 
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 33.8, 33.3, 31.6, 29.7, 22.9, 20.7; HRMS m/z calcd for C30H42O7 [M+Na]+: 537.2828, found 
537.2816
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 CHAPTER 2.  STUDIES TOWARD THE TOTAL SYNTHESIS OF AMPHIDINOLIDE B 
 
 
2.1 BACKGROUND 
 
2.1.1 Isolation 
 
 
The amphidinolides represent an expansive and structurally diverse class of macrocyclic marine 
natural products that exhibit potentially useful biological activity.  Their common origin is the 
cultured symbiotic dinoflagellate Amphidinium sp. isolated from the Okinawan flatworm of the 
genus Amphiscolops.67  Emerging as one of the most pharmacologically impressive constituents 
of this family of bioactive microagal metabolites is the highly functionalized, 26-membered 
macrolide, amphidinolide B1 (133).   
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Figure 18.  The Amphidinolide B Group
                                                 
67 Ishibashi, M.; Ohizumi, Y.; Hamashima, M.; Nakamura, H.; Hirata, Y.; Sasaki, T.; Kobayashi, J. J. Chem. Soc., 
Chem. Commun. 1987, 1127. 
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  Amphidinolide B1 (133) was originally isolated in 1987 by Kobayashi and coworkers 
from cultured dinoflagellates obtained from the Okinawan flatworm, Amphiscolops breviviridis. 
Its gross structure was elucidated by 2D-NMR analysis; however, its relative and absolute 
stereochemical assignments remained unclear.  Shimizu et al. later disclosed the isolation of 133 
along with two other isomeric macrolides, denoted amphidinolides B2 (134) and B3 (135),68 from 
a larger free-swimming dinoflagellate collected off the coast of  the U.S. Virgin Islands in 
1994.69 As a result of the efforts of both Shimizu and Kobayashi, the relative and absolute 
stereochemistry of the amphidinolide B group was established through X-ray diffraction 
studies69 as well as the independent synthesis and chiral HPLC analysis of the C22–C26 subunit, a 
known chemical degradation product of amphidinolide B1.70
 
2.1.2 Structural Features 
 
Amphidinolide B1 (133) exhibits a high degree of molecular complexity with many key 
structural features.  The molecule itself is a highly decorated 26-membered macrolide that 
contains two distinct regions of functionality. The C14–C26 portion of 133 is highly oxygenated 
and includes a syn diol relationship, a tertiary carbinol stereocenter at C16 and a β-hydroxy 
carbonyl moiety while the C1–C13 portion remains relatively devoid of oxygenated functionality 
with the exception of the C8–C9 allylic epoxide and the (E)-enoate ester linkage. Overall, 
amphidinolide B1 (133) possesses nine stereogenic centers (seven hydroxyl-bearing stereocenters 
and two isolated methyl-bearing stereocenters) in addition to four double bonds which include a 
potentially acid sensitive s-cis diene. 
                                                 
68 Amphidinolides B2 and B3 were later identified as the C18 and C22 epimers of 133, respectively.  See Figure 15. 
69 Bauer, I.; Maranda, L.; Shimizu, Y.; Peterson, R. W.; Cornell, L.; Steiner, J. R.; Clardy, J. J. Am. Chem. Soc. 
1994, 116, 2657. 
70 Ishibashi, M.; Ishiyama, H.; Kobayashi, J. Tetrahedron Lett. 1994, 35, 8241. 
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 2.1.3 Biological Activity 
 
 
In addition to possessing a synthetically challenging molecular architecture, amphidinolide B1 
(133) is among the most biologically active members of the amphidinolide family of natural 
products.  It exhibits very potent cytotoxicity against the human epidermoid carcinoma KB cell 
line (IC50 = 4.2 ng/mL) as well as human colon HCT 116 and murine lymphoma L1210 cells 
(IC50 = 0.14 ng/mL).  As in the case of (–)-laulimalide (1), the C8–C9 epoxide moiety is believed 
to play a critical role in the biological activity expressed by 133.  Single crystal X-ray analysis of 
amphidinolide B1 confirms the presence of an intraannular hydrogen bond between the epoxide 
functionality and the C21 hydroxyl group giving 133 a seemingly well-defined rectangular 
structure.69 Comparison of the activity displayed by 133 and its C21 epimer (amphidinolide D) 
strongly suggests the importance of the allylic epoxide in the observed biological activity as 
amphidinolide D is 100 times less potent than 133. The necessity of the epoxide residue was also 
demonstrated via structural modification of 133; epoxide ring opening with MeOH resulted in a 
derivative of amphidinolide B1 that displayed a 600-fold decrease in biological activity compared 
to the parent compound.71   
Presently, there have been no literature reports regarding the mechanism of action of 
amphidinolide B1.  Limited natural supply coupled with the current lack of a synthetic route to 
133 has severely hampered such investigations.  Although no total synthesis of 133 has been 
communicated to date, the combination of its structural complexity, potential chemotherapeutic 
utility, and limited natural abundance has made amphidinolide B1 an extremely attractive target 
                                                 
71 Kobayashi, J.; Ishibashi, M, Chem. Rev. 1993, 93, 1753. 
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 molecule for synthetic organic chemists and has led to several reports describing the syntheses of 
major fragments.72   
 
2.1.4 Previous Synthetic Work 
 
The first synthetic approach toward the total synthesis of amphidinolide B1 (133), depicted in 
Figure 19, was disclosed by Chakraborty et al. in 1997.  From a retrosynthetic standpoint, 
Chakraborty envisioned the assembly of 133 occurring via a Stille coupling to form the C13–C14 
s-cis diene moiety with subsequent macrolactonization to close the 26-membered ring.  These 
disconnections led to the lower C1–C13 fragment 136 and the upper C14–C26 fragment 137.   
Fragment 137 was constructed through an aldol reaction between aldehyde 138 and methyl 
ketone 139 (dr = 3:2).  The lower C1–C13 fragment 136 was prepared via the Nozaki-Hiyama-
Kishi coupling of aldehyde subunit 140 and vinyl iodide 141 (syn:anti 3:7) to set the requisite 
anti-diol relationship for epoxide formation. Subsequent Wittig homologation then installed the 
E-α,β-unsaturated carboxylate ester.   
 
                                                 
72 (a) Cid, B.; Pattenden, G. Tetrahedron Lett. 2000, 41, 7373.  (b) Ohi, K.; Nishiyama, S. Synlett 1999, 571.  (c) 
Ohi, K.; Nishiyama, S. Synlett 1999, 573.  (d) Eng, H. M.; Myles, D. C. Tetrahedron Lett. 1999, 40, 2275.  (e) Eng, 
H. M.; Myles, D. C. Tetrahedron Lett. 1999, 40, 2279.  (f) Chakraborty, T. K.; Thippewamy, D. Synlett 1999, 150.  
(g)Ishiyama, H.; Takemura, T.; Tsuda, M.; Kobayashi, J. J. Chem. Soc., Perkin Trans. 1 1999, 1163.  (h) 
Chakraborty, T. K.; Thippewamy, D.; Suresh, V. R. Chem. Lett. 1997, 563.  (i) Chakraborty, T. K.; Suresh, V. R. 
Chem. Lett. 1997, 565.   (j) Lee, D. H.; Lee, S. –W.  Tetrahedron Lett. 1997, 38, 7909.  (k) Ohi, K.; Shima, K.; 
Hamada, K.; Saito, Y.; Yamada, N.; Ohba, S.; Nishiyama, S. Bull. Chem. Soc. Jpn. 1998, 71, 2433. 
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Figure 19.  Chakraborty Approach to the Major Fragments of Amphidinolide B1
 
 
 
 Following the initial report by Chakraborty, Nishiyama and coworkers described a 
second strategy aimed at the enantioselective total synthesis of 133 that made extensive use of 
the chiral pool (Figure 20).  Retrosynthetically, Nishiyama’s approach resembles that of 
Chakraborty calling for the Pd(0)-mediated synthesis of the s-cis diene as well as ring closure via 
the macrocyclization of the resulting seco acid and arriving at the C1–C13 and C14–C26 fragments 
142 and 143, respectively.  Fragment 142 was prepared by Claisen rearrangement and 
subsequent Wittig reaction of allyl vinyl ether 144 which in turn was synthesized in 18 steps, 
including an asymmetric Evans alkylation to install the C11 methyl-bearing stereocenter, from 
commercially available D-erythrose.  Fragment 143 was assembled via a dithiane anion addition 
to primary iodide 145.  Dithiane 146 was prepared via Wittig reaction of the known (2S, 4S)-(+)-
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 pentanediol derived aldehyde 14773 and iodide 145 was synthesized from (3S)-methyl 3,4-
dihydroxybutanoate. 
 
 
O
Me
Me
O
OHMe
Me
O
Me
O
MeHO
1
6
13
18
21
26
HO
OH O
Me
Me
OTBDPS
OTIPS
Me
O
Me
MeTIPSO
TIPSO
OH
OEt
S
S
Me
Me
OTBDPS
Stille
Macrolactonization
Wittig
I
O O
Me Me
Me
TMS
Me
OTBDPS
OMPM
S
S
Me
Me
O
OMPM
S
S
OHC OH
OH
OH
OHC
Me
Me
OTBS
MeO2C OH
OH
TBDPS O
133
142
143
145 146
147
144
Dithiane Anion 
Addition
Claisen 
Rearrangement
 
Figure 20.  Nishiyama Approach to the Major Fragments of Amphidinolide B1
 
 In 1999, several partial syntheses of amphidinolide B1 were completed in close 
succession beginning with a highly convergent route published by Myles.  Macrolide formation 
was envisioned to proceed through a fragment uniting nucleophilic addition between a vinyl 
                                                 
73Shioiri, T.; Imaeda, T.; Hamada, Y.  Heterocycles 1997, 46, 421. 
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 anion derived from ketone 148 and aldehyde 149 followed by macrolactonization.  The C1–C13 
fragment 148 was synthesized from sulfone 150 and chiral ester 151 via a Trost/Julia olefination.  
Construction of the upper C14–C26 fragment 149 was achieved by employing a Roush-Masamune 
olefination of β-ketophosphonate 152 and the (S)-ethyl-(L)-(+)-lactate derived α-chiral aldehyde 
153.  Sharpless asymmetric dihydroxylation of the resulting E-olefin then installed the C21,C22-
syn-diol relationship (Figure 21).    
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Figure 21.  Myles Approach to the Major Fragments of Amphidinolide B1 
 
 
 Twelve years after first isolating and establishing the absolute stereochemistry of 
amphidinolide B1, Kobayashi et al. published synthetic approaches to both the lower C1–C13 
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 fragment 154 and the upper C14–C26 of 155 (Figure 22).  Fragment 154 was prepared by the 
addition of an organocerium reagent derived from alkyne 156 into aldehyde 157 followed by 
Wittig olefination to introduce the (E)-α,β-unsaturated ester moiety.  Subunits 156 and 157, in 
turn, were obtained from 1,4-butanediol and (2S, 4S)-(+)-pentanediol, respectively.  To arrive at 
upper fragment 155, Kobayashi employed an aldol reaction between aldehyde 138 and methyl 
ketone 158 to form the C18–C19 bond.  Aldehyde 138 was synthesized from commercially 
available 3-methylbut-3-en-1-ol employing Sharpless asymmetric dihydroxylation technology to 
install the C16 tertiary carbinol stereocenter.  Construction of the highly oxygenated C19–C26 
ketone subunit 158 was achieved by Wittig olefination and subsequent dihydroxylation of 
Shioiri’s pentanediol derived aldehyde.  
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Figure 22.  Kobayashi Approach to the Major Fragments of Amphidinolide B1 
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  Synthetic efforts by Lee et al. (Figure 23) arrived at the enantioselective preparation of 
major fragments 159 and 160 of amphidinolide B1.  The synthesis of the C1–C13 fragment 159, 
first disclosed in 1997, incorporated the asymmetric allylation of an Evans oxazolidinone with 
2,3-dibromopropene to successfully install the C11 methyl-bearing stereocenter.  A more recent 
report described Lee’s approach to the C14–C26 fragment 160 that involved construction of the 
C20–C21 bond via nucleophilic addition of a vinyl lithium species derived from iodide 161 to 
aldehyde 162.  Vinyl iodide 161 was prepared by Takai olefination of α-chiral aldehyde 163 
which in turn was manufactured from ethyl-(S)-lactate.  The C16 tertiary carbinol stereocenter in 
aldehyde 162 was generated via Sharpless asymmetric epoxidation with subsequent ring opening 
with dimethyl cuprate.   
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Figure 23.  Lee Approach to the Major Fragments of Amphidinolide B1 
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  The most advanced route to the total synthesis of amphidinolide B1 has been recently 
described by Pattenden and Cid (Figure 24).  The retrosynthetic strategy called for the union of 
the major C1–C13 and C14–C26 fragments, 164 and 165, respectively, via an esterification of 
carboxylic acid 164 and the C25 secondary alcohol in fragment 165.  A subsequent 
intramolecular Stille coupling would then close the 26-membered macrocycle.  The synthesis of 
fragment 165 was accomplished through an aldol coupling of ketone 166, derived from (2S, 4S)-
pentanediol, and aldehyde 167.  Aldehyde 167 was prepared from 3-methyl-2-penten-4-yn-1-ol 
via Sharpless epoxidation to install the C16 tertiary carbinol and silylstannylation with subsequent 
cuprate addition to form the requisite trisubstituted olefin.  The lower fragment 164 was 
assembled via Julia olefination of (R)-3-methylglutarate derived epoxyaldehyde 168 and sulfone 
169.  Unfortunately, after having united major fragments 164 and 165 by esterification to form 
170, the critical intramolecular Stille reaction was unsuccessful in closing the macrolide. 
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Figure 24.  Pattenden Approach to the Major Fragments of Amphidinolide B1 
 
 
2.2 RETROSYNTHETIC ANALYSIS 
 
Our retrosynthetic approach to amphidinolide B1 is outlined in Figure 25.  As in previous 
approaches, bond cleavage along the C1-macrolactone as well as C14–C15 of the s-cis diene were 
recognized as strategic disconnections that would enhance the convergency of the synthesis by 
effectively dividing the target molecule into two equally complex halves, the lower C1–C13 
fragment 171 and the upper C14–C26 fragment 172.  Palladium-mediated coupling of vinyl iodide 
172 and the pinacol boronate ester moiety in 171 was envisioned to unite the major fragments, 
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 forming the acid-sensitive diene moiety, and subsequent Yamaguchi macrolactonization would 
be employed to close the 26-membered ring.   
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Figure 25.  Retrosynthetic Approach to Amphidinolide B1 
 
 
2.3     THE C1–C13 FRAGMENT 
 
2.3.1 Retrosynthesis 
 
 
The lower C1–C13 fragment of amphidinolide B1 (133) can be further dissected at the C6–C7 
olefin to deliver sulfone 173 and epoxyaldehyde 174 as illustrated in Figure 26.    Subunit 173 
would be readily accessible from the reduction and subsequent olefination of commercially 
available γ-butyrolactone, while the enantioselective synthesis of 174 would be predicated on the 
synthetic elaboration of optically active β-lactone products of asymmetric AAC reaction 
technology.  
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Figure 26.  Retrosynthesis for the C1–C13 fragment of amphidinolide B1
 
 
 
2.3.2 Synthesis of the C1-C6 Subunit 
 
We had envisaged a rapid synthesis of the C1–C6 subunit of amphidinolide B1 occurring from 
commercially available γ-butyrolactone (Scheme 24).  The synthesis of 173 commenced with the 
DIBAL-H reduction of 175 to the corresponding lactol 176 and subsequent trapping of the open 
form of 176 with phosphorane 177  to arrive at (E)-α,β-unsaturated carboxylate ester 178 in 
good yield.74  Primary alcohol 178 was recognized as a versatile synthon that could be 
transformed into a variety coupling partners for either a Wittig or Julia olefination reaction.  
Electing to pursue the Julia olefination strategy, sulfone formation was achieved through a 
Mitsunobu reaction of alcohol 178 (DEAD, PPh3, THF) with 2-mercaptobenzothiazole followed 
by oxidation of the resulting thioether with catalytic MnSO4•H2O and 30% H2O2 (74% yield).75   
 
 
                                                 
74 The geometry of the (E)-olefin in ester 178 was confirmed via 1D NOE spectroscopy (500 MHz).  Irradiation of 
the C3 vinyl hydrogen resulted no observable NOE enhancement in the adjacent methyl group. 
75 Alonso, D. A.; Nájera, C.; Varea, M. Tetrahedron Lett. 2002, 43, 3459. 
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 Scheme 24.  Synthesis of the C1–C6 Subunit 173a
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aConditions:  (a) i. DIBAL-H, CH2Cl2, ii. 177, THF.  (b) DEAD, PPh3, 2-mercaptobenzothiazole, 
THF, 0 °C → rt.  (d) 30 % H2O2, NaHCO3, MnSO4•H2O (5 mol %) CH3CN.
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2.3.3 Synthesis of the C7–C13 Subunit76 
 
Having arrived at a convenient synthetic route to the C1–C6 sulfone subunit,   we turned our 
attention toward the synthesis of epoxy aldehyde 174.  Once again, the aid of the catalytic AAC 
reaction was enlisted to prepare the highly enantiomerically enriched β-lactone 179 in 95% ee 
employing 20 mol % of the second generation unsymmetrical Al (III)-triamine catalyst 180. 
Cuprate mediated SN2 ring opening of lactone 179 afforded the corresponding carboxylic acid 
181 in good yield and efficiently installed the C11 methyl-bearing stereocenter.  Acid to enol 
triflate interconversion was then accomplished by first treating 181 with 2 equiv of MeLi in THF 
to provide the requisite methyl ketone (56%).  Enolization of 182 with potassium 
hexamethyldisilazide (KHMDS) at –78 °C followed by electrophilic capture of the enolate 
oxygen atom with N-phenyltrifluoromethanysulfonimide (PhNTf2) then furnished vinyl triflate 
183 in 85% yield.    In anticipation of the planned fragment uniting Suzuki reaction, triflate 183 
                                                 
76 All synthetic work described in this section was accomplished by Apsara Gopalarathnam (unpublished results).  
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 was transformed into the corresponding pinacol boronate ester 184 by a palladium catalyzed 
coupling with bis(pinacolato)diborane in good yield.  Silyl ether 184 was then elaborated to 
allylic alcohol 185 via the four step sequence of deprotection, oxidation, Horner-Wadsworth-
Emmons olefination, and ester reduction.  Sharpless asymmetric epoxidation of allylic alcohol 
185 with subsequent oxidation of the primary alcohol would then provide epoxyaldehyde 
fragment 174 (Scheme 25).   
 
 
Scheme 25.  Synthesis of the C7–C13 Subunit 185a
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 2.4 THE C14–C26 FRAGMENT 
 
2.4.1 Retrosynthetic Analysis 
 
The hydrophilic C14–C26 fragment of amphidinolide B1 (133) represents the most densely 
functionalized portion of the natural product.  Fragment 172 would be prepared by Sharpless 
asymmetric dihydroxylation of the α,β-unsaturated ketone 186 followed by carbostannylation 
and tin-halogen exchange to generate the vinyl iodide to be used in the fragment uniting Suzuki 
reaction.   Further dissection of the C14–C26 fragment along the C21–C22 olefin would deliver β-
ketophosphonate 187 and α-chiral aldehyde 147 as target subunits.  The installation of the C18 
hydroxyl-bearing stereocenter in fragment 187 would result from the strategic use of AAC 
reaction technology (Figure 27).   
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Figure 27.  Retrosynthesis for the C14–C26 fragment of amphidinolide B1
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 2.4.2 Installation of the C16 Tertiary Carbinol Stereocenter 
 
The most synthetically straightforward approach for establishing the C16 tertiary carbinol 
stereocenter in fragment 172, aside from the commonly employed Sharpless asymmetric 
epoxidation strategy, was envisioned to be an asymmetric allylation of the commercially 
available acetylenic ketone, 4-trimethylsilyl-3-butyn-2-one.  However, unlike the asymmetric 
allylation of aldehydes which has enjoyed much success in the literature,77 the corresponding 
reaction involving ketone substrates has remained a far more challenging synthetic endeavor due 
to the marked difference in reactivity between aldehydes and ketones.   
 One of the few examples of the asymmetric allylation of ketones was described by H. C. 
Brown.78  While most of the methyl ketone substrates examined by Brown resulted in poor levels 
of asymmetric induction, the allylboration of 3-butyn-2-one resulted in moderate 
enantioselectivity furnishing the corresponding homoallylic alcohol 188 in 75% ee.  Encouraged 
by this result, we applied Brown’s asymmetric allylboration conditions to 4-trimethylsilyl-3-
butyn-2-one (190).  Treating a –78 °C solution of allyldiisopinocampheylborane 189 in Et2O 
with acetylenic ketone 190 afforded the desired allyl addition product 191 in 52% yield.  In order 
to assay the enantioselectivity of the reaction, the tertiary alcohol product was derivatized as the 
ester of (R)-methoxyphenylacetic acid (DCC, DMAP).  Unfortunately, 1H NMR analysis of the 
crude product mixture revealed a 1:1 mixture of ester diastereomers (192).  
 
 
 
 
 
                                                 
77 Keck, G. E.; Tarbet, K. H.; Geraci, L. S. J. Am. Chem. Soc. 1993, 115, 8467. 
78 Jadhav, P. K.; Bhat, K. S.; Perumal, T.; Brown, H. C. J. Org. Chem. 1986, 51, 432. 
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 Scheme 26.  Attempted C16 Tertiary Carbinol Installation via Asymmetric Brown Allylation   
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 A survey of the more recent literature concerning the synthesis of chiral homoallyic 
alcohols via catalytic, asymmetric ketone allylation led to our investigation of the Ti(IV)-BINOL 
based systems of Tagliavini79 and Walsh.80  In 1999, Tagliavini et al. published the first example 
of a catalytic, asymmetric ketone allylation for the enantioselective preparation of tertiary 
homoallylic alcohols (Scheme 27).  Employing a Ti(IV)-(R)-BINOL catalyst ent-25 (20 mol%) 
and tetraallyltin as the allylating agent (40 mol%), moderate to good enantioselectivities (29-
80% ee) were obtained for a variety of aromatic, aliphatic, and α,β-unsaturated ketone 
substrates.  Although no examples of acetylenic ketones were reported, we sought to examine the 
effectiveness of these reaction conditions for the installation of the C16 tertiary carbinol 
stereocenter of amphidinolide B1.  Treating a solution of Cl2Ti(IV)-(R)-BINOL catalyst ent-25 in 
                                                 
79 Casolari, S.; D’Addario, D.; Tagliavini, E. Org. Lett. 1999, 1, 1061. 
80 Waltz, K. M.; Gavenonis, J.; Walsh, P. J. Angew. Chem. Int. Ed. 2002, 41, 3697. 
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 CH2Cl2 with 190 at ambient temperature resulted in the formation of alcohol 191 in 82% isolated 
yield.  As described previously in the case of Brown allylboration, the resulting tertiary alcohol 
product was then converted to its corresponding (R)-methoxyphenyl acetate ester and assayed by 
500 MHz 1H NMR spectroscopy.  Unfortunately, a disappointing 1.2:1 ratio of ester 
diastereomers was observed. 
Scheme 27.  Attempted C16 Tertiary Carbinol Installation via Asymmetric Tagliavini Ti(IV)-
BINOL Allylation  
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  The recent investigations by Walsh lead to a major breakthrough in the catalytic, 
asymmetric allylation of ketones.  Through a more detailed examination of the catalyst system 
utilized by Tagliavini, it was discovered that the major titanium-containing component was 
BINOL-Ti(OiPr)2. When BINOL-Ti(OiPr)2 was prepared independently from BINOL and 
Ti(OiPr)4 with subsequent removal of iPrOH and employed in allylation reactions, 
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 enantioselectivities comparable to those obtained by Tagliavini were obtained.   However, when 
the catalyst preparation was not followed by removal of iPrOH, a marked increase in 
enantioselectivity of the tertiary alcohol product of the allylation reaction was realized.  
Optimized reaction conditions entailed treating a solution of BINOL (20-30 mol%) and Ti(OiPr)4 
(20-30 mol%) in CH2Cl2 with iPrOH (20 equiv) followed by the ketone substrate and 
tetraallylstannane (1.5 equiv).  Encouraged by the high levels of enantioselectivity obtained by 
Walsh et al., we prepared alcohol 191 in 88% yield according to the published procedure 
(Scheme 28).  However, conversion of the resulting tertiary alcohol product to its corresponding 
(R)-methoxyphenyl acetate ester once again revealed synthetically unacceptable levels of 
diastereoselection (3:2).   
 
Scheme 28.  Attempted C16 Tertiary Carbinol Installation via Walsh Protocol 
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 Given the unsatisfactory results obtained in the previously described allylation reactions, 
we turned our attention to a reagent system successfully employed by Mukaiyama and coworkers 
for the asymmetric allylation of aldehydes and activated ketones (Figure 28).81  Mukaiyama’s 
protocol incorporates chiral diisopropyltartrate ligands (5.0 equiv) into Sn(II)-catecholate 193 
(2.0 equiv)82 to afford the corresponding stannate complex 194 which is speculated to undergo 
oxidative addition with allyl bromide (2.0 equiv) in the presence of catalytic amounts of CuI (10 
mol%) to produce the chiral Sn(IV)-allylating agent 195.  Reaction of 195 with various aromatic 
aldehyde and pyruvate electrophiles in CH2Cl2 at –78 °C afforded the corresponding homoallylic 
alcohols in high yield with excellent levels of enantioselectivity.   
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Figure 28.  Mukaiyama’s Asymmetric Allylation of Carbonyl Compounds 
 
 
Intrigued by the high enantioselectivities observed by Mukaiyama, and confident in our ability to 
transform the activating benzyl ester moiety into the requisite TMS-alkyne in subunit 187, we 
                                                 
81 (a) Nishida, M.; Tozawa, T.; Yamada, K.; Mukaiyama, T. Chem. Lett. 1996, 1125.  (b)Yamada, K.; Tozawa, T.; 
Nishida, M.; Mukaiyama, T. Bull. Chem. Soc. Jpn. 1997, 70, 2301. 
82 Honnick, W. D.; Zuckerman, J. J. Inorg. Chem. 1978, 17, 501. 
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 elected to explore the possibility of initiating our synthesis of fragment 172 with the asymmetric 
allylation of benzyl pyruvate.   
 
2.4.3 Synthesis of the C14–C21 Subunit 
 
The synthesis of the C14–C21 β-ketophosphonate subunit 187 commenced with the asymmetric 
allylation of benzyl pyruvate with the chiral Sn(IV) allylating agent 195 according to the 
published procedure described by Mukaiyama et al.75 Initially, there was some concern as to the 
reproducibility of this literature procedure as the high enantioselectivities were representative of 
very small-scale reactions.  In Mukaiyama’s examples, reactions typically employed 0.2 mmol 
(~35 mg) of the benzyl pyruvate substrate.  Incorporating this allylation protocol into our 
synthetic scheme for the preparation of 187 would obviously require performing the reaction on 
significantly larger scale, and we were concerned whether we would observe the same excellent 
enantioselectivity in a large scale reaction.  Gratifyingly, performing the reaction on 3.0 g of 
benzyl pyruvate afforded tertiary alcohol 196 in 52% yield with 94% ee (Scheme 29).  Silyl 
protection of the chiral tertiary alcohol with TBSOTf and 2,6-lutidine then delivered silyl ether 
197 in 87% yield.   
 
 
Scheme 29.  Mukaiyama Asymmetric Sn(IV)-Allylation of Benzyl  Pyruvatea
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 While the benzyl ester was essential for the activation of the allylation substrate, it now 
required further elaboration to an alkyne.  This was envisioned to occur by half-reduction to the 
corresponding aldehyde with subsequent Corey-Fuchs homologation to provide the protected 
alkyne 198 (Scheme 30).  However, attempted half-reduction of 197 to the corresponding 
aldehyde 199 with 1.0 equivalent of DIBAL-H at –90 °C consistently resulted in mixtures of the 
desired aldehyde product 199, starting ester, and overreduction to alcohol 200.  Given this 
inability to control the half-reduction, benzyl ester 197 was treated with an excess of DIBAL-H 
to cleanly afford the corresponding alcohol 200 which was then cleanly oxidized to the desired 
aldehyde under Parikh-Doering conditions.83  Corey-Fuchs homologation84 of aldehyde 199 with 
CBr4 and PPh3 in CH2Cl2 furnished the vinyl dibromide 201 in 85 % yield from alcohol 200.  
After treating 201 with nBuLi and TMSCl, we arrived at the trimethylsilyl-protected alkyne 198. 
 
 
Scheme 30.  Conversion of Benzyl Ester 197 to Alkyne 198a 
TBSO Me
BnO
O
TBSO Me
OH
TBSO Me
H
O
TBSO Me
Br Br
TBSO Me
TMS
a b
c
d
aConditions:  (a) DIBAL-H, CH2Cl2, –78 °C.  (b) SO3•py, DMSO, Et3N, CH2Cl2, 
0 °C.  (c) PPh3, CBr4, CH2Cl2.  (d) i. nBuLi, THF, –78 °C.  ii. TMSCl, –78 °C to 0 °C.
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 With alkyne 198 in hand, we attempted to apply the asymmetric AAC reaction to form 
the C18–C19 bond and concomitantly establish the requisite C18 hydroxyl-bearing stereocenter of 
                                                 
83 Parikh, J. R.; Doering, W. E.  J. Am. Chem. Soc. 1967, 89, 5505. 
84 Corey, E. J.; Fuchs, P. L. Tetrahedron Lett. 1972, 36, 3769. 
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 amphidinolide B1 (Scheme 31).  Selective ozonolysis of the monosubstituted olefin over the 
TMS-protected alkyne proceeded rapidly at –78 °C in CH2Cl2/MeOH/py (5:5:1) to afford the 
desired aldehyde coupling partner for the AAC reaction.  There was some concern regarding the 
protected tertiary alcohol stereocenter in aldehyde 202.  In all previous examples of 
diastereoselective AAC reactions to achieve 1,3-stereochemical relationships, the aldehyde 
component of the AAC contained a protected secondary alcohol stereocenter where the small 
hydrogen atom could be oriented toward the approaching ketene nucleophile.  In the present 
reaction, the C16 methyl group would be aligned with the incoming nucleophile, and the manner 
in which this more sterically demanding substituent would affect the observed 
diastereoselectivity of the reaction was uncertain. We were pleased to discover that subjecting 
aldehyde 202 to standard AAC conditions (10 mol% of (S, S)-catalyst 36) resulted in the 
complete conversion of 202 to the corresponding β-lactone 203 in 87% isolated yield with high 
levels of diastereoselectivity (dr = 30:1) induced by the chiral aluminum triamine catalyst.    
 
Scheme 31.  AAC-Based Installation the C18 Hydroxyl-Bearing Stereocentera 
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 According to our previously described retrosynthetic strategy, completion of the C14–C21 
β-ketophosphonate subunit 187 was predicated on the regioselective ring opening of lactone 203 
with a lithium phosphonate anion. This transformation is greatly underrepresented in the 
literature, most likely due to the low availability of enantiomerically enriched β-lactones; 
however, a few related examples exist that encouraged our pursuit of this bond construction.  It 
has been demonstrated that, when treated with alkylidenetriphenylphosphoranes, β-propiolactone 
undergoes ring opening at the carbonyl carbon to afford δ-hydroxy-β-ketophosphoranes in 
modest yield (Eq 14).85 Also, γ- and δ-lactones have been shown to react with 
lithiumalkylphosphonates arriving at the corresponding β-ketophosphonate (Eq 15).86  Based on 
this precedent, we anticipated the successful nucleophilic addition/elimination reaction between 
β-lactones and lithium alkylphosphonates. 
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 To explore the reactivity of enantiomerically enriched β-lactones toward lithium 
alkylphosphonates, hydrocinnamaldehyde derived lactone 61 was selected as a test substrate 
(Scheme 32).  We were pleased to learn that treating a –78 °C solution of the lithium anion of 
                                                 
85 Le Roux, J.; Le Corre, M. J. Chem. Soc., Chem. Commun. 1989, 1464. 
86 Altenbach, H.-J.; Holzapfel, W.; Smerat, G.; Finkler, S. H. Tetrahedron Lett. 1985, 26, 6329. 
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 diethylmethylphosphonate 204 (1.5 equiv) in THF with lactone 61 resulted in the formation of 
the desired β-ketophosphonate 205 in 52% isolated yield; however, it was accompanied by a 
significant amount (15%) of a by-product 206 that apparently resulted from the acylation of the 
newly generated lithium alkoxide product of β-lactone ring opening based on 1H NMR and MS 
analysis.  
 
 
Scheme 32.  Lithium Phosphonate Anion Ring Opening of b-Lactone 61 
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 The formation of self-acylated product 206 would suggest a competition for the β-lactone 
electrophile existing between the intended lithium diethylphosphonate nucleophile and the newly 
generated lithium alkoxide arising from ring opening of 61.  Presumably, a marked increase in 
the concentration of the phosphonate anion should work to suppress the competitive nucleophilic 
addition by the lithium alkoxide.  Indeed, doubling the concentration of lithium diethyl 
phosphonate (3.0 equiv) effectively eliminated the self-acylation product87 and furnished the 
desired β-ketophosphonate 205 in 83% yield.    
 Having successfully demonstrated the synthesis of β-ketophosphonates from 
enantiomerically enriched β-lactones, we could then apply this new strategy to complete the β-
                                                 
87 No detectable amount of self-acylation product 206 was observed upon 1H NMR analysis of crude product 
mixtures. 
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 ketophosphonate subunit 187 (Scheme 33).  Lithiation of 3.0 equiv of diethylmethylphosphonate 
at –78 °C in THF, followed by treatment with β-lactone electrophile 203 resulted in 
regioselective lactone ring opening to β-ketophosphonate 207 in 82% yield.  Employing the 
lithium anion of dimethylmethyl phosphonate cleanly afforded the corresponding β-
ketophosphonate 208 in slightly higher yields (88-90%).  The resulting secondary alcohol was 
then protected as its tert-butyldimethylsilyl ether (TBSCl, imidazole, DMF) thus completing the 
synthesis of the C14–C21 subunit. 
 
 
Scheme 33.  Completion of the C14–C21 Subunit 187a 
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2.4.4 Synthesis of the C22–C26 Subunit 
 
We had originally envisioned a potential route to the C22–C26 α-chiral aldehyde fragment of 147 
commencing with the enantiomerically enriched β-lactone 105 (Scheme 34).  Treatment of 105 
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 with excess dimethylmagnesiocuprate resulted in SN2 ring opening to establish the requisite C23 
methyl-bearing stereocenter and delivered carboxylic acid 209 in 79% yield.  Acid 209 was then 
efficiently converted to the corresponding aldehyde 210 (85%) according to Brown’s one-pot 
reduction/oxidation sequence previously employed in the total synthesis of (–)-laulimalide. 
 
Scheme 34.  Synthesis of Aldehyde 210a 
a b
79% 85%
a Conditions:  (a) CuBr, MeMgBr, TMSCl, THF/DMS,  –50 °C to rt. (b) i. 
BH3·SMe2, Et2O; ii. PCC, CH2Cl2.
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Installation of the requisite C25 hydroxyl-bearing stereocenter was to be accomplished via 
a diastereoselective dimethylzinc addition to aldehyde 210.  While the asymmetric addition of 
diethylzinc to aromatic and aliphatic aldehydes has been well established, the corresponding 
dimethylzinc additions are lesser known.88  Initial attempts to arrive at suitable reaction 
conditions to promote the desired dimethylzinc addition employed Soia’s N,N-di-n-
butylnorephedrine amino alcohol catalyst 211 (Eq 16).  However, subjecting aldehyde 210 to a 0 
°C solution of 211 (10 mol%) and Me2Zn (2.2 equiv) in toluene for 24 h resulted in a sluggish 
reaction that afforded the secondary alcohol product 212 as a 4:1 inseparable mixture of 
diastereomers (500 MHz 1H NMR)  in rather modest yield (~35%).  The ineffectiveness of this 
protocol prompted the investigation of other means of promoting this transformation. 
 
                                                 
88 Pu, L.; Yu, H.-B. Chem. Rev. 2001, 101, 757 and references therein. 
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 Another intriguing possibility for achieving the desired diastereoselective dimethylzinc 
addition to aldehyde 210 was described by Yus et al. in the total synthesis of the pine beetle 
pheromone, (–)-frontalin (213).89  The key step in the synthesis of 213 involved the 
enantioselective addition of dimethylzinc to an α,β-unsaturated ketone 214 at 0 °C in the  
presence of Ti(OiPr)4 and a substoichiometric amount of the chiral sulfonamide ligand (1R, 2R)-
bis(hydroxycamphorsulfonamido)cyclohexane (HOCSAC) 21590 to afford the chiral tertiary 
alcohol 216 in 81% yield with an enantiomeric excess of 89% (Scheme 35).  
 
Scheme 35.  Asymmetric Dimethylzinc Addition to Ketones:  Total Synthesis of (–)-Frontalin 
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89 Yus, M.; Ramón, D. J.; Prieto, O. Eur. J. Org. Chem. 2003, 15, 2745. 
90 Ligand 215 and ent-215 were prepared according to the literature procedure:  Balsells, J.; Walsh, P. J. J. Am. 
Chem. Soc. 2000, 122, 3250. 
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 Given the success with the sterically and electronically more demanding ketone substrate, we 
anticipated similar results with aldehyde 210.  Exposure of 210 to these reaction conditions did 
result in an increased isolated yield of alcohol 212 (62%); however, no selectivity was achieved 
based on 500 MHz 1H NMR analysis of the crude reaction mixture (dr = 1:1) (Eq 17).  
Attributing the lack of selectivity to a possible mismatched substrate/catalyst pairing, the 
reaction was repeated with the enantiomeric (1S, 2S)-sulfonamide ligand ent-215.  
Disappointingly, no selectivity was observed possibly owing to unfavorable steric interactions 
caused by the preexistent β-stereocenter in 210.  
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Me
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 A rapid alternative synthesis of the C22–C26 fragment amphidinolide B1 from (2S, 4S)-
(+)-pentanediol was disclosed in Shioiri’s total synthesis of geodiamolide A.73  This method has 
also been applied in several other syntheses of the upper fragment of 133 and was viewed as a 
convenient option (Scheme 36). Selective monosilylation of 217 with sodium hydride and 
triethylsilyl chloride at ambient temperature yielded the monoprotected diol 218 in 91% yield.91  
We elected to mono-protect the diol as the triethylsilyl ether in an attempt to build orthogonality 
into our protecting group strategy as the late stage macrolactonization to close the 26-membered 
ring will require selective removal of the C25 protecting group to ensure a higher degree of 
success. Tosylation of the remaining secondary alcohol was performed with p-toluenesulfonyl 
                                                 
91 McDougal, P. G.; Rico, J. G.; Oh, Y.-I.; Condon, B. D. J. Am. Chem. Soc. 1986, 51, 3388. 
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 chloride in pyridine solvent to obtain the secondary tosylate 219 in 53% yield accompanied by 
an unidentifed by-product after 4 days at 4 °C.  A far more efficient reagent system for the 
tosylation of secondary alcohol 218 was realized by substituting 1,4-diazabicyclo[2.2.2]octane 
(DABCO) for pyridine.92   Tosylate 219 could now be obtained in 85% yield after 1.5 h at 0 °C 
without any undesired elimination products.  Cyanide displacement of the secondary tosylate 
(NaCN, DMSO, 50 °C) arrived at nitrile 220 and subsequent DIBAL-H reduction provided the 
C22–C26 α-chiral aldehyde subunit 221 which was used without further purification. 
 
Scheme 36.  Synthesis of the C22–C26 Subunit 221a 
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2.4.5 Subunit Coupling and Functionalization for Fragment Union 
 
 
Assembly of the two subunits 187b and 221 was achieved under Roush-Masamune olefination 
conditions (LiCl, DIPEA, CH3CN) to deliver the desired (E)-olefin 222 as a single regioisomer 
                                                 
92 Hartung, J.; Hünig, S.; Kneuer, R.; Schwarz, M.; Wenner, H.  Synthesis 1997, 12, 1433. 
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 in moderate yield (Scheme 37).93  Installation of the syn-diol moiety was then performed 
according to the reaction conditions described in Myles’ synthesis of the C14–C26 fragment of 
amphidinolide B1.76f    Exposure of enone 222 to a 0 °C suspension of  AD-mix α (2.1 g/mmol),  
K2OsO4•2H2O (10 mol%), and (DHQ)2PHAL (10 mol%) in 1:1 tBuOH/H2O  resulted in the 
sluggish dihydroxylation of the electron-deficient (E)-olefin affording the desired diol 
diastereomer 223 in 31% isolated yield along with a second diol diastereomer and unreacted 
starting material after 24 h at 0 °C. 
 
Scheme 37.  Fragment Union and Diol Installation 
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93 Blanchette, M. A.; Choy, W.; Davis, J. T.; Essenfield, A. P.; Masamune, S.; Roush, W. R.; Sakai, T. Tetrahedron 
Lett. 1984, 25, 2183. 
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 Poor reproducibility of the yields in the synthesis of TES–protected aldehyde 221 led us 
to prepare the more commonly employed TBS–protected aldehyde 147.72  Aldehyde 147 was 
generated according to the literature procedure (Scheme 36) with the only modification being the 
incorporation of the DABCO-mediated tosylation protocol.  Roush-Masamune olefination of 
phosphonate 187b and aldehyde 147 (LiCl, DIPEA, CH3CN) afforded the desired (E)-olefin 186 
in slightly higher yield (70%).  Enone 186 was then subjected to the previously described 
Sharpless reagent system (AD-mix α (2.1 g/mmol), K2OsO4•2H2O (10 mol%), and 
(DHQ)2PHAL (10 mol%) in 1:1 tBuOH/H2O).  Methanesulfonamide (1.0 equiv) was also added 
to the reaction in an attempt to accelerate osmate ester hydrolysis.  The added 
methanesulfonamide served its purpose as near complete consumption of the starting enone was 
observed by TLC after 8 h at 0 °C.  Although yields of the syn diol 224 were improved from 
earlier trials (42-50%), they were still variable and not synthetically acceptable for such a late 
stage reaction.  Additional attempts at enhancing the isolated yield of 224 by increasing the 
osmium and chiral amine loading from 10 to 20 mol% proved to be ineffective.  Protection of the 
diol was then achieved using excess TBSOTf (3.0 equiv) and 2,6-lutidine (5.0 equiv) to furnish 
the fully protected C14–C26 fragment 225 (Scheme 38).    
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 Scheme 38.  Fragment Coupling and Diol Installation 
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2.5 FUTURE WORK 
 
Given the inefficient introduction of the C21,C22 syn-diol via the Sharpless asymmetric 
dihydroxylation of olefin 186, an alternative route involving a diastereoselective glycolate aldol 
reaction will be investigated (Figure 29).  Such a strategy would require the regioselective 
generation of (Z)-enolate 226 from lactone 203 derived ketone 227 which would serve to 
selectively add to the previously synthesized C22–C26 aldehyde 147 to generate the required syn 
diol relationship. 
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Figure 29.  Diastereoselective Glycolate Aldol Reaction in the Formation of the C21,C22 syn-diol 
Relationship of Amphidinolide B1
 
 
 Completion of the total synthesis of amphidinolide B1 will be predicated on the union of 
the major fragments 172, 173, and 174 (Figure 30).  The C14–C26 fragment 172 will be 
functionalized for fragment coupling through the deprotection and subsequent carbostannylation 
of the C14–C15 alkyne to furnish the requisite trisubstituted olefin 228.  Julia olefination of 
epoxyaldehyde 174 and sulfone 173 will then assemble the intact C1–C13 fragment 171.  Suzuki 
coupling between vinyl iodide 172, dervied from lithium halogen exchange of 228, and the 
pinacol boronate ester moiety in 171 will be employed to unite the major fragments, forming the 
s-cis diene moiety.  Silyl deprotection and Yamaguchi macrolactonization of seco acid 229 will 
then complete the total synthesis of amphidinolide B1 (133). 
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Figure 30.  Completion of the Total Synthesis of Amphidinolide B1 
 
 
 
 
 
 
 
 
 151
 2.6 CONCLUSIONS 
 
Asymmetric AAC reactions have been instrumental in our recent studies toward the total 
synthesis of the cytotoxic marine natural product, amphidinolide B1 (133).  By exploiting the 
synthetic utility of AAC reaction technology, key stereochemical relationships present in major 
fragments 172 and 174 were established.  A highly enantioselective installation of the C16 
tertiary carbinol stereocenter was acheived through the large-scale application of Mukaiyama’s 
Sn(IV)-allylation protocol, and a rapid synthesis of sulfone subunit 173 was realized from 
commercially available γ-butyrolactone.  Also, for the first time, the regioselective ring opening 
of β-lactones by phosphonate anions has been documented. 
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 2.7 EXPERIMENTAL SECTION 
 
General Information: Optical rotations were measured on a Perkin-Elmer 241 digital 
polarimeter with a sodium lamp at ambient temperature and are reported as follows:  [α]D (c 
g/100mL, solvent) with units of degree•g•cm-3.  Infrared spectra were recorded on a Nicolet 
Avatar 360 FT-IR spectrometer.  1H NMR spectra were recorded on Bruker DPX 301 and DPX 
302 (300 MHz) spectrometers.  Chemical shifts are reported in ppm from tetramethylsilane with 
the solvent resonance as the internal standard (CHCl3: δ 7.27 ppm).  Data are reported as 
follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = broad, 
m = multiplet), coupling constants (Hz), integration.  13C NMR spectra were recorded on Bruker 
DPX 301 and DPX 302 spectrometers (75 MHz) with complete proton decoupling.  Chemical 
shifts are reported in ppm from tetramethylsilane with the solvent as the internal standard 
(deuterochloroform: δ 77.0 ppm).    Mass spectra were obtained on a VG-7070 or Fisons 
Autospec high resolution magnetic sector mass spectrometer.   
Analytical thin layer chromatography was performed on EM Reagent 0.25 mm silica gel 
60-F plates.  Flash chromatography was performed as previously described on EM silica gel 60 
(230-240 mesh).94    Analytical high performance liquid chromatography (HPLC) was performed 
on a Hewlett Packard 1100 liquid chromatograph equipped with a variable wavelength UV 
detector (deuterium lamp, 190-600 nm), using a Daicel Chiralpak™ AS-H column (250 × 4.6 
mm) (Daicel Inc.).  HPLC grade isopropanol and hexanes were used as the eluting solvents. 
All experiments were carried out under a nitrogen atmosphere in oven or flame-dried 
glassware using standard inert atmosphere techniques for introducing reagents and solvents.  
Tetrahydrofuran (THF) was either distilled from potassium benzophenone ketyl or passed 
                                                 
94 Still, W.C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923. 
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 through two columns of alumina, and diethyl ether (Et2O) was distilled from sodium benzophone 
ketyl.  Dichloromethane (CH2Cl2), dimethylsulfide (DMS), N,N-diisopropylethylamine (DIPEA), 
and triethylamine (Et3N) were distilled from CaH2 under N2.   
 
 (2E)-tert-Butyl-6-hydroxy-2-methylhex-2-enoate (178):  To a –78 
°C solution of 1.9 g of γ-butyrolactone (22.0 mmol) in 35 mL of 
CH2Cl2 was added a 24 mL of a 1.0 M solution of DIBAL-H in hexanes dropwise via syringe.  
The resulting clear, colorless solution was maintained at –78 °C for 1 h, then quenched with 
MeOH (2 mL) and saturated Rochelle’s salt (2 mL).  The mixture was warmed to ambient 
temperature and maintained for 2 h.  The layers were separated and the aqueous layer was 
extracted with CH2Cl2 (3 × 15 mL).  The combined organics were dried over Na2SO4, filtered, 
and concentrated to yield a colorless oil that was used immediately in the next reaction without 
further purification.   
Me
OtBu
O
HO
 To a 0 °C solution of 9.0 g of phosphorane 177 (23.0 mmol) in 50 mL of THF was added 
a solution of lactol 176 in 10 mL of THF dropwise via syringe.  The reaction was allowed to 
warm to ambient temperature overnight, at which point 20 mL of H2O was added.  The mixture 
was extracted with Et2O, and the combined organics were washed with brine, dried over Na2SO4, 
filtered, and concentrated.  Purification by flash chromatography (30% Et2O/pentane) provided 
3.11 g (70%) of the title compound as a clear, colorless oil:  IR (thin film): 3427, 2977, 2933, 
2872, 1705, 1648, 1456, 1168, 851, 745 cm-1; 1H NMR (300 MHz, CDCl3): δ 6.61 (dt, J = 1.3, 
7.5 Hz, 1H), 3.60 (t, J = 6.5 Hz, 2H), 2.37 (brs, 1H), 2.20 (q, J = 7.5 Hz, 2H), 1.75 (s, 3H), 1.66 
(tt, J = 6.5 Hz, 2H), 1.44 (s, 9H); 13C NMR (75 MHz, CDCl3): δ  167.5, 140.3, 129.5, 79.9, 62.0, 
31.4, 28.0, 24.9, 12.2; LRMS (EI, 70eV):  m/z 144 [M-tBu]+; HRMS calcd for C7H12O3:  
144.0786, found 144.0792. 
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  tert-Butyl-6-(benzothiazol-2-ylsulfanyl)-2-methylhex-2-
enoate:  To a 0 °C solution of 0.334 g of 2-
mercaptobenzothiazole (2.0 mmol) and 0.393 g of PPh3 (1.5 
mmol) in 10 mL of THF was added 0.200 g of alcohol 178 (1.0 mmol) in 2 mL of THF.  The 
resulting yellow solution was then treated with 0.285 mL of diethylazodicarboxylate (1.8 mmol) 
slowly dropwise via syringe.  After maintaining for 45 min at ambient temperature, the resulting 
suspension was diluted with Et2O (20 mL) and H2O (20 mL).  The organic layer was separated 
and the aqueous layer was extracted with Et2O (2 × 20 mL).  The combined organics were 
washed with brine, dried over Na2SO4, filtered, and concentrated.  Hexanes were added and the 
resulting white precipitate was removed by filtering through Celite.  Purification of the crude 
product by flash chromatography on silica gel (2% EtOAc/hexanes) afforded 0.260 g (74%) of 
the title compound as a pale yellow oil.  IR (thin film): 3062, 2976, 2930, 1704, 1650, 1456, 
1427, 1291, 1254, 995 cm-1; 1H NMR (300 MHz, CDCl3): δ  7.88 (d, J = 8.1 Hz, 1H), 7.76 (d, J 
= 7.9 Hz, 1H), 3.38 (t, J = 7.1 Hz, 2H), 2.36 (q, J = 7.4 Hz, 2H),  1.82 (s, 3H), 1.49 (s, 9H); 13C 
NMR (75 MHz, CDCl3): δ  167.2, 166.5, 153.1, 139.0, 135.1, 130.3, 125.9, 124.1, 121.4, 120.8, 
80.0, 32.9, 28.2, 28.0 (3C), 27.5, 12.4; HRMS calcd for C18H23NO2S2:  349.1170, found 
349.1171. 
OtBu
O
Me
S
N
S
 
tert-Butyl-6-(benzothiazol-2-ylsulfonyl)-2-methylhex-2-
enoate (173):   To a solution of 0.200 g of thioether (0.573 
mmol) and 5 mg of MnSO4•H2O (0.029 mmol) at ambient 
temperature was added an aqueous mixture of 0.300 mL of 30% H2O2 dropwise via syringe.  The 
resulting pale orange mixture was maintained at ambient temperature for 5 h at which point 
saturated aqueous NaCl was added (20 mL).  The reaction mixture was extracted with Et2O (3 
OtBu
O
Me
S
N
S
OO
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 × 20 mL).  The combined organics were then dried over anhydrous Na2SO4, filtered, and 
concentrated.  Purification the crude product by flash chromatography on silica gel (10% 
Et2O/hexanes) afforded  0.150 g (69%) of the title compound as a colorless, viscous oil:  IR (thin 
film): 3065, 2976, 2930, 1701, 1649, 1555, 1473, 1330, 1150, 853 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 8.19 (d, J = 8.0 Hz, 1H), 8.00 (d, J = 7.9 Hz, 1H), 7.65–7.54 (m, 2H), 6.52 (br t, J = 
7.4 Hz, 1H),   3.51 (br t, J = 7.6 Hz, 2H), 2.31 (dt, J = 7.4, 7.4 Hz, 2H), 2.02 (tt, J = 7.4, 7.4 Hz, 
2H), 1.74 (s, 3H), 1.45 (s, 9H); 13C NMR (75 MHz, CDCl3): δ  166.8, 165.5, 152.5, 137.4, 136.6, 
131.1, 128.0, 127.6, 125.3, 122.2, 80.2, 54.0, 27.9 (3C), 26.9, 21.5, 12.4; HRMS calcd for 
C18H23NO4S2:  381.1068, found 381.1053. 
 
 (2R)-Benzyl-2-hydroxy-2-methylpent-4-enoate (196):42  To a white 
suspension of 6.00 g of tin (II) catecholate (26.4 mmol), 0.251 g of CuI 
(1.32 mmol), and 14.0 mL of (–)-diisopropyltartrate (66.0 mmol) in 40 mL of CH2Cl2 at ambient 
temperature was added a solution of 9.90 mL of DBU (66.0 mmol) in 40 mL of CH2Cl2 via 
syringe.  The resulting clear, pale pink solution was maintained at ambient temperature for 1 h, 
cooled to –85 °C, then treated with a solution of 2.35 g of benzyl pyruvate (13.2 mmol) in 40 mL 
of CH2Cl2 dropwise via syringe pump over the course of 1 h.  A solution of 2.30 mL of allyl 
bromide (26.4 mmol) in 40 mL of CH2Cl2 was added slowly via syringe pump (over 2.5 h) and 
the reaction mixture was maintained overnight at –80 °C.  The reaction was quenched with 1 M 
HCl (200 mL) and hexanes (80 mL), then extracted with 2:1 hexanes/CH2Cl2 (3 × 150 mL).  The 
combined organics were washed with brine, dried over anhydrous Na2SO4, filtered, and 
concentrated.  Purification by flash chromatography on an ISCO CombiFlash Companion™ 
(330 g column, 8-20% Et2O/pentane) to obtain 1.50 g (52%) of a pale yellow liquid:  Separation 
HO Me
BnO
O
 156
 of enantiomers by chiral HPLC [Daicel Chiralpak AS-H column, 0.9 % iPrOH/hexanes, 0.7 
mL/min, Tr 18.7 min (S) and 19.2 min (R)] determined the enantiomeric excess to be 94%; [α]D 
=  +6.9 (c 1.2, CHCl3); 1H NMR (300 MHz, CDCl3): δ 7.34–7.42 (m, 5H), 5.73 (dddd, J = 7.3, 
7.3, 10, 18 Hz, 1H), 5.20 (s, 3H), 5.05–5.12 (m, 2H), 3.13 (s, 1H), 2.53 (dd, J = 7.3, 14 Hz, 1H), 
2.40 (dd, J = 7.3, 14 Hz, 1H), 1.45 (s, 3H).  
 
(2R)-Benzyl-2-(tert-butyldimethylsilyloxy)-2-methylpent-4-enoate 
(197):  To a 0 °C solution of 1.0 g of alcohol 196 (4.54 mmol) in 7 mL of 
CH2Cl2 was added 1.60 mL of 2, 6-lutidine (13.6 mmol) followed by 1.67 mL of tert-
butyldimethylsilyltrifluoromethanesulfonate (7.27 mmol).  The reaction was warmed to ambient 
temperature and maintained for 2 h.  Saturated aqueous NaHCO3 was added (10 mL) and the 
mixture was extracted with CH2Cl2 (3 × 30 mL).  The combined organics were washed with 
brine, dried over anhydrous Na2SO4, filtered, and concentrated.  Purification by flash 
chromatography on silica gel (1% EtOAc/hexanes) yielded 1.32 g (87%) of the title compound 
as a clear, colorless liquid:   [α]D = +3.3 (c 2.4, CHCl3); IR (thin film): 3077, 3035, 2955, 2929, 
2894, 2856, 1749, 1641, 1498, 1457, 1376, 1253, 1004, 836 cm-1; 1H NMR (300 MHz, CDCl3): 
δ 7.45–7.30 (m, 5H), 5.80 (dddd, J = 7.2, 7.2, 10, 17 Hz, 1H), 5.15 (d, J = 12 Hz, 1H), 5.10 (d, J 
= 12 Hz, 1H), 4.95-5.07 (m, 2H), 2.50 (dd, J = 7.3, 14 Hz, 1H), 2.40 (dd, J = 7.0, 14 Hz, 1H), 
1.44 (s, 3H), 0.87 (s, 9H), 0.077 (s, 3H), 0.065 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 174.7, 
135.8, 133.2, 128.5, 128.4, 128.2, 118.0, 66.6, 46.5, 25.9, 25.8, 18.3, –2.69, –3.11; LRMS (EI, 
70eV):  m/z 293 (M+ - CH2CHCH2); HRMS calcd for C16H25O3Si:  293.1573, found 293.1570. 
TBSO Me
BnO
O
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 (2R)-2-(tert-butyldimethylsilyloxy)-2-methyl-pent-4-en-1-ol (200): To a –
70 °C solution of 1.85 g of ester 197 (5.54 mmol) in 55 mL of CH2Cl2 was 
added a 1.0 M solution of diisobutylaluminum hydride (DIBAL-H) in hexanes dropwise via 
syringe.  The resulting clear, colorless solution was allowed to warm to –30 °C over 2 h 
whereupon 0.900 mL of MeOH (22.1 mmol) was slowly added.  The reaction mixture was then 
warmed to ambient temperature, treated with saturated aqueous Rochelle’s salt (125 mL), and 
maintained for 2.5 h.   The mixture was extracted with CH2Cl2 (3 × 100 mL) and the combined 
organics were washed with brine.  The organic layer was then dried over anhydrous Na2SO4, 
filtered, and concentrated.  Purification by flash chromatography on silica gel (4% Et2O/pentane) 
afforded 1.17 g (92%) of the title compound as a clear, colorless liquid:  [α]D = –0.5 (c 1.9, 
CHCl3); IR (thin film): 3444, 3077, 2955, 2931, 2889, 2858, 1641, 1468, 1374, 1254, 1048, 836 
cm-1; 1H NMR (300 MHz, CDCl3): δ 5.80 (dddd, J = 7.4, 7.4, 11, 16 Hz, 1H), 5.06–5.11 (m, 
2H), 3.40 (d, J = 11 Hz, 1H), 3.33 (d, J = 11 Hz, 1H), 2.35 (dd, J = 7.5, 14 Hz, 1H), 2.28 (dd, J = 
7.4, 14 Hz, 1H), 1.20 (s, 3H), 0.89 (s, 9H), 0.13 (s, 6H); 13C NMR (75 MHz, CDCl3): δ 134.2, 
117.8, 76.1, 69.9, 44.2, 25.8 (3C), 23.9, –2.1; LRMS (EI, 70eV):  m/z 229 [M-H] +; HRMS calcd 
for C12H25O2Si:  229.1624, found 229.1623. 
TBSO Me
OH
 
 
(2R)-2-(tert-butyldimethylsilyloxy)-2-methyl-pent-4-enal (199): To a 0 °C 
solution of 1.1 g of alcohol 200 (4.78 mmol) in 20 mL of CH2Cl2 was added 
3.33 mL of Et3N (23.9 mmol), 13 mL of DMSO (mmol), and 2.28 g of SO3•py.  The reaction 
mixture was maintained for 3 h at 0 °C, and then treated with a pH 7 buffer solution (15 mL).    
The combined organics were washed with brine, dried over anhydrous Na2SO4, filtered, and 
concentrated.    The crude product mixture was purified by flash chromatography on silica gel 
TBSO Me
O
H
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 (1% Et2O/pentane) to obtain 1.09 g (100%) of aldehyde 199 as a clear, colorless liquid:  [α]D = 
+25 (c 2.2 , CHCl3); IR (thin film): 3080, 2965, 2931, 2897, 2858, 2798, 2706, 1739, 1642, 
1254, 837, 777 cm-1; 1H NMR (300 MHz, CDCl3): δ 9.57 (s, 1H), 5.79 (dddd, 7.2, 7.2, 10, 17 
Hz, 1H), 5.00–5.20 (m, 2H), 1.28 (s, 3H), 0.92 (s, 9H), 0.12 (s, 3H), 0.11 (s, 3H); 13C NMR (75 
MHz, CDCl3): δ 204.2, 132.2, 118.8, 43.5, 25.8 (3C), 22.5, –2.31, –2.41; LRMS (EI, 70eV):  m/z 
213 [M-CH3]+; HRMS calcd for C11H21O2Si:  213.1311, found 213.1312. 
 
 (3R)-tert-Butyl-[1-(2, 2-dibromovinyl)-1-methyl-but-3-enyloxy]-
dimethylsilane (201):  To a 0 °C solution of 5.01 g of PPh3 (19.1 mmol) in 19 
mL of CH2Cl2 was added a solution of 3.17 g of CBr4 (9.56 mmol) in 19 mL dropwise via 
syringe.  The resultant orange-yellow solution was maintained at 0 °C for 20 min, whereupon 
1.09 g of aldehyde 199 in 19 mL of CH2Cl2 was added.  After 1h, the reaction mixture was 
diluted with 10% EtOAc/hexanes (150 mL) and filtered through silica gel.  Purification by flash 
chromatography (hexanes) provided 1.60 g (87%) of the title compound as a clear, colorless 
liquid:  [α]D = +13 (c 2.1, CHCl3); IR (thin film): 3078, 2955, 2931, 2893, 2857, 1641, 1606, 
1470, 1373, 1255, 1154, 1076, 1003, 836   cm-1; 1H NMR (300 MHz, CDCl3): δ 6.69 (s, 1H), 
5.83 (dddd, J = 7.1, 7.1, 9.3, 15 Hz, 1H),  2.54 (dd, J = 7.3, 14 Hz, 1H), 2.42 (dd, J = 7.0, 14 Hz, 
1H), 1.49 (s, 3H), 0.89 (s, 9H), 0.13 (s, 3H), 0.12 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 145.6, 
133.6, 118.0, 86.2, 46.7, 27.1, 25.9 (3C), –2.1, –2.4; LRMS (EI, 70eV):  m/z 369 [M-CH3]+; 
HRMS calcd for C12H21OSiBr: 366.9728, found 366.9744. 
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 (4R)-4-tert-Butyldimethylsilyloxy)-4-methyl-6-trimethylsilyl-hex-1-
en-5-yne (198):  To a –78 °C solution of 1.55 g of vinyl bromide 201 
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 (4.04 mmol) in 20 mL of THF was added 7.60 mL of a 1.6 M solution of nBuLi in hexanes 
dropwise via syringe.  The resulting pale yellow solution was maintained for 1 h at –78 °C, then 
warmed to 0 °C for an additional 1 h.  After cooling to –78 °C, the reaction mixture was treated 
with 1.52 mL of freshly distilled TMSCl (12.1 mmol).  The reaction was allowed to warm slowly 
to 0 °C over 3 h.  Saturated aqueous NH4Cl was added (40 mL), and the mixture was extracted 
with Et2O (3 × 100 mL).  The combined organics were washed with brine, dried over anhydrous 
Na2SO4, filtered, and concentrated.  Purification by flash chromatography on silica gel (hexanes) 
afforded 0.920 g (77%) of the title compound 198 as a clear, colorless liquid:  [α]D = +0.64 (c 
2.2, CHCl3); IR (thin film): 3079, 2958, 2932, 2899, 2858, 2169, 1643, 1252, 839, 776 cm-1; 1H 
NMR (300 MHz, CDCl3): δ 5.90 (ddt, J = 7.2, 11, 18 Hz, 1H), 5.10- 5.01 (m, 2H), 2.38 (d, J = 
7.1 Hz, 2H), 1.39 (s, 3H), 0.87 (s, 9H), 0.18 (s, 15H); 13C NMR (75 MHz, CDCl3): δ 134.3, 
117.6, 110.1, 88.3, 68.8, 49.6, 30.4, 25.7, 18.1, –0.2, –2.9, –3.0; LRMS (EI, 70eV):  m/z 281 [M-
CH3] +; HRMS calcd for C15H29OSi2: 281.1757 found 281.1744.            
 
(3R)-3-(tert-Butyldimethylsilyloxy)-3-methyl-5-trimethylsilyl-pent-4-
ynal (202):  A –78 °C solution of 0.415 g of olefin 198 (1.40 mmol) in 3.3 
mL of CH2Cl2, 3.3 mL of MeOH, and 0.7 mL of pyridine was treated with O3 until a pink color 
was observed.  The reaction was quenched with 0.384 g of PPh3 (1.40 mmol) and allowed to 
warm to ambient temperature.  The crude product mixture was concentrated and purified by flash 
chromatography (10% CH2Cl2/hexanes) to obtain 0.360 g (86%) of a clear, colorless liquid:  [α]D 
=  +36 (c 1.4, CHCl3); IR (thin film): 2959, 2931, 2898, 2858, 2739, 2170, 1731, 1252, 1115, 
1041, 840 cm-1; 1H NMR (300 MHz, CDCl3): δ 9.88 (t, J = 2.9 Hz, 1H), 2.58 (brd, J = 2.9 Hz, 
2H), 1.54 (s, 3H), 0.86 (s, 9H), 0.21 (s, 6H), 0.18 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 201.9, 
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 107.9, 90.4, 66.6, 56.9, 31.3, 25.5, 17.9, –0.4, –2.9, –3.3; LRMS (EI, 70eV):  m/z 283 [M-CH3] +; 
HRMS calcd for C14H27O2Si2:  283.1549, found 283.1556. 
 
(4S, 2′R)-4-[2-tert-Butyldimethylsilyloxy)-2-methyl-4-trimethylsilyl-
but-3-ynyl]-oxetan-2-one (203):  To a solution of 0.127 g of  triamine 
ligand 36 (0.235 mmol) in 1.0 mL of CH2Cl2 at ambient temperature was added 0.130 mL of a 
2.0 M solution of trimethylaluminum in hexanes dropwise via syringe.  The clear, colorless 
catalyst solution was maintained for 2.5 h at ambient temperature, then diluted with CH2Cl2 (7 
mL).  After cooling to –50 °C, 0.695 mL of DIPEA (3.99 mmol) was added followed by 0.330 
mL of acetyl bromide (4.46 mmol).  The resulting pale yellow solution was stirred at –50 °C 
whereupon 0.700 g of aldehyde 202 (2.35 mmol) in CH2Cl2 (1.5 mL) was added dropwise via 
syringe.  The reaction was maintained for 3 h at –50 °C, and was quenched by pouring into cold 
hexanes (50 mL).  The resulting mixture was filtered through silica gel (Et2O) and concentrated.  
The crude product was then purified by flash chromatography (1% EtOAc/hexanes) to afford 
0.720 g (87%) of the title compound as a pale yellow oil:  [α]D =  +30 (c 2.3, CHCl3); IR (thin 
film): 2957, 2930, 2857, 2169, 1835, 1251, 1165, 1125, 1077, 868 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 4.83 (dddd, J = 4.2, 4.2, 5.7, 8.8 Hz, 1H), 3.57 (dd, J = 5.7, 17 Hz, 1H), 3.29 (dd, J = 
4.2, 17 Hz, 1H), 2.32 (dd, J = 4.2, 14 Hz, 1H), 2.03 (dd, J = 9.0, 14 Hz, 1H), 1.50 (s, 3H), 0.86 
(s, 9H), 0.22 (s, 3H), 0.19 (s, 9H), 0.15 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 168.5, 107.9, 
90.3, 69.1, 67.8, 48.9, 44.6, 31.6, 31.5, 25.6 (3C), 17.9, –0.34 (3C), –3.0, –3.1; LRMS (EI, 
70eV):  m/z 325 [M-CH3] +; HRMS calcd for C16H29O3Si2:  325.1655, found 325.1647. 
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 (4S)-Diethyl 4-hydroxy-2-oxo-6-phenylhexylphosphonate (205):  
To a –78 °C solution of 0.165 mL of diethylmethylphosphonate 
(1.13 mmol) in 3.0 mL of THF was added 0.640 mL of a 1.6 M solution of nBuLi in hexanes 
dropwise via syringe.  The resulting cloudy, white suspension was maintained for 30 min, then 
treated with 0.066 g of lactone 61 (0.375 mmol) in THF (0.75 mL).  The reaction was maintained 
at –78 °C for 45 min.  Saturated aqueous NH4Cl (3 mL) was added, and the mixture was 
extracted with Et2O (3 × 10 mL).  The combined organics were washed with brine, dried over 
anhydrous Na2SO4, filtered, and concentrated.  Purification by flash chromatography on silica 
gel (80% EtOAc/hexanes) provided 0.102 g (83%) of the title compound as a pale yellow oil:   
[α]D = +18 (c 4.0, CHCl3); IR (thin film):  3400, 3061, 3026, 2984, 2930, 1713, 1246, 1024, 971 
cm-1; 1H NMR (300 MHz, CDCl3): δ 7.28–7.19 (m, 2H), 7.19–7.10 (m, 3H), 4.20–3.95 (m, 5H), 
3.55 (brd, J = 3.5 Hz, 1H), 3.12 (s, 1H), 3.05 (s, 1H), 2.85–2.55 (m, 4H), 1.85–1.60 (m, 2H) 1.28 
(t, J = 7.0 Hz, 6H); 13C NMR (75 MHz, CDCl3): δ 202.3, 141.6, 128.2 (2C), 128.1 (2C), 125.6, 
66.7, 62.5, 62.4, 50.9, 43.7, 38.1, 31.5, 16.1, 16.0; LRMS (EI, 70eV):  m/z 328; HRMS calcd for 
C16H25O5P:  328.1440, found 328.1452. 
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 (4S,6R)-Diethyl-[6-(tert-butyldimethyl-silyloxy)-4-
hydroxy-6-methyl-2-oxo-8-trimethylsilyl-oct-7-ynyl]-
phosphonate (207):  To a –78 °C solution of 0.360 mL of diethylmethylphosphonate (2.47 
mmol) in 6.0 mL of THF was added 1.40 mL of a 1.6 M solution of nBuLi in hexanes dropwise 
via syringe.  The resulting cloudy, white suspension was maintained for 30 min, then treated with 
0.233 g of lactone 203 in THF (1.2 mL).  The reaction was maintained at –78 °C for 1 h.  
Saturated aqueous NH4Cl (10 mL) was added, and the mixture was extracted with EtOAc (3 
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 × 30 mL).  The combined organics were washed with brine, dried over anhydrous Na2SO4, 
filtered, and concentrated.  Purification by flash chromatography on silica gel (50% 
EtOAc/hexanes) provided 0.281 g (83%) of β-ketophosphonate 207 as a pale yellow oil:  [α]D = 
+22 (c 2.4, CHCl3); IR (thin film): 3405, 2957, 2930, 2857, 2167, 1716, 1252, 1028, 840 cm-1; 
1H NMR (300 MHz, CDCl3): δ 4.44 (dddd, J = 2.4, 5.4, 9.3, 12.0 Hz, 1H), 4.10 m, 4H), 3.73 
(brs, 1H), 3.11 (dd, J = 13.6, 17.5 Hz, 1H), 3.07 (dd, J = 13.6, 17.5 Hz, 1H), 2.77 (dd, J = 7.3, 
16.2 Hz, 1H), 2.68 (dd, J = 5.2, 16.2, Hz, 1H), 1.87 (dd, J = 9.2, 14 Hz, 1H), 1.72 (dd, J = 2.4, 14 
Hz, 1H), 1.48 (s, 3H), 1.29 (t, J = 7.0 Hz, 6H), 0.82 (s, 9H), 0.17 (s, 6H), 0.11 (s, 9H); 13C NMR 
(75 MHz, CDCl3): δ 201.0 (d, J = 25 Hz), 109.5, 89.6, 69.0, 65.1, 51.3, 50.3, 43.9, 42.2, 30.2, 
25.6 (3C), 17.8, 16.2, 16.1, –0.47 (3C), –2.9, –3.2; LRMS (EI, 70eV):  m/z 477 [M-CH3] +; 
HRMS calcd for C21H42O6Si2P:  477.2258, found 477.2257. 
 
(4S, 6R)-Diethyl-[4, 6-bis-(tert-butyldimethyl-silyloxy)-
6-methyl-2-oxo-8-trimethylsilyl-oct-7-ynyl]-
phosphonate (187a):  To a 0 °C solution of 0.280 g of alcohol 207 in 1.2 mL of DMF was added 
0.078 g of imidazole (1.14 mmol) and 0.172 g of tert-butyldimethylchlorosilane (1.14 mmol).  
The reaction mixture was then warmed to ambient temperature and maintained for 48 h.  A 
mixture of saturated aqueous NaHCO3 (5 mL) and brine (5 mL) was added, and the crude 
reaction was extracted with EtOAc (3 × 30 mL).  The combined organics were dried over 
anhydrous Na2SO4, filtered, and concentrated.  The crude product was then purified by flash 
chromatography (20% EtOAc/hexanes) to afford 0.276 g (80%) of the title compound as a 
viscous, pale yellow oil:  [α]D =  +28 (c 1.4, CHCl3); IR (thin film): 2957, 2930, 2898, 2857, 
2166, 1717, 1472, 1252, 1027, 838 cm-1; 1H NMR (300 MHz, CDCl3): δ 4.52–4.42 (m, 1H), 4.09 
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 (p, J = 7.1 Hz, 4H), 3.15–2.90 (m, 3H), 2.79 (dd, J = 8.6, 15.8 Hz, 1H), 1.84 (dd, J = 9.3, 13.9 
Hz, 1H), 1.68 (dd, J = 2.3, 13.9 Hz, 1H), 1.39 (s, 3H), 1.28 (t, J = 7.0 Hz, 6H), 0.80 (s, 18H), 
0.16 (s, 3H), 0.13  (s, 9H), 0.097 (s, 3H), 0.063 (s, 3H), 0.012 (s, 3H); 13C NMR (75 MHz, 
CDCl3): δ 200.6 (d, J = 26 Hz), 109.1, 89.5, 68.3, 67.4, 62.2, 52.6, 51.8, 44.7, 43.0, 32.4, 25.8 
(3C), 25.7 (3C), 17.9, 17.8, 16.2, 16.1, –0.37 (3C), –3.0, –3.2, –4.3, –4.8; LRMS (ESI):  m/z 629; 
HRMS calcd for [C28H59O6Si3PNa]+:  629.3255, found 629.3273. 
 
(4S, 6R)-Dimethyl-[6-(tert-butyldimethyl-silyloxy)-4-
hydroxy-6-methyl-2-oxo-8-trimethylsilyl-oct-7-ynyl]-
phosphonate (208):  To a –78 °C solution of  0.335 mL of dimethylmethylphosphonate (3.13 
mmol) in 7.5 mL of THF was added  1.80 mL of a 1.6 M solution of nBuLi in hexanes dropwise 
via syringe.  The resulting cloudy, white suspension was maintained for 30 min, then treated with 
0.355 g of lactone 203 in THF (2.5 mL).  The reaction was maintained at –78 °C for 1 h.  
Saturated aqueous NH4Cl (10 mL) was added, and the mixture was extracted with EtOAc (3 
× 30 mL).  The combined organics were washed with brine, dried over anhydrous Na2SO4, 
filtered, and concentrated.  Purification by flash chromatography on silica gel (50% 
EtOAc/hexanes) provided 0.438 g (90%) of β-ketophosphonate 208 as a pale yellow oil:  [α]D = 
+25 (c 2.5, CHCl3); IR (thin film): 3408, 2957, 2857, 2167, 1718, 1473, 1253, 1183, 1116, 1043, 
842 cm-1; 1H NMR (300 MHz, CDCl3): δ 4.45 (dddd, J = 2.5, 5.0, 7.5, 9.7 Hz, 1H), 3.77 (s, 3H), 
3.73 (s, 3H), 2.77 (dd, J = 7.5, 16 Hz, 1H), 2.67 (dd, J = 5.0, 16 Hz, 1H), 1.88 (dd, J =  9.2, 14 
Hz, 1H), 1.73 (dd, J = 2.5, 14 Hz, 1H), 1.49 (s, 3H), 0.83 (s, 9H), 0.20-0.17 (m, 6H), 0.13 (s, 
9H); 13C NMR (75 MHz, CDCl3): δ 200.9 (d, J = 26 Hz), 109.5, 89.7, 69.0, 65.1, 52.9, 51.3, 
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 50.2, 42.8, 41.1, 30.2, 25.6 (3C), 17.8, –0.46 (3C), –2.9, –3.2; LRMS (EI, 70eV):  m/z 449 [M-
CH3]+; HRMS calcd for C19H38O6Si2P:  449.1945, found 
449.1927. 
 (4S, 6R)-Dimethyl-[4, 6-bis-(tert-
butyldimethylsilyloxy)-6-methyl-2-oxo-8-trimethylsilyl-oct-7-ynyl]-phosphonate (187b):  To 
a 0 °C solution of 0.430 g of alcohol 208 (0.927 mmol) in 1.2 mL of DMF was added 0.126 g of 
imidazole (1.85 mmol) and 0.280 g of tert-butyldimethylchlorosilane (1.85 mmol).  The reaction 
mixture was then warmed to ambient temperature and maintained for 16 h.  A mixture of 
saturated aqueous NaHCO3 (5 mL) and brine (5 mL) was added, and the crude reaction was 
extracted with EtOAc (3 × 25 mL).  The combined organics were dried over anhydrous Na2SO4, 
filtered, and concentrated.  The crude product was then purified by flash chromatography 
(EtOAc/hexanes) to afford  0.430 g (80%) of the title compound as a viscous, pale yellow oil:  
[α]D =  +29 (c 1.3, CHCl3); IR (thin film): 2956, 2930, 2897, 2857, 2166, 1719, 1473, 1253, 
1187, 1035, 838 cm-1; 1H NMR (300 MHz, CDCl3): δ 4.51 (dddd, J = 9.0, 9.0 Hz, 1H), 3.76 (s, 
3H), 3.73 (s, 3H), 2.96-3.16 (m, 3H), 2.79 (dd, J = 8.8, 16Hz, 1H), 1.86 (dd, J = 9.5, 14 Hz, 1H), 
1.71 (dd, J = 2.4, 14 Hz, 1H), 1.41 (s, 3H), 0.82 (s, 18 H), 0.18 (s, 3H), 0.16 (s, 9H), 0.12 (s, 3H), 
0.085 (s, 3H), 0.035 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 200.5, 109.0, 89.6, 68.3, 67.4, 52.3, 
52.7, 51.8, 43.6, 41.9, 32.4, 25.8 (3C), 25.7 (3C), 17.9, 17.8, –0.34, –2.9, –3.2, –4.2, –4.8; LRMS 
(EI, 70eV):  m/z 563 [M-CH3]+; HRMS calcd for C25H52O6Si3P:  563.2809, found 563.2801. 
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 (3R)-4-(tert-Butyldiphenylsilyloxy)-3-methylbutyric acid (209):   
To a –50 °C solution of 2.69 g of CuBr (18.8 mmol) in 185 mL of THF 
and 20 mL of dimethylsulfide was added 12.5 mL of a 3.0 M ethereal solution of 
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 methylmagnesium bromide (37.5 mmol) slowly dropwise. The resulting clear, faint green 
solution was stirred at –50 °C for 30 min then warmed to –30 °C for 30 min.  The reaction was 
then cooled to –50 °C and 4.6 g of 7 (12.5 mmol) in 15 mL of THF was added via cannula.  
After maintaining the reaction at –50 °C for 45 min, 2.4 mL of TMSCl (18.8 mmol) was added 
and the reaction was allowed to warm to ambient temperature overnight.  A mixture of saturated 
NH4Cl (500 mL) and 1 M HCl (200 mL) was added and the mixture was extracted with Et2O (4 
× 150 mL). The combined organics were washed with saturated NH4Cl and brine (50 mL), dried 
over Na2SO4, filtered, and concentrated.  The crude product was purified by flash 
chromatography on silica gel (10% EtOAc/hexanes) to afford 3.85 g (79%) of the title compound 
209 as a pale yellow viscous oil:  [α]D =  +6.3 (c 1.1, CHCl3); IR (thin film):  3071, 3049, 2960, 
2931, 2858, 1709, 1589, 1428, 1112, 702;  1H NMR (300 MHz, CDCl3): δ  7.75–7.65 (m, 4H), 
7.50–7.35 (m, 6H),  3.59 (dd, J = 4.9, 9.9 Hz, 1H), 3.46 (6.6, 9.9 Hz, 1H), 2.75–2.60 (m, 1H), 
2.35–2.15 m, 2H), 1.06 (s, 9H), 0.98 (d, J = 6.4 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 179.8, 
135.6 (4C), 133.6 (2C), 129.6 (2C), 127.5, 68.1, 38.2, 32.8, 26.8 (3C), 19.2, 16.8; LRMS (EI, 
70eV):  m/z 299 [M-tBu]+; HRMS calcd for C17H19O3Si:  299.1103, found 299.1111. 
 
 (3R)-4-(tert-Butyldiphenylsilyloxy)-3-methylbutyraldehyde (210):  
To a solution of 1.15 g of carboxylic acid 209 (3.23 mmol) in 30 mL of 
Et2O at ambient temperature was added 2.4 mL of a 2.0 M THF solution of H3B•SMe2 (4.84 
mmol) slowly dropwise.  The resulting clear, colorless solution was heated to reflux and 
maintained for 45 min.  After cooling to ambient temperature, the solvent was removed, and the 
remaining viscous residue was dissolved in 30 mL of CH2Cl2.  To this colorless solution was 
added 1.75 g of pyridinium chlorochromate (8.08 mmol), and the resulting brown suspension 
OTBDPS
Me
H
O
 166
 was heated to reflux and maintained for 1 h.  The reaction was then cooled to ambient 
temperature, diluted with Et2O, filtered through Celite, and concentrated.  Purification of the 
crude product by flash chromatography on silica gel (5% EtOAc/hexanes) afforded 0.950 g 
(85%) of the title compound as a viscous, colorless oil:  [α]D =  +2.9 (c 1.6, CHCl3); IR (thin 
film):  3134, 3071, 3050, 2959, 2717, 1726, 1589, 1112 cm-1; 1H NMR (300 MHz, CDCl3):  δ 
9.80 (t, J = 2.2 Hz, 1H), 7.70–7.60 (m, 4H), 7.45–7.35 (m, 6H), 3.59 (dd, J = 5.0, 9.9 Hz, 1H), 
3.44 (dd, J = 7.0, 9.9 Hz, 1H), 2.70–2.55 (m, 1H), 2.40–2.20 (m, 2H), 1.06 (s, 9H), 0.95 (d, J = 
6.6 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 202.4, 135.6 (4C), 133.5, 129.7 (3C), 127.7 (4C), 
68.4, 48.1, 31.3, 26.8 (3C), 19.2, 16.7; LRMS (EI, 70eV):  m/z 283 [M-tBu]+; HRMS calcd for 
C17H19O2Si:  283.1154, found 283.1153. 
 
 (4R)-5-(tert-Butyldiphenylsiloxy)-4-methylpentan-2-ol (212):  To a 
0 °C solution of 0.018 g of (R,R)-HOCSAC ligand X (0.032 mmol) in 
1.0 mL of toluene was added 0.125 mL of Ti(OiPr)4 (0.417 mmol) followed by 0.385 mL of a 2.0 
M solution of Me2Zn in toluene (0.769 mmol).  The resulting pale green solution was then 
cooled to –25 °C and 0.109 g of aldehyde 210 (0.320 mmol) in 0.5 mL of toluene was added 
dropwise via syringe.  The reaction was maintained for 24 h at –25 °C before being quenched by 
MeOH (1 mL) and saturated aqueous NH4Cl (3 mL).  The mixture was extracted with Et2O (3 
× 10 mL) and the combined organics were washed with brine, dried over Na2SO4, filtered, and 
concentrated.  Purification by flash chromatography on silica gel (10% EtOAc/hexanes) provided 
0.071 g (62% combined yield of a 1:1 mixture of diastereomers) of title compound 212 as a 
clear, colorless oil:  IR (thin film): 3364, 3071, 3050, 2961, 2930, 2857, 1472, 1428, 1112, 702 
cm-1; 1H NMR (300 MHz, CDCl3):  δ 7.74–7.68 (m, 8H), 7.50–7.38 (m, 12H), 4.03–3.88 (m, 
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 2H), 3.55 (t, J = 5.9 Hz, 4H), 2.66 (brs, 1H), 2.30 (brs, 1H), 1.98–1.80 (m, 2H), 1.60–1.30 (m, 
4H), 1.22 (t, J = 5.7 Hz, 6H), 1.09 (s, 18H), 0.94 (d, J = 7.4 Hz, 3H), 0.91 (d , J = 7.0 Hz, 3H); 
13C NMR (75 MHz, CDCl3): δ 135.6, 133.5, 129.6, 127.6, 69.8, 69.0, 66.4, 65.6, 44.7, 43.9, 
33.7, 32.5, 26.8 (6C), 24.2, 23.5, 19.2, 17.5; HRMS calcd for [C22H32O2SiNa]+:  379.2069, found 
379.2064. 
 
 (2S, 4S)-4-Triethylsilyloxypentan-2-ol (218):    To a 0 °C solution of 0.494 g 
of (2S, 4S)-(+)-pentanediol (4.74 mmol) in 9.5 mL of THF was added 0.228 g 
of a 60% dispersion of NaH in mineral oil (5.69 mmol) portionwise.  Gas evolution and a white 
precipitate were observed.  The resulting cloudy, white suspension was warmed to ambient 
temperature and maintained for 2 h.  The resulting orange mixture was then treated with 0.955 
mL of triethylchlorosilane (5.69 mmol) and maintained for 2 h. The reaction mixture was then 
diluted with Et2O then washed with brine.  The ether layer was then dried over Na2SO4, filtered, 
and concentrated.  Purification by flash chromatography on silica gel (5% EtOAc/hexanes) 
provided g of title compound 218 as a clear, colorless liquid:  [α]D =  +21 (c 2.6, CHCl3); IR 
(thin film): 3432, 2960, 2878, 1458, 1415, 1375, 1239, 1124, 744 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 4.12-4.26 (m, 2H), 3.48 (brs, 1H), 1.67 (ddd, J = 3.9, 9.6, 14.0 Hz, 1H), 1.50 (ddd, J = 
2.3, 4.9, 14.0 Hz, 1H), 1.25 (d, J = 6.3 Hz, 3H), 1.17 (d, J = 6.2 Hz, 3H), 0.98 (t, J = 7.8 Hz, 9H), 
0.63 (q, J = 7.8 Hz, 6H); 13C NMR (75 MHz, CDCl3): δ 67.5, 64.4, 45.8, 23.7, 22.8, 6.7, 4.8; 
LRMS (EI, 70eV):  m/z 217 [M-H]+, 189 [M-CH3CH2]+ ; HRMS calcd for C9H21O2Si: 189.1311, 
found 189.1309. 
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  (2S, 4S)-4-Triethylsilyloxy-2-pentyl-4-methylphenylsulfonate (219):  To a 
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 0 °C solution of 3.10 g of alcohol 218 (14.2 mmol) and 3.19 g of DABCO (28.4 mmol) in 20 mL 
of CH2Cl2 was added 4.07 g of TsCl (21.3 mmol) portionwise.  The resulting white suspension 
was maintained at 0 °C for 30 min then at ambient temperature for 1 h. The reaction mixture was 
diluted with CH2Cl2 (20 mL) and filtered through silica gel (CH2Cl2).  The filtrate was then 
concentrated to afford 5.0 g (94%) of a clear, colorless oil:  [α]D =  +21 (c 1.9, CHCl3); IR (thin 
film): 2956, 2913, 2877, 1599, 1458, 1365, 1240, 1008, 904, 816, 743 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 7.79 (d, J = 8.3 Hz, 2H), 7.32 (d, J = 8.1 Hz, 2H), 4.81 (m, 1H), 3.87 (m, 1H), 2.43 (s, 
3H), 1.75 (ddd, J = 3.9, 7.8, 14 Hz, 1H), 1.59 (ddd, J =  4.4, 8.3, 14 Hz, 1H), 1.24 (d, J =  6.3 Hz, 
3H), 1.10 (d, J = 6.1 Hz, 3H), 0.94 (t, J = 8.0 Hz, 9 H), 0.58 (q,  J = 8.0 Hz, 6H) ; 13C NMR (75 
MHz, CDCl3): δ 144.2, 135.1, 129.6 (2C), 127.4 (2C), 78.6, 65.1, 47.2, 24.3, 21.6, 21.5, 6.8 
(3C), 5.1 (3C). 
 
  (2R, 4S)-2-Methyl-4-triethylsilyloxypentanenitrile (220):  To a solution 
of 0.286 g of tosylate 219 (0.769 mmol) in 0.9 mL of DMSO was added 
0.151 g of NaCN (3.08 mmol) at ambient temperature.  The reaction mixture was heated to 50 °C 
and maintained for 24 h.  After cooling to ambient temperature, the crude, orange reaction 
mixture was purified by flash chromatography on silica gel (5% Et2O/pentane) to provide 0.127 
g (73%) of the title compound as a clear, colorless liquid: [α]D =  +3.1 (c 1.4, CHCl3); IR (thin 
film): 2956, 2913, 2878, 2239, 1459, 1378, 1239, cm-1; 1H NMR (300 MHz, CDCl3): δ 4.01–
3.90 (m, 1H), 2.75 (ddq J = 7.3, 1.88 (ddd, J = 7.1, 7.1, 13.9 Hz, 1H), 1.58 (ddd, J = 5.4, 7.3, 
13.1 Hz, 1H), 1.33 (d, J = 7.1 Hz, 3H), 1.21 (d, J = 6.0 Hz, 3H). 0.97 (t, J = 7.8 Hz, 9H), 0.61 (q, 
J = 7.9 Hz, 6H); 13C NMR (75 MHz, CDCl3): δ 123.3, 65.4, 43.5, 23.5, 21.5, 17.9, 6.8 (3C), 5.0 
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 (3C); LRMS (EI, 70 eV):  m/z 198 [M-CH3CH2]+; HRMS calcd for C10H20NOSi:  198.1314, 
found 198.1313. 
 
 (8E)-(3R, 5S, 10R, 12S)-3, 5-Bis-(tert-
butyldimethylsilyloxy)-3, 10-dimethyl-12-
triethylsilyloxy-1-trimethylsilyltridec-8-en-1-yn-7-one 
(222):  To a   –78 °C solution of 0.125 g of nitrile 220 
(0.550 mmol) in 1.2 mL of CH2Cl2 was added 0.580 mL of a 1.0 M solution of DIBAL-H in 
hexanes dropwise via syringe.  The resulting colorless solution was maintained at –78 °C for 1 h, 
then quenched with 1 M KHSO4 (5 mL).  The reaction mixture was warmed to ambient 
temperature and extracted with Et2O (3 × 20 mL).  After washing with 1M KHSO4 and brine, the 
combined organics were dried over Na2SO4, filtered, and concentrated to afford 0.103 g (82%) of 
aldehyde 221 as a clear, colorless liquid that was used immediately in the next reaction without 
further purification.   
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To a mixture of 0.045 g of LiCl (0.522 mmol) in 2.0 mL of CH3CN at ambient 
temperature was added 0.302 g of β-ketophosphonate 187b (0.522 mmol) in 1.2 mL of CH3CN.  
The reaction mixture was stirred for 5 min then treated with 0.076 mL of DIPEA (0.435 mmol) 
dropwise via syringe.  The resulting white suspension was maintained for 15 min whereupon 
0.100 g of aldehyde 221 (0.435 mmol) in 1.2 mL of CH3CN was added.  The suspension 
dissipated, and the resulting pale yellow solution was maintained for 60 h at ambient 
temperature.  Saturated aqueous NH4Cl was added (10 mL) and the mixture was extracted with 
EtOAc (3 × 25 mL). The combined organics were washed with brine, dried over anhydrous 
Na2SO4, filtered, and concentrated. Purification by flash chromatography (1% EtOAc/hexanes) 
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 provided 0.175 g (59%) of the title compound as a viscous, pale yellow oil:  [α]D =  +12 (c 2.0, 
CHCl3); IR (thin film): 2957, 2857, 2167, 1696, 1678, 1626, 1462, 1365, 1251, 991, 838 cm-1; 
1H NMR (300 MHz, CDCl3): δ 6.72 (dd, J = 7.6, 16 Hz, 1H), 6.07 (dd, J = 1.1, 16 Hz, 1H), 4.60 
(dddd, J = 2.6, 2.6, 9.1, 9.1 Hz, 1H), 3.88–3.78 (m, 1H), 2.98 (dd, J = 2.5, 15 Hz, 1H), 2.75 (dd, 
J = 9.1, 15 Hz, 1H), 2.46 (m, 1H), 1.91 (dd, J = 9.2, 14 Hz, 1H), 1.78 (dd, J = 2.6, 14 Hz, 1H), 
1.62 (ddd, J = 7.3, 7.3, 14 Hz, 1H), 1.46 (s, 3H), 1.33 (ddd, J = 5.6, 7.7, 14 Hz, 1H), 1.15 (d, J = 
6.0 Hz, 3H), 1.05 (d, J = 6.7 Hz, 3H), 0.96 (t, J = 7.8 Hz, 9H), 0.84 (s, 9H), 0.83 (s, 9H), 0.55-
0.63 (m, 6H), 0.21 (s, 3H), 0.19 (s, 9H), 0.16 (s, 3H), 0.11 (s, 3H), 0.03 (s, 3H); 13C NMR (75 
MHz, CDCl3): δ 199.1, 152.1, 129.2, 109.3, 89.5, 68.4, 67.6, 66.0, 52.4, 49.4, 46.1, 33.1, 32.5, 
25.9 (3C), 25.8 (3C), 24.0, 19.2, 18.0, 17.9, 6.9 (3C), 5.1 (3C), –0.25, –2.8, –3.1, –4.2, –4.6; 
HRESIMS calcd for [C36H74O4Si4Na]+:  705.4562, found 705.4567. 
 
 (3R, 5S, 8R, 9S, 10R, 12S)-3, 5-Bis-(tert-
butyldimethylsilyloxy)-3, 10-dimethyl-12-
triethylsilyloxy-1-trimethylsilyltridec-8-en-1-yn-7-one 
(223):  To a suspension of 0.200 g of AD-mix α in 0.8 
mL of  tBuOH/H2O (1:1) was added 3.5 mg of K2OsO4•2H2O (9.53 µmol), 7.5 mg of 
(DHQ)2PHAL (9.53 µmol), and 24 mg of NaHCO3 (286 µmol).   The resulting yellow-orange 
suspension was maintained for 10 min, cooled to 0 °C, then treated with 0.065 g of enone 222 
(95.3 mmol) in 0.3 mL of tBuOH/H2O (1:1) dropwise via syringe.  The reaction mixture was 
maintained for 20 h at 0 °C at which point 0.038 g of Na2SO3 was added.  After warming to 
ambient temperature, the resulting brown mixture was maintained for 1 h and diluted with 
EtOAc (10 mL).  The layers were separated and the aqueous layer was extracted with EtOAc (2 
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 × 15 mL).  The combined organics were washed with brine, dried over Na2SO4, filtered, and 
concentrated. The crude reaction mixture was purified by flash chromatography on silica gel (3% 
EtOAc/hexanes) to provide 0.021 g (31%) of the title compound as a clear, colorless oil:  [α]D = 
+10 (c 1.8, CHCl3); IR (thin film): 3452, 2957, 2930, 2857, 2167, 1715, 1463, 1373, 1252, 1118, 
1074, 9990, 838 cm-1; 1H NMR (300 MHz, CDCl3): δ  4.67–4.57 (m, 1H), 4.12 (dd, J = 1.7, 4.2 
Hz, 1H), 3.77 (d, J = 4.2 Hz, 1H), 3.03 (dd, J = 2.8, 16 Hz, 1H), 2.86 (dd, J = 8.4, 16 Hz, 1H), 
2.14 (d, J = 9.0 Hz, 1H), 2.05–1.88 (m, 2H), 1.79 (dd, J = 2.7, 14 Hz, 1H), 1.66 (ddd, J = 3.4, 
9.3, 13 Hz, 1H), 1.46 (s, 3H),  1.18 (d, J = 6.0 Hz, 3H), 1.03 (d, J = 6.8 Hz, 3H), 0.97 (t, J = 8.0 
Hz, 9H), 0.84 (s, 18H), 0.66–0.56 (m, 6H), 0.21 (s, 3H), 0.19 (s, 9H), 0.13 (s, 3H), 0.128 (s, 3H), 
0.076 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 209.5, 109.1, 89.8, 74.6, 68.4, 67.0, 66.3, 51.8, 
47.0, 43.5, 34.0, 32.5, 29.7, 25.9 (3C), 25.7 (3C), 24.8, 18.0, 17.9, 15.4, 6.9 (3C), 5.2 (3C),  –
0.27, –2.8, –3.1, –4.2, –4.6; HRESI-MS calcd for C36H76O6Si4Na:  739.4617, found 739.4636. 
 
 (8E)(3R, 5S, 10R, 12S)-3, 5, 12-Tris-(tert-
butyldimethylsilyloxy)-3, 10-dimethyl-1-
trimethylsilyltridec-8-en-1-yn-7-one (186):  To a 
mixture of 0.073 g of LiCl (1.73 mmol) in 4 mL of 
CH3CN at ambient temperature was added 1.0 g of β-ketophosphonate 187b (1.73 mmol) in 4 
mL of CH3CN.  The reaction mixture was stirred for 5 min then treated with 0.250 mL of DIPEA 
(1.49 mmol) dropwise via syringe.  The resulting white suspension was maintained for 15 min 
whereupon 0.285 g of aldehyde 147 (0.435 mmol) in 4 mL of CH3CN was added.  The 
suspension dissipated, and the resulting pale yellow solution was maintained for 60 h at ambient 
temperature.  Saturated aqueous NH4Cl was added (20 mL) and the mixture was extracted with 
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 EtOAc (3 × 50 mL). The combined organics were washed with brine, dried over anhydrous 
Na2SO4, filtered, and concentrated. Purification by flash chromatography (1% EtOAc/hexanes) 
provided 0.590 g (70%) of the title compound as a viscous, pale yellow oil:  [α]D =  +16 (c 1.1, 
CHCl3); IR (thin film): 2957, 2929, 2896, 2857, 2167, 1701, 1677, 1626, 1472, 1463, 1361, 
1252, 990, 837 cm-1; 1H NMR (300 MHz, CDCl3): δ 6.71 (dd, J = 7.5, 15.9 Hz, 1H), 6.06 (d, J = 
15.9 Hz, 1H), 4.65–4.53 (m, 1H), 3.89–3.76 (m, 1H), 2.97 (dd, J = 2.2, 15.2 Hz, 1H), 2.73 (dd, J 
= 9.1, 15.2 Hz, 1H), 2.45 (m, 1H), 1.89 (dd, J = 9.3, 13.9 Hz, 1H), 1.76 (dd, J = 2.5, 13.9 Hz, 
1H), 1.59 (ddd, J = 7.3, 7.3, 14 Hz, 1H), 1.44 (s, 3H), 1.29 (ddd, J = 5.6, 7.7, 14 Hz, 1H), 1.12 
(d, J = 6.0 Hz, 3H), 1.03 (d, J = 6.7 Hz, 3H), 0.87 (s, 9H), 0.83 (s, 9H), 0.81 (s, 9H), 0.20 (s, 3H), 
0.18 (s, 9H), 0.15 (s, 3H), 0.09 (s, 3H), 0.05–0.02 (m, 6H), 0.01 (s, 3H); 13C NMR (75 MHz, 
CDCl3): δ 199.1, 152.2, 129.1, 109.3, 89.5, 68.4, 67.6, 66.0, 52.4, 49.4, 46.0, 33.0, 32.5, 25.9 
(3C), 25.8 (3C), 25.7 (3C), 24.0, 19.0, 18.0, 18.0, 17.9, –0.24, –2.8, –3.1, –4.1, –4.2, –4.6, –4.8; 
HRESIMS calcd for [C36H74O4Si4Na]+:  705.4562, found 705.4595. 
 
(3R, 5S, 8R, 9S, 10R, 12S)-3, 5, 12-Tris-(tert-
butyldimethylsilyloxy)-3, 10-dimethyl-1-trimethylsilyl-
tridec-8-en-1-yn-7-one (224):  To a suspension of 0.422 g 
of AD-mix α in 1.6 mL of  tBuOH/H2O (1:1) was added 
0.015 g of K2OsO4•2H2O (40.2 µmol), 0.031 mg of (DHQ)2PHAL (40.2 µmol), 0.051 g of 
NaHCO3 (0.602 mmol), and 0.038 g of methanesulfonamide (0.402 mmol).   The resulting 
yellow-orange suspension was maintained for 10 min, cooled to 0 °C, then treated with 0.137 g 
of enone 186 (0.200 mmol) in 0.8 mL of tBuOH/H2O (1:1) dropwise via syringe.  The reaction 
mixture was maintained for 8 h at 0 °C at which point 0.076 g of Na2SO3 was added.  After 
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 warming to ambient temperature, the resulting brown mixture was maintained for 1 h and diluted 
with EtOAc (10 mL).  The layers were separated and the aqueous layer was extracted with 
EtOAc (2 × 15 mL).  The combined organics were washed with brine, dried over Na2SO4, 
filtered, and concentrated. The crude reaction mixture was purified by flash chromatography on 
silica gel (3% EtOAc/hexanes) to provide 0.061 g (42%) of the title compound as a clear, 
colorless oil:  [α]D = +13 (c 5.3, CHCl3); IR (thin film): 3456, 2957, 2929, 2897, 2857, 2167, 
1717, 1472, 1463, 1361, 1252, 1118, 1073, 990, 837 cm-1; 1H NMR (300 MHz, CDCl3): δ  4.67–
4.57 (m, 1H), 4.12 (dd, J = 1.7, 4.2 Hz, 1H), 3.98–3.86 (m, 1H), 3.77 (d, J = 4.2 Hz, 1H), 3.03 
(dd, J = 2.8, 16 Hz, 1H), 2.86 (dd, J = 8.4, 16 Hz, 1H), 2.14 (d, J = 9.0 Hz, 1H), 2.05–1.88 (m, 
2H), 1.79 (dd, J = 2.7, 14 Hz, 1H), 1.66 (ddd, J = 3.4, 9.3, 13 Hz, 1H), 1.46 (s, 3H),  1.18 (d, J = 
6.0 Hz, 3H), 1.03 (d, J = 6.8 Hz, 3H), 0.97 (t, J = 8.0 Hz, 9H), 0.84 (s, 18H), 0.66–0.56 (m, 6H), 
0.21 (s, 3H), 0.19 (s, 9H), 0.131 (s, 3H), 0.128 (s, 3H), 0.076 (s, 3H); 13C NMR (75 MHz, 
CDCl3): δ 209.5, 109.1, 89.8, 74.6, 68.4, 67.0, 66.3, 51.8, 47.0, 43.5, 34.0, 32.5, 29.7, 25.9 (3C), 
25.7 (3C), 24.8, 18.0, 17.9, 15.4, 6.9 (3C), 5.2 (3C),  –0.27, –2.8, –3.1, –4.2, –4.6; HRESI-MS 
calcd for C36H76O6Si4Na:  739.4617, found 739.4647. 
 
 
 (3R, 5S, 8R, 9S, 10R, 12S)-3, 5, 8, 9, 12-Pentakis-(tert-
butyldimethylsilyloxy)-3, 10-dimethyl-1-trimethylsilyl-
tridec-1-yn-7-one (225):  To a 0 °C solution of 0.015 g of 
diol 224 (20.9 µmol) in 0.4 mL of CH2Cl2 was added 12 µL 
of 2, 6-lutidine (110 µmol) followed by 14 µL of tert-butyldimethyltrifloromethane sulfonate 
(62.8 µmol) dropwise via syringe.  The reaction was warmed to ambient temperature and 
maintained for 2 h at which point saturated aqueous NaHCO3 (3 mL) was added.  The mixture 
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 was extracted with CH2Cl2 (3 × 10 mL) and the combined organics were washed with brine.  
After being dried over Na2SO4, filtered, and concentrated, the resulting oil was purified by flash 
chromatography on neutral silica gel (Iatrobeads–1% EtOAc/hexanes) to afford 0.015 g of the 
title compound as a pale yellow oil:  [α]D = +25 (c 1.8, CHCl3); IR (thin film):  2930, 2896, 
2858, 2167, 1722, 1473, 1463, 1254, 1069, 836, 775 cm-1; 1H NMR (300 MHz, CDCl3): δ 4.60–
4.50 (m, 1H), 4.06 (d, J = 4.6 Hz, 1H), 3.95-3.76 (m, 1H), 3.75–3.63 (m, 1H), 2.95 (dd, J = 6.5, 
17.7 Hz, 1H), 2.81 (dd, J = 5.4, 17.7 Hz, 1H), 2.10–1.95 (m, 1H), 1.84 (dd, J = 6.2, 13.7 Hz, 
1H), 1.72 (dd, J = 5.2, 13.7 Hz, 1H), 1.45 (s, 3H), 1.12 (d, J = 5.9 Hz, 3H), 0.95 (s, 9H), 0.91 (s, 
9H), 0.88 (s, 9H), 0.85 (s, 18 H), 0.77 (d, J = 6.7 Hz, 3H), 0.19 (s, 9H), 0.15 (s, 3H), 0.13 (s, 
6H), 0.10 (s, 6H), 0.08 (s, 3H), 0.04 (s, 6H), 0.02 (s, 3H), 0.00 (s, 3H); 13C NMR (75 MHz, 
CDCl3): δ 207.0, 109.6, 89.4, 81.1, 79.2, 68.8, 66.2, 66.1, 52.2, 49.8, 45.6, 32.4, 30.3, 26.1 (3C), 
26.0 (3C), 25.9 (6C), 25.8 (3C), 25.7, 24.6, 18.4, 18.3, 18.1, 18.0, 18.0, 17.9, –0.20 (3C), –2.8, –
2.9 (2C), –3.8, –4.1, –4.2, –4.3, –4.5, –4.6, –4.9; HRESI-MS calcd for C48H104O6Si6Na:  
967.6346, found 967.6359.  
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 CHAPTER 3.  DIASTEREOSELECTIVE β-LACTONE ENOLATE ALKYLATION IN 
THE CONSTRUCTION OF QUATERNARY CARBON STEREOCENTERS 
 
 
3.1 BACKGROUND 
 
Asymmetric quaternary carbon formation represents an important and challenging area in 
organic synthesis.95  Enolate alkylation has emerged as the most common method for achieving 
the stereoselective installation of quaternary carbons.  This traditional enolate alkylation strategy 
can potentially be limited by poor control over the E/Z geometry in the reacting α,α-
disubstituted enolate which ultimately compromises reaction diastereoselection.  Such issues 
have been resolved through the use of metal chelates or cyclic enolate moities which are often 
times incorporated within the structure of a chiral auxiliary.96 While these methods have been 
quite successful in the construction of quaternary carbon stereocenters, a disadvantage arises in 
the necessity of added synthetic manipulations to install and remove the auxiliary from the 
desired material.  An interesting alternative to chiral auxiliary mediated asymmetric quaternary 
carbon formation can be realized through the alkylation of β-lactone enolates.   
                                                 
95 For recent reviews on the asymmetric synthesis of quaternary carbon stereocenters see:  a) Fuji, K. Chem. Rev. 
1993, 93, 2037.  b)  Corey, E. J.; Guzman-Perez, A. Angew. Chem. Int. Ed. 1998, 37, 388.  
96 (a) Boeckman, R. K., Jr.; Boehmler, D. Musselman, R. A. Org. Lett. 2001, 3, 3777.  (b) Frater, G. Helv. Chim. 
Acta 1979, 62, 2825.  (c) Manthorpe, J. M.; Gleason, J. L. Angew. Chem. Int. Ed. 2002, 41, 2338.  (d) Groaning, M. 
D.; Meyers, A. I. Tetrahedron 2000, 56, 9843. 
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 The earliest examples of β-lactone enolate alkylation to form asymmetric quaternary 
centers were reported by Mulzer et al.97  Treating α-substituted β-lactones 230 derived from the 
corresponding 3-hydroxycarboxylic acids with lithium diisopropylamide (LDA) in THF at –78 
°C cleanly generated the corresponding lithium enolate 231 which was subsequently trapped 
with a variety of electrophiles to afford α,α-disubstituted β-lactones in good yield and with 
excellent diastereoselectivity (>98:2).  The origin of the observed trans-selectivity in the 
formation of the quaternary carbon center was attributed to the conformational rigidity of the 
lactone enolate system whereby incoming electrophiles would approach opposite the bulky C4 
substituent in order to minimize nonbonded interactions (Figure 28).   
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Figure 31.  Rationale for the observed diastereoselectivity in the alkylation of β-lactone enolates 
 
 
These preliminary investigations, while successful in demonstrating the utility β-lactone 
enolates for the diastereoselective formation of quaternary carbon stereocenters, were limited to 
the use of α-phenyl substituted lactones with bulky C4 substituents (iPr, tBu).  In the case of 
lactone enolates unsubstituted at C3, the rapid dimerization of enolate 232 and another lactone 
molecule occurs to form the Claisen self-condensation product 233 in high yield (Eq 18). 
                                                 
97 (a) Mulzer, J.; Kerkmann, T. J. Am. Chem. Soc. 1980, 102, 3620.  (b) Mulzer, J.; Kerkmann, T. Angew. Chem., 
Int. Ed. Engl. 1980, 19, 465.  (c) Mulzer, J.; Chucholowski, A. Angew. Chem., Int. Ed. Engl. 1982, 21, 777.  (d) 
Mulzer, J.; Chucholowski, A.; Lammer, O.; Jibril, I.; Huttner, G. J. Chem. Soc., Chem. Commun. 1983, 869. 
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Following the initial reports by Mulzer, further investigation into the enolization and 
subsequent alkylation of C3 unsubstituted β-lactones was undertaken.  In 1987, Seebach et al. 
disclosed the first successful example of the alkylation of a C3 unsubstituted β-lactone enolate 
employing (S)-β-butyrolactone (91).98  Seebach’s enolization method required slowly treating a 
solution of LDA with lactone 91 at very low temperatures (–100 °C).  Subsequent addition of 
either methyl or ethyl iodide (2.0 equiv) at –78 °C resulted in the generation of trans-3,4-
disubstituted lactones 234 and 235 in modest yield with good levels of diastereoselection. 
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234  R = Me; 31% (dr 8:1)
235 R = Et;  37% (dr 9:1)
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Another interesting approach to achieve the formal enolization and alkylation of C3-
unsubstituted β-lactones was later reported by Mead and Yang (Eq 20).99  The strategy involved 
the disilylative alkylation of a 3-trimethylsilyl-2-oxetanone 236 in the presence of 
tris(dimethylamino)sulfur(trimethylsilyl)difluoride (TASF) and MeI.  The lactone products 237 
were obtained in variable yields with modest trans-diastereoselection. 
                                                 
98 Griesbeck, A.; Seebach, D. Helv. Chim. Acta 1987, 70, 1320. 
99 Mead, K. T.; Yang, H.-L. Tetrahedron Lett. 1989, 30, 6829. 
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 The most recent example involving the alkylation of C3-unsubstituted β-lactone enolates 
was described by Parsons et al. in the total synthesis of the potent pancreatic lipase inhibitor (–)-
tetrahydrolipstatin 238 (Eq 21).100  The requisite hexyl side chain of the natural product was to 
be introduced via the enolization and subsequent alkylation of lactone 239. Extensive 
optimization identified the combination of NaHMDS as base and the presence of an in situ 
electrophile (1-iodohex-2-ene) as the most effective reaction conditions for achieving β-lactone 
enolate alkylation.  The desired monoalkylated product 240 was obtained in 36% isolated yield 
(52% based on recovered starting material) along with 26% of the dialkylated β-lactone 241. 
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100 Parsons, P. J.; Cowell, J. K. Synlett 2000, 1, 107. 
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 3.2 ENOLATE ALKYLATION OF AAC-DERIVED β-LACTONES 
 
We envisaged that the enantiomerically enriched β-lactone products of asymmetric acyl halide-
aldehyde cyclocondensation (AAC) reaction technology would offer an efficient means for 
establishing equivalent bond constructions.   Enolization and subsequent alkylation of β-lactones 
of type 242 should afford trans-3,4-disubstituted lactones which could then be resubjected to the 
reaction conditions in the presence of a different electrophile to result in the production of β-
lactones possessing asymmetric quaternary stereocenters. 
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Figure 32.  AAC-Derived β-Lactones in Asymmetric Quaternary Carbon Formation 
 
 
Although prior literature precedent suggested that the enolization and subsequent 
alkylation of C3-unsubstituted β-lactones was a nontrivial endeavor, we desired a set of reaction 
conditions that would efficiently generate β-lactone enolates for subsequent iterative 
functionalization with alkylating agents to afford asymmetric quaternary carbon stereocenters.  
Initially, we examined the very low temperature reaction conditions for β-lactone enolate 
formation reported by Seebach.74  Following Seebach’s protocol, a –100 °C solution of LDA in 
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 THF was slowly treated with a THF solution of (4S)-4-phenethyloxetan-2-one  61 via syringe 
pump (Eq 22).  This solution was then warmed to –78 °C and MeI was added.  Unfortunately, 
these conditions yielded a complex mixture of products, presumably owing to the competing 
Claisen self-condensation pathway described by Mulzer, along with unreacted starting material 
by TLC and 1H NMR analysis.  None of the desired trans-3,4-disubstituted lactone 243a was 
observed.   
O
O i) LDA, THF    –100 °C
Ph
O
O
PhMe
ii)    MeI
     –78 °C
complex mixture
O
O
Ph
+
(22)
61
243a
 
 
 
Turning to Parsons’ previously described total synthesis of (–)-tetrahydrolipstatin, we 
next sought to improve upon these earlier results that incorporated an in situ electrophile to 
intercept the reactive β-lactone enolate.    In an attempt to repeat the result obtained by Parsons, a 
–100 °C solution of NaHMDS (1.0 equiv) and MeI (1.5 equiv) in THF was slowly treated with a 
THF solution of lactone 61 via syringe pump (Eq 23).  After work-up and chromatographic 
separation, we were pleased to obtain trans-3,4-disubstituted lactone 243 in 36% isolated yield 
as a 10:1 mixture of anti/syn diastereomers along with 20% of the 3,3-dimethylated product 244 
and 17% of unreacted starting material in accordance with that observed by Parsons.  The 
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 observed coupling constant in the 1H NMR spectrum of lactone 243 (J3,4 = 4.0 Hz) was indicative 
of the formation of the trans-disubstituted lactone.101
 
 
NaHMDS (1.0 equiv)
O
O
Ph
MeI (1.5 equiv)
 THF
    –100 °C
O
O
PhMe
+
O
O
PhMe Me
36% 20%
(23)
61 243a 244
 
 
 
 
Attempts at optimizing this alkylation reaction first entailed a reverse addition of base to 
the lactone and electrophile at low temperature (Eq 24).  Syringe pump addition of NaHMDS 
(1.0 equiv) to a –100 °C solution of lactone 61 and MeI (1.5 equiv) in THF resulted complete 
consumption of the starting lactone and an increased yield of the desired trans-disubstituted 
product 241 to 47%.  An additional 11% of the disubstituted by-product was also obtained.  The 
isolated yield of lactone 241 was eventually maximized by employing the previously described 
reverse addition of base to the starting lactone and a large excess of the MeI electrophile (5.0 
equiv) at –100 °C.  Lactone 241 was obtained in 63% isolated yield (dr ~ 10:1) along with an 
additional 11% of dialkylated material representing the highest isolated yield for the alkylation 
of a C3-unsubstituted β-lactone enolate to date. 
 
 
NaHMDS (1.0 equiv)
O
O
Ph
MeI (5.0 equiv)
 THF
    –100 °C
O
O
PhMe
+
O
O
PhMe Me
63% 11%
(dr ~ 10:1)
(24)
61 243a 244
 
                                                 
101 Mulzer, J.; Pointner, A.; Chucholowski, A.; Bruntrup, G. J. Chem. Soc., Chem. Commun. 1979, 52. 
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 These optimized conditions were then used in conjunction with a variety of electrophiles 
in order to examine the scope of the alkylation reaction.   While MeI delivered lactone 243a in 
63% yield, the less active ethyl iodide electrophile (entry b) afforded none of the desired trans-
disubstituted lactone.  More highly activated allyl and benzyl bromides provided the expected 
trans-lactone products 243b-c, however, only in modest yields (entries c and e) potentially 
owing to competitive self-condensation.  In an attempt to suppress the nonproductive self-
condensation reaction pathway, a more highly activated alkylating agent, allyl iodide, was 
employed (entry d). Gratifyingly, allyl iodide proved to be substantially more reactive than allyl 
bromide allowing enolate alkylation to effectively compete with the nonproductive self-
condensation pathway affording (3S, 4S)-3-allyl-4-phenethyl-oxetan-2-one 243b in 68% isolated 
yield along with minor amounts of the corresponding diallylated material. 
 
 
Table 5.  Enolization and Alkylation of α-Unsubstituted β-Lactones 
O
O
THF, –100 °C
entry
a
b
c
Yielda
(%)
63 (243a)
---
38 (243b)
R–X
NaHMDS, R–X
d 68 (243b)
Ph
O
O
PhR
CH3I
CH3CH2I
CH2CHCH2Br
CH2CHCH2I
e PhCH2Br 38 (243c)
aIsolated yields of purified products.
61 243a-c
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 While the efficient preparation of 3,4-trans-alkylated products were limited to 
substitution patterns derived from very reactive electrophiles, i.e. MeI and allyl iodide, these 
initial experiments generated quantities of several β-lactone substrates for further investigation 
into the stereoselective installation of quaternary carbon centers.  Employing similar reaction 
conditions as described in the initial alkylation step (NaHMDS, in situ R–X, THF, –78 °C) 
lactones 243a-c were successfully enolized and trapped in situ with various electrophiles (Table 
5).  Activated electrophiles such as allyl and benzyl bromide (entries a, b, f, and h) cleanly 
afforded the corresponding α,α-disubstituted β-lactones in excellent yield with high levels of 
diastereoselectivity.  Similarly, substanitially poorer primary alkyl iodide electrophiles (EtI and 
nBuI) were also effective alkylating agents toward β-lactone enolates (entries c and d).  However, 
increased steric bulk in the structure of the electrophile (entry e) was not tolerated when the β-
branched isobutyl iodide was employed resulting in a significantly lower yield of the 
corresponding α,α-disubstituted β-lactone 245e.  These alkylation experiments successfully 
demonstrated the synthetic utility of the enantiomerically enriched β-lactone products of the 
AAC reaction toward asymmetric quaternary carbon construction; however, our inability to 
efficiently prepare trans-disubstituted β-lactones with C3 substituents other than methyl or allyl 
severely limited the generality of the method. 
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 Table 6.  Alkylation of 3,4-trans-Disubstituted β-Lactones 
anti:synb,c
O
O
R1 R2
O
O
R1
R3
R2
NaHMDS, R3–X
THF, –78 °C
Me
Me
Me
Me
Me
Allyl
entry
a
b
c
d
e
g
R3–X
Yield
(%)a
CH2CH2Ph
CH2CH2Ph
CH2CH2Ph
CH2CH2Ph
CH2CH2Ph
CH2CH2Ph
CH2CHCH2Br
BnBr
(CH3)2CHCH2I
EtI
CH3(CH2)2CH2I
MeI
93 (245a)
94 (245b)
94 (245c)
88 (245d)
10 (245e)
91 (245g)
97:3
93:7
>98:2
–
14:86
95:5
R1 R2
f Me CH2OBn CH2CHCH2Br 93 (245f) >98:2
h Bn CH2CH2Ph CH2CHCH2Br 89 (245h) 5:95
243a-c 245a-h
 
aIsolated yields of purified products.  bDiastereomer ratios were determined by 1H NMR analysis of crude product 
mixtures.  cStereochemistry of major diastereomer was assigned based on literature precedent.  See ref. 74d. 
 
 
 
 In an attempt to circumvent the initial problematic enolization and alkylation of α-
unsubstituted β-lactones, we eagerly turned to a newly developed AAC reaction employing the 
second generation unsymmetrical aluminum(III) triamine catalyst 180.   This second generation 
AAC reaction employs substoichiometric amounts of catalylst 180 (10-20 mol %) and enables 
the effective preparation of 3,4-cis-disubstituted β-lactones (246) from a variety of aldehydes 
and alkyl-substituted ketenes (Figure 32).102    The resulting lactones were obtained in good yield 
with good to excellent enantio- and diastereoselectivities.   
                                                 
102 Nelson, S. G.; Zhu, C.; Shen, X. J. Am. Chem. Soc. 2004, 126, 14. 
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Figure 33.  Second generation asymmetric acyl halide-aldehyde cyclocondensation (AAC) 
reactions of substituted ketenes 
 
 
 Merging the newly acquired 3,4-cis-disubstituted β-lactone products from the second 
generation AAC reaction with the previously described alkylation protocol resulted in the 
successful installation of  quaternary carbon stereocenters in a variety of α-substituted β-lactones 
that had formerly been inaccessible through traditional AAC reaction technology (Table 6).  
Lactones containing either ethyl or n-propyl substituents at the α-position (entries a, b, and c) 
were readily enolized and alkylated in good yield with high levels of diastereoselectivity 
(anti/syn >98:2). Bulky α-substituents (entry d) were also tolerated affording the corresponding 
α,α-substituted β-lactone 247d as a single diastereomer in 94% yield.   
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 Table 7.  Alkylation of 3,4-cis-Disubstituted β-Lactones 
anti:synb,c
O
O
R1 R2
O
O
R1
R3
R2
NaHMDS, R3–X
THF, –78 °C
Et
nPr
nPr
iPr
Me
Me
entry
a
b
c
d
e
f
R3–X
Yield
(%)a
CH2CH2Ph
CH2CH2Ph
CH2CH2Ph
CH2CH2OBn
Ph
C6H11
CH2CHCH2Br
CH2CHCH2Br
CH2CHCH2Br
BnBr
BnBr
BnBr
92 (247a)
83 (247b)
86 (247c)
94 (247d)
52 (247e)
48 (247f)
>98:2
>98:2
>98:2
95:5
>98:2
>98:2
R1 R2
Meg CH2CH2Ph EtI 21 (247g) >98:2
Meh CH2CH2Ph nBuI 12 (247h) >98:2
Mei CH2CH2Ph MeI 69 (247i) –
246a-f 247a-i
 
aIsolated yields of purified products.  bDiastereomer ratios were determined by 1H NMR analysis of crude product 
mixtures.  cStereochemistry of major diastereomer was assigned based on literature precedent.  See ref. 74d. 
 
 
 
 Limitations to the method were observed, however, when a methyl group was 
incorporated at the C3 position of the β-lactone substrates (entries e-h).  While the observed 
diastereoselectivity in the alkylation event remained constant (≥ 95:5), isolated yields of the β-
lactone products were significantly attenuated.  These low isolated yields can potentially be 
attributed to the competitive Claisen self-condensation reaction pathway reported by Mulzer and 
Seebach.  As depicted in Figure 33, nucleophilic attack of a lactone enolate on the starting cis-
3,4-disubstituted β-lactone can proceed along a relatively unhindered trajectory reminiscent of a 
C3-unsubstituted substrate resulting in substantial enolate acylation and further lactone 
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 consumption via oligomerization.  As previously observed in the case of C3 unsubstituted β-
lactone enolates, the nature of the alkylating agent appears to play a major role in the degree of 
competition between alkylation and self-condensation as more reactive electrophiles (entries e, f, 
and i) afforded the corresponding α,α-disubstituted β-lactones in higher yields than less reactive 
primary alkyl iodides (entries g and h).  Although poor yields were obtained when using 3,4-cis-
disubstituted β-lactones containing an α-methyl group, we have previously demonstrated the 
success of 3,4-trans-disubstituted lactones possessing an α-methyl group in the 
diastereoselective β-lactone enolate alkylation in the construction of quaternary carbon 
stereocenters.  This difference in reactivity between the two diastereomeric lactones can be 
rationalized by a hindered trajectory of a lactone enolate approaching a trans lactone from either 
face.  As a result, the two approaches are complementary. 
 
O R
H
Me
H
O R
H
H
Me
O O
Nuc Nuc
Nuc
 
Figure 34.  Rationalization for low yields of alkylation with 3-methyl-3,4-cis-disubstituted β-
lactones  
 
3.3 SYNTHETIC APPLICATION OF α,α-DISUBSTITUTED β-LACTONES 
 
Having prepared a variety of α,α-disubstituted β-lactones, a series of  investigations were 
conducted to determine whether the increased steric bulk of the newly installed quaternary 
carbon stereocenter would impact the differential electrophilic reactivity patterns typically 
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 displayed by less substitiuted β-lactones.  To our delight, treatment of lactones 245f and 245b 
with La(OtBu)3 and BnOH resulted in based-mediated alcoholysis cleanly affording the ring 
opened ester aldol adducts 248a and 248b.  Further elaboration of β-hydroxyester c by 
mesylation and subsequent elimination then provided the α, α-disubstituted β, γ-unsaturated 
carboxylate ester 249 in 61% yield (Scheme 39).   
 
Scheme 39.  La(OtBu)3 Mediated Ring Opening of α,α-Disubstituted β-Lactones 
O
O
Me
R1
R2
BnO R2
O
MeR1
OH R1 R2 Yield (%)
CH2CHCH2 CH2OBn 92 (248a)
CH2Ph CH2CH2Ph 86 (248b)
La(OtBu)3 
BnOH
THF
BnO
O
Me
OH
Ph
Ph
BnO
O
Me
Ph
Ph
1)  MsCl, Et3N
2)  DBU
61%
248b 249  
 
 
Similarly, geminal α-substitution appears to have little effect on the azide-mediated SN2 
ring opening of β-lactones (Table 8).  When lactones 245b-d were subjected to NaN3 (2.0 equiv) 
in DMSO at 50 °C,103 the corresponding β-azido acids were obtained in near quantitative yield.  
However, when the steric environment around the electrophilic  C4 stereocenter was dramatically 
increased (entry d), the SN2 pathway became less accessible resulting in a 5:1 mixture of starting 
lactone and the desired β-azido acid after 3 days at 50 °C.  Despite the low reactivity observed 
with especially hindered substrates, azide-mediated ring opening of α, α-disubstituted β-lactones 
                                                 
103 Nelson, S. G.; Spencer, K. L. Angew. Chem. Int. Ed. 2000, 39, 1323. 
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 has proven to be an efficient strategy leading to synthetically useful α, α-disubstituted β-amino 
acids. 
Table 8.  Azide-Mediated SN2 Ring Opening of α,α-Disubstituted β-Lactones 
 
O
O
R1
R3
R2 DMSO, 50 °C
Me
Me
Me
entry
a
b
c
Yielda
(%)
Et
nBu
CH2Ph
98 (250a)
95 (250b)
97 (250c)
R1 R2
HO R2
O
R1R3
N3NaN3
d
R3
CH2CH2Ph
CH2CH2Ph
CH2CH2Ph
iPr Ph 14 (250d)CH2Ph
245b-d, 
247d
250a-d
 
aIsolated yields of purified products.   
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 3.4 CONCLUSIONS 
 
The enantiomerically enriched β-lactone products of catalytic, asymmetric acyl halide-aldehyde 
cyclocondensation (AAC) reactions have been successfully employed in the stereoselective 
construction of quaternary carbon stereocenters.  Treatment of β-lactones of type 242 with 
NaHMDS at low temperature resulted in enolization and subsequent alkylation with in situ 
electrophiles to afford trans-3,4-disubstituted lactones in moderate to good yield with good 
levels of diastereoselectivity.  Resubjecting the monoalkylated products to the reaction 
conditions and employing a different electrophile resulted in the efficient production of α,α-
disubstituted-β-lactones in high yield with high trans-diastereoselectivity. 
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F3CO2S SO2CF3
Catalyst 36
242
>88% yield
~95:5 dr  
 
 A more efficient route to α,α-disubstituted β-lactones was realized by employing the 
recently developed second generation AAC reaction.  This approach avoided the initial 
problematic enolization and alkylation of α-unsubstituted β-lactones by installing the enolate 
stabilizing α-stereocenter via the reaction of aldehydes with alkyl substituted ketenes in the 
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 presence of substoichiometric amounts of catalyst 180.  Asymmetric quaternary carbon 
formation could now be accomplished in two steps affording the desired α,α-disubstituted-β-
lactones  in high yield with excellent diastereoselectivity. 
 
>82% yield
~98:2 dr
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Once synthesized, the quaternary center containing lactones were subjected to traditional 
β-lactone ring opening reaction conditions to furnish the corresponding α,α-disubstituted ester 
aldol adducts and β-azido acids in excellent yield. 
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 3.5 EXPERIMENTAL SECTION 
 
General Procedure for the Enolization and Alkylation of α-Unsubstituted β-Lactones:  To a 
–100 °C solution of 0.209 g of lactone 61 (1.19 mmol) and 0.370 mL of MeI (5.93 mmol) in 60 
mL THF was added 1.20 mL of a 1.0 M solution of NaHMDS in THF slowly via syringe pump 
over 1 h.   The reaction was maintained for an additional 1 h at –100 °C, then quenched with 
saturated aqueous NH4Cl.  After warming to ambient temperature, the reaction mixture was 
extracted with EtOAc and the combined organics were washed with brine.  The organic layer 
was dried over Na2SO4, filtered, and concentrated. Purification by flash chromatography on 
silica gel (4% EtOAc/hexanes) provided 0.142 g (63%) of lactone 243a as a clear, colorless oil.   
 
 (3S, 4S)-3-Methyl-4-phenethyl-oxetan-2-one (243a):  [α]D = –82 (c 1.7, 
CHCl3); IR (thin film):  3063, 3028, 2936, 2876, 1824, 1603, 1496, 1455, 
1385, 1127 cm-1; 1H NMR (300 MHz, CDCl3):  δ 7.35–7.19 (m, 5H), 4.18 (ddd, J = 4.0, 5.9, 7.5 
Hz, 1H), 3.21 (dq, J = 4.0, 7.5 Hz, 1H), 2.84 (ddd, J = 5.8, 8.8, 14.3 Hz, 1H), 2.76–2.65 (m, 1H), 
2.27–2.03 (m, 2H), 1.33 (d, J = 7.5 Hz, 3H); 13C NMR (75 MHz, CDCl3):  δ 171.6, 140.0, 128.5, 
128.2, 126.2, 78.5, 50.7, 35.6, 31.1, 12.2;  LRMS (EI, 70eV):  m/z 190; HRMS calcd for 
C12H14O2:  190.0994, found 190.0993. 
O
O
Me Ph
 
 (3S, 4S)-3-Allyl-4-phenethyl-oxetan-2-one (243b):  Purification by flash 
chromatography on silica gel (2% EtOAc/hexanes) afforded 0.155 g (68%) 
of a clear, colorless oil:  [α]D = –61 (c 2.3, CHCl3); IR (thin film):  3083, 3064, 3027, 2931, 
2861, 1820, 1642, 1603, 1497, 1454, 1384, 1122 cm-1; 1H NMR (300 MHz, CDCl3):  δ 7.35–
O
O
Ph
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 7.19 (m, 5H), 5.85–5.69 (m, 1H), 5.16 (brs, 1H), 5.12 (dd, J = 1.4, 5.7 Hz, 1H), 4.28 (ddd, J = 
4.0, 5.5, 7.7 Hz, 1H), 3.30 (ddd, J = 4.0, 6.1, 8.3 Hz, 1H), 2.88–2.64 (m, 2H), 2.58–2.39 (m, 2H), 
2.26–2.03 (m, 2H); 13C NMR (75 MHz, CDCl3):  170.4, 140.0, 132.9, 128.5, 128.2, 126.3, 118.2, 
76.3, 55.3, 35.8, 31.4, 31.2; LRMS (EI, 70eV):  m/z 216; HRMS calcd for C14H16O2: 216.1150, 
found 216.1149. 
 
 (3S, 4S)-3-Benzyl-4-phenethyl-oxetan-2-one (243c):  Purification by 
flash chromatography on silica gel (2% EtOAc/hexanes) afforded 0.110 
g (38%) of a pale yellow oil:  [α]D = –19 (c 1.8, CHCl3); IR (thin film):  3086, 3062, 3028, 2926, 
2860, 1820, 1603, 1497, 1454, 1384, 1120 cm-1; 1H NMR (300 MHz, CDCl3):  δ 7.38–7.27 (m, 
6H), 7.25–7.11 (m, 4H), 4.33 (ddd, J = 4.2, 6.1, 7.2 Hz, 1H), 3.52 (ddd, J = 4.2, 6.0, 9.1 Hz, 1H), 
3.13 (dd, J = 6.0, 14.3 Hz, 1H), 2.99 (dd, J = 9.0, 14.3 Hz, 1H), 2.66 (ddd, J = 5.7, 9.4, 14.6 Hz, 
1H), 2.56–2.49 (m, 1H), 2.25–2.11 (m, 1H), 2.03–1.90 (m, 1H); 13C NMR (75 MHz, CDCl3):  
δ 170.3, 140.0, 137.0, 128.8, 128.6, 128.5, 128.1, 127.0, 126.2, 76.4, 57.1, 35.5, 33.4, 29.6; 
LRMS (EI, 70eV):  m/z 266; HRMS calcd for C18H18O2:  266.1307, found 266.1298. 
O
O
Ph
 
 (3S, 4R)- 4-Benzyloxymethyl-3-methyl-oxetan-2-one (243d): 
Purification by flash chromatography on silica gel (10% 
EtOAc/hexanes) afforded 0.188 g (35%) of a pale yellow oil:   [α]D = –48 (c  2.3, CHCl3); IR 
(thin film):  3063, 3031, 2867, 1821, 1496, 1454, 1362, 1117 cm-1; 1H NMR (300 MHz, CDCl3):  
δ 7.40–7.27 (m, 5H), 4.60 (s, 2H), 4.34 (ddd, J = 4.3, 4.3, 4.3 Hz, 1H), 3.80 (dd, J = 3.2, 11.7 
Hz, 1H), 3.72 (dd, J = 4.6, 11.7 Hz. 1H), 3.59 (dq, J = 4.1, 7.6 Hz, 1H), 1.39 (d, J = 7.6 Hz, 3H); 
O
O
O
Me
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 13C NMR (75 MHz, CDCl3):  δ 171.3, 137.4, 128.3, 127.7, 127.5, 77.2, 73.5, 69.0, 47.2, 12.0; 
LRMS (EI, 70eV):  m/z 178; HRMS calcd for C11H14O2:  178.0994, found 178.0996. 
 
General Procedure for the Enolization and Alkylation of α-Substituted β-Lactones:  
To a –78 °C solution of 0.092 g of lactone 243a (0.484 mmol) and 0.210 mL of allyl bromide 
(2.42 mmol) in 6 mL of THF was added 0.580 mL of a 1.0 M solution of NaHMDS in THF 
slowly via syringe pump over 45 min. The reaction was maintained at –78 °C for 1 h. Saturated 
aqueous NH4Cl was added and the mixture was warmed to ambient temperature. The reaction 
mixture was extracted with EtOAc and the combined organics were washed with brine.  The 
organic layer was then dried over Na2SO4, filtered, and concentrated. Purification by flash 
chromatography on silica gel (3% EtOAc/hexanes) afforded 0.096 g (86%) of a pale yellow oil. 
 
 (3S, 4S)-3-Allyl-3-methyl-4-phenethyl-oxetan-2-one (245a):  [α]D =     –44 
(c  2.2, CHCl3); IR (thin film):  3083, 3022, 2975, 2935, 2863, 1818, 1644, 
1598, 1496, 1455, 1378, 1101 cm-1; 1H NMR (300 MHz, CDCl3):  δ 7.35–
7.30 (m, 2H), 7.26–7.20 (m, 3H), 5.76 (dddd, J = 7.3, 7.3, 10.2, 17.2 Hz, 1H), 5.22–5.13 (m, 
2H), 4.36 (dd, J = 4.5, 9.3 Hz, 1H), 2.85 (ddd, J = 5.4, 9.8, 14.1 Hz, 1H), 2.69 (ddd, J = 6.9, 11, 
13.8 Hz, 1H), 2.49 (dd, J = 7.0, 14 Hz, 1 H), 2.39 (dd, J = 7.6, 14 Hz, 1H), 2.08 (dddd, J = 5.4, 
9.3, 9.3, 14 Hz, 1H), 1.95 (dddd, J = 4.5, 6.8, 11, 14 Hz, 1H), 1.28 (s, 3H);  13C NMR (75 MHz, 
CDCl3):  δ 174.2, 140.4, 131.6, 128.6, 128.3, 126.3, 119.8, 79.8, 56.7, 40.0, 32.4, 31.6, 14.4; 
LRMS (EI, 70eV):  m/z 230; HRMS calcd for C15H18O2: 230.1307, found 230.1307. 
O
O
PhMe
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 (3S, 4S)-3-Ethyl-3-methyl-4-phenethyl-oxetan-2-one (245c): Isolated as a 
pale yellow oil (94%, single diastereomer): [α]D = –47 (c 1.0, CHCl3); IR 
 2971, 2937, 2880, 1818, 1496, 1455, 1384, 1105 cm(thin film):  3027,
 
 
-1; 1H NMR (300 MHz, 
CDCl3):  δ 7.35–7.17 (m, 5H), 4.28 (dd, J = 4.3, 9.3 Hz, 1H), 2.86 (ddd, J = 5.4, 9.7, 14 Hz, 1H), 
2.70 (ddd, J = 7.1, 9.2, 14 Hz, 1H), 2.12 (dddd, J = 4.1, 9.3, 9.3, 14 Hz, 1H), 1.96 (dddd, J = 4.4, 
6.3, 11, 14 Hz, 1H), 1.75 (bq, J = 7.3 Hz, 2H), 1.26 (s, 3H), 1.00 (t, J = 7.4 Hz, 3H);  13C NMR 
(75 MHz, CDCl3):  δ 174.8, 140.5, 128.6, 128.4, 126.3, 80.1, 57.8, 32.6, 31.7, 28.7, 13.9, 8.56; 
LRMS (EI, 70eV):  m/z 218; HRMS calcd for 218.1307: found, 218.1305. 
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 (3S, 4S)-3-Benzyl-3-methyl-4-phenethyl-oxetan-2-one (245b):    [α]D = –
25 (c 2.0, CHCl3); IR (thin film):  3062, 3027, 2931, 1820, 1603, 1496, 1454, 
1382, 1104 cm-1; 1H NMR (300 MHz, CDCl3):  δ 7.34-7.24 (m, 6H), 7.17-
7.08 (m, 4H), 4.42 (dd, J = 4.4, 9.3 Hz, 1H), 3.09 (d, J = 14 Hz, 1H), 2.84 (d, J = 14 Hz, 1H), 
2.78 (ddd, J = 5.3, 9.6, 14 Hz, 1H), 2.57 (ddd, J = 7.3, 12, 14 Hz, 1H), 2.06 (dddd, J = 5.3, 9.3, 
9.3, 14 Hz, 1H), 1.86 (dddd, J = 4.4, 7.2, 12, 14 Hz, 1H), 1.27 (s, 3H); 13C NMR (75 MHz, 
CDCl3):  δ 174.5, 140.3, 135.4, 129.8, 128.6, 128.5, 128.4, 127.2, 126.3, 79.3, 57.9, 41.5, 32.1, 
31.7, 15.1; LRMS (EI, 70eV):  m/z 280; HRMS calcd for  C19H20O2:  280.1463, found 280.1470. 
O
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 (3S, 4S)-3-Butyl-3-methyl-4-phenethyl-oxetan-2-one (245d): Purification 
by flash chromatography on silica gel (2% EtOAc/hexanes) afforded the title 
compound as a pale yellow oil (88%):  [α]D =  –49 (c 2.4, CHCl3); IR (thin 
film):  3063, 3027, 2957, 2934, 2862, 1822, 1496, 1455, 1382, 1112 cm-1; 1H NMR (300 MHz, 
CDCl3):  δ 7.36–7.31 (m, 2H), 7.27–7.21 (m, 3H), 4.31 (dd, J = 4.3, 9.4 Hz, 1H), 2.87 (ddd, J = 
O
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 5.3, 10, 14 Hz, 1H), 2.70 (ddd, J = 6.9, 9.4, 14 Hz, 1H), 2.09 (dddd, J = 5.4, 9.4, 9.4, 14 Hz, 1H), 
1.96 (dddd, J = 4.3, 6.9, 11, 14 Hz, 1H), 1.70 (dd, J = 7.2, 9.0 Hz, 2H), 1.50–1.39 (m, 1H), 1.38–
1.31 (m, 2H), 1.29–1.20 (s+m, 4H), 0.93 (t, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3):  δ  
174.9, 140.4, 128.5, 128.3, 126.3, 80.5, 57.2, 35.5, 32.5, 31.7, 26.2, 22.8, 14.3, 13.8; LRMS (EI, 
70eV):  m/z 246; HRMS calcd for C16H22O2:  246.1619, found 246.1613. 
 
 (3S, 4S)-3-Isobutyl-3-methyl-4-phenethyl-oxetan-2-one (245e): 
Purification by flash chromatography on silica gel (2% EtOAc/hexanes) 
afforded lactone 245e as a pale yellow oil (10%):  [α]D = –53 (c  0.2, CHCl3); 
IR (thin film):  3027, 2958, 2871, 1820, 1455, 1383, 1120  cm-1; 1H NMR (300 MHz, CDCl3):  
δ 7.35–7.29 (m, 2H), 7.27–7.20 (m, 3H), 4.33 (dd, J = 3.7, 9.6 Hz, 1H), 2.91 (ddd, J = 5.3, 9.3, 
14 Hz, 1H), 2.69 (ddd, J = 7.7, 8.5, 14 Hz, 1H), 2.14–1.93 (m, 2H), 1.81–1.73 (m, 2H), 1.56 (dd, 
J = 6.0, 10 Hz, 1H), 1.25 (s, 3H), 0.96 (d, J = 6.3 Hz, 3H), 0.81 (d, J = 6.4 Hz, 3H); 13C NMR 
(75 MHz, CDCl3):  δ 175.3, 140.5, 128.6, 128.4, 126.3, 81.7, 56.7, 44.5, 32.4, 31.8, 24.4, 23.9, 
22.4, 14.1; LRMS (EI, 70eV):  m/z 246; HRMS calcd for C16H22O2:  246.1619, found 246.1616. 
O
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(3S, 4R)- 3-Allyl-4-benzyloxymethyl-3-methyl-oxetan-2-one (245f):  
Isolated as a pale yellow oil (93%, single diastereomer): [α]D = –9.1 (c  
2.8, CHCl3); IR (thin film):  3066, 3031, 2976, 2865, 1824, 1642, 1496, 
1455, 1101 cm-1; 1H NMR (300 MHz, CDCl3):  δ 7.41–7.31 (m, 5H), 5.78 (dddd, J = 6.9, 7.7, 
11, 18 Hz, 1H), 5.24–5.23 (m, 1H), 5.21–5.17 (m, 1H), 4.63 (d, J = 12 Hz, 1H), 4.56 (d, J = 12 
Hz, 1H), 4.51 (dd, J = 5.2, 6.4 Hz, 1H), 3.78 (dd, J = 6.4, 11 Hz, 1H), 3.73 (dd, J = 5.2, 11 Hz, 
1H), 2.52 (ddt, J = 1.2, 6.8, 14 Hz, 1H), 2.42 (ddt, J = 1.0, 7.7, 14 Hz, 1H), 1.29 (s, 3H); 13C 
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 NMR (75 MHz, CDCl3): δ 173.7, 137.3, 131.4, 128.4, 127.8, 127.6, 120.0, 77.6, 73.6, 68.4, 57.1, 
40.0, 14.2; LRMS (EI, 70eV):  m/z 247 (M+H); HRMS calcd for C15H18O3:  246.1256, found 
246.1246. 
 
 
(3R, 4S)-3-Allyl-3-benzyl-4-phenethyl-oxetan-2-one (245h):  Purification 
by flash chromatography on silica gel (3% EtOAc/hexanes) afforded the 
title compound as a pale yellow oil:  (84%):  [α]D = –51 (c  3.0, CHCl3); IR 
(thin film): 3063, 3028, 2926, 2859, 1816, 1640, 1603, 1496, 1454, 1114 cm-1; 1H NMR (300 
MHz, CDCl3): δ 7.38–7.25 (m, 10H), 5.73 (dddd, J = 6.5, 8.0, 14, 17 Hz, 1H), 5.22 (br d, J = 10 
Hz, 1H), 5.12 (dq, J = 1.3, 17 Hz, 1H), 4.50 (dd, J = 3.8, 9.9 Hz, 1H), 3.31 (d, J = 14 Hz, 1H), 
2.96 (ddd, J = 5.1, 9.8, 14 Hz, 1H), 2.80 (d, J = 14 Hz, 1H), 2.77 (ddd, J = 7.1, 9.2, 14 Hz, 1H), 
2.40 (brdd, J = 6.4, 14 Hz, 1H), 2.31–2.17 (m, 2H), 2.10 (dddd, J = 3.8, 7.1, 9.9, 11 Hz, 1H);  13C 
NMR (75 MHz, CDCl3):  δ 173.0, 140.4, 135.2, 131.6, 130.2, 128.6, 128.4, 127.0, 126.3, 120.2, 
79.0, 60.2, 36.4, 34.7, 32.3, 31.8; LRMS (EI, 70eV):  m/z 306; HRMS calcd for C21H22O2:  
306.1620, found 306.1609. 
O
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 (3R, 4S)-3-Allyl-3-methyl-4-phenethyl-oxetan-2-one (245g):  Isolated 
as a pale yellow oil (94%, 6:1 mixture of diastereomers):  IR (thin film):  
3064, 3027, 2958, 2930, 2863, 1822, 1641, 1603, 1496, 1455, 1109 cm-1; 1H NMR (300 MHz, 
CDCl3): δ   7.36–7.31 (m, 2H), 7.27–7.20 (m, 3H), 5.80 (dddd, J = 6.6, 7.8, 10, 14 Hz, 1H), 
5.20–5.05 (m, 2H), 4.25 (dd, J = 4.0, 9.8 Hz, 1H), 2.90 (ddd, J = 5.3, 9.3, 14 Hz, 1H), 2.68 (ddd, 
J = 7.7, 7.7, 14 Hz, 1H), 2.54 (ddt, J = 1.4, 6.6, 14 Hz, 1H), 2.34 (ddt, J = 1.0, 7.8, 14 Hz, 1H), 
2.20–1.94 (m, 2H), 1.38 (s, 3H); 13C NMR (75 MHz, CDCl3):  δ 174.2, 140.4, 131.9, 
O
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 128.6, 128.4, 126.3, 119.3, 82.6, 56.0, 34.8, 32.2, 31.7, 19.8; LRMS (EI, 70eV):  m/z 230; 
HRMS calcd for C15H18O2:  230.1307, found 230.1312. 
  
(3S, 4S)-3-Allyl-3-ethyl-4-phenethyl-oxetan-2-one (247a): Isolated as a 
pale yellow oil (92%, single diastereomer):  [α]D = –41 (c  2.1, CHCl3); IR 
(thin film):  3083, 3063, 3027, 2973, 2882, 1817, 1732, 1642, 1604, 1496, 
1455, 1112 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.36–7.31 (m, 2H), 7.27–7.20 (m, 3H), 5.74 
(dddd, J = 7.5, 7.5, 10, 17 Hz, 1H), 5.22–5.15 (m, 2H), 4.36 (dd, J = 3.9, 9.9 Hz, 1H), 2.87 (ddd, 
J = 5.1, 10, 14 Hz, 1H), 2.69 (ddd, J = 6.9, 9.5, 14 Hz, 1H), 2.55–2.42 (m, 2H), 2.12 (dddd, J = 
5.2, 9.7, 9.7, 14 Hz, 1H), 1.96 (dddd, J = 3.9, 6.9, 10, 14 Hz, 1H), 1.90 (dddd, J = 7.5, 7.5, 7.5, 
15 Hz, 1H),  1.66 (dddd, J = 7.5, 7.5, 7.5, 15 Hz, 1H), 1.05 (t, J = 7.5 Hz, 3H); 13C NMR (75 
MHz, CDCl3):  δ 173.6, 140.5, 131.6, 128.6, 128.4, 126.3, 119.7, 79.9, 60.4, 36.0, 32.0, 31.8, 
21.1, 8.4;  LRMS (EI, 70eV):  m/z 244; HRMS calcd for C16H20O2, 244.1463, found 244.1472.       
O
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 (3S, 4S)-3-Benzyl-4-phenethyl-3-propyl-oxetan-2-one (247c): 
Isolated as a pale yellow oil (86%, single diastereomer):   [α]D = –32     
(c  2.1, CHCl3); IR (thin film):  3086, 3062, 2960, 2873, 1815, 1603, 
1496, 1455, 1108 cm-1; 1H NMR (300 MHz, CDCl3): δ  7.37–7.23 (m, 6H), 4.40 (dd, J = 3.7, 9.9 
Hz, 1H), 3.15 (d, J = 14 Hz, 1H),  2.88 (d, J = 14 Hz, 1H), 2.80 (ddd, J = 5.1, 9.7, 14 Hz, 1H), 
2.58 (ddd, J = 7.5, 8.9, 14 Hz, 1H), 2.10 (dddd, J = 5.0, 9.3, 14 Hz, 1H), 1.89 (dddd, J = 3.7, 7.4, 
9.6, 14 Hz, 1H), 1.80–1.62 (m, 2H), 1.60–1.46 (m, 2H), 0.98 (t, J = 7.0 Hz, 3H);  13C NMR (75 
MHz, CDCl3):  δ 173.8, 140.4, 135.5, 129.7, 128.6, 128.5, 128.4, 127.1, 126.3, 79.0, 61.4, 38.1, 
O
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 31.6, 31.2, 17.6, 14.5; LRMS (EI, 70eV):  m/z 308; HRMS calcd for C21H24O2: 308.1776, found 
308.1781. 
 
  (3R, 4S)-3-Benzyl-3-isopropyl-4-phenyl-oxetan-2-one (247d): Isolated as a 
white solid (94%, single diastereomer):  [α]D = –78 (c  1.6, CHCl3); IR (thin 
film):  3063, 3027, 2958, 2930, 1811, 1495, 1454, 1373, 1268, 1140, 921, 758 
cm-1; 1H NMR (300 MHz, CDCl3): δ 7.45–7.30 (m, 10H), 5.27 (s, 1H), 3.25 (d, J = 14 Hz, 1H), 
2.86 (d, J = 14 Hz, 1H), 2.20 (septet, J = 6.8 Hz, 1H), 1.16 (d, J = 6.8 Hz, 3H), 0.52 (d, J = 6.8 
Hz, 3H); 13C NMR (75 MHz, CDCl3):  δ 173.5, 135.7, 134.8, 130.5 (2C), 128.9 (2C), 128.6, 
128.3 (2C), 127.3, 126.7 (2C), 78.2, 68.5, 32.8, 28.3, 17.6, 16.2;  LRMS (EI, 70eV):  m/z 236 
[M-CO2]+; HRMS calcd for C18H20:  236.1565 , found 236.1566.       
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 (3S, 4S)-3-Allyl-4-cyclohexyl-3-methyloxetan-2-one (247e):   Isolated as a 
pale yellow oil (52%, 19:1 mixture of diastereomers):  [α]D = +3.0 (c  2.0, 
CHCl3); IR (thin film):  3080, 2932, 2854, 1823, 1642, 1452, 1382, 1137, 985, 
925, 847 cm-1; 1H NMR (300 MHz, CDCl3): δ 5.75 (dddd, J = 7.4, 7.4, 10, 18 Hz, 1H), 5.23–
5.20 (m, 1H), 5.18–5.13 (m, 1H), 3.96 (d, J = 11 Hz, 1H), 2.48 (dd, J = 7.0, 14 Hz, 1H), 2.38 
(dd, J = 7.6, 14 Hz, 1H), 2.01–1.89 (m, 1H), 1.85–1.61 (m, 4H), 1.56–1.47 (m, 1H), 1.31 (s, 3H), 
1.29–1.12 (m, 2H), 1.10–0.82 (m, 2H); 13C NMR (75 MHz, CDCl3):  δ 174.7, 132.0, 119.7, 84.4, 
56.4, 40.4, 38.2, 29.1, 28.3, 26.1, 25.1, 25.0, 14.5;  LRMS (EI, 70eV):  m/z 208; HRMS calcd for 
C13H20O2, 208.1463, found 208.1470. 
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 General procedure for the La(OtBu)3-Mediated Ring Opening of α, α-Disubstituted β-
Lactones:25a  To a solution of La(OtBu)3 in THF was added benzyl alcohol at ambient 
temperature.  The reaction mixture was maintained until complete consumption of the starting 
material was observed by TLC.  The reaction was then purified by column chromatography. 
 
 (1′R, 2S)- Benzyl-2-(2-benzyloxy-1′-hydroxyethyl)-2-
methylpent-4-enoate (248a):  Purification by flash 
chromatography (5% EtOAc/hexanes) afforded 0.022 g 
(92%) of hyroxyester 248a as a clear, colorless oil:  [α]D = –8.6   (c  2.7, CHCl3); IR (thin film): 
3467, 3065, 3032, 2979, 2919, 1731, 1640, 1454, 1214, 1086, 739, 698; 1H NMR (300 MHz, 
CDCl3): δ  7.40–7.25 (m, 10H), 5.76–5.60 (m, 1H), 5.08–4.98 (m, 2H), 4.49 (s, 2H), 3.85 (ddd, J 
= 2.8, 5.9, 7.0 Hz, 1H), 3.62 (dd, J = 2.8, 9.8 Hz, 1H), 3.54 (dd, J = 5.9, 9.8 Hz, 1H), 3.22 (d, J = 
7.0 Hz, 1H), 2.58 (dd, J = 7.2, 13.6 Hz, 1H), 2.28 (dd, J = 7.7, 13.6 Hz, 1H), 1.18 (s, 3H); 13C 
NMR (75 MHz, CDCl3):  δ 175.4, 137.9, 135.9, 133.1, 128.5, 128.4, 128.1, 127.8, 127.7, 75.0, 
73.6, 71.0, 66.5, 48.9, 40.7, 17.7; LRMS (EI, 70eV):  m/z 263 [M-C7H7]+; HRMS calcd for 
C15H19O4:  263.1283, found 263.1274. 
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(2S, 3S)-2-Benzyl-3-hydroxy-2-methyl-5-phenyl-pentanoic acid 
benzyl ester (248b):  Purification by flash chromatography (5% 
EtOAc/hexanes) afforded 0.073 g (86%) of hyroxyester 248b as a 
clear, colorless oil:    [α]D = –35   (c  1.8, CHCl3); IR (thin film):   
3506, 3085, 3062, 3028, 2948, 2858, 1720, 1603, 1496, 1454, 1273, 1100 cm-1; 1H NMR (300 
MHz, CDCl3): δ 7.34–7.18 (m, 12H), 7.10–7.05 (m, 2H), 5.10 (s, 2H), 3.61 (ddd, J = 1.8, 8.9, 11 
Hz, 1H), 3.11 (d, J = 13 Hz, 1H), 2.97 (ddd, J = 4.8, 10, 14 Hz, 1H), 2.86 (d, J = 13 Hz, 1H), 
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 2.80 (d, J = 8.8 Hz, 1H), 2.64 (ddd, J = 6.7, 9.9, 14 Hz, 1H), 1.89 (dddd, J = 1.8, 6.7, 10, 14 Hz, 
1H), 1.56 (dddd, J = 4.8, 10, 11, 14 Hz, 1H), 1.14 (s, 3H); 13C NMR (75 MHz, CDCl3):  δ 176.4, 
142.1, 136.8, 135.5, 130.1, 128.6, 128.5, 128.4, 128.3, 128.2, 128.1, 126.6, 125.8, 75.1, 66.5, 
52.3, 42.5, 34.1, 32.8, 17.6; LRMS (EI, 70eV):  m/z 388, 370 (M-H2O); HRMS calcd for 
C26H28O3:  388.2038, found 388.2036. 
 
 (2S)-2-Benzyl-2-methyl-5-phenylpent-3-enoic acid benzyl 
ester (249): To a 0°C solution of 0.036 g of hydroxyester 248b 
(0.093 mmol) and 26 µL of Et3N (0.186 mmol) in 0.9 mL of 
CH2Cl2 was added 11 µL of methanesulfonyl chloride (0.139 mmol).  The reaction was 
maintained at 0°C for 30 min, and then diluted with ether (10 mL).  The resulting cloudy white 
mixture was washed with saturated aqueous NaHCO3 and brine.  The organics were dried over 
Na2SO4, filtered, and concentrated.  The crude mesylate was then dissolved in benzene, treated 
with DBU, and heated at reflux for 18 h.  Upon cooling to ambient temperature, the reaction 
mixture was washed with saturated aqueous NaHCO3 followed by brine.  The organic layer was 
again dried over Na2SO4, filtered, and concentated. Purification by flash chromatography on 
silica gel (5% EtOAc/hexanes) afforded 0.021 g (61%) of the title compound 249 as a clear, 
colorless oil:  [α]D = +13   (c 1.3, CHCl3); IR (thin film):  3085, 3062, 3029, 2979, 2935, 1731, 
1603, 1495, 1454, 1100, 976 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.36–7.21 (m, 10H), 7.15–
7.08 (m, 4H), 5.83 (dt, J = 1.3, 16 Hz, 1H), 5.62 (dt, J = 6.7, 16 Hz, 1H), 5.15 (s, 2H), 3.39 (d, J 
= 6.7 Hz, 2H), 3.11 (d, J = 13 Hz, 1H), 2.91 (d, J = 13 Hz, 1H), 1.28 (s, 3H); 13C NMR (75 MHz, 
CDCl3):  δ 175.3, 140.2, 137.1, 136.0, 134.6, 130.4, 128.7, 128.5, 128.4, 128.3, 128.1, 128.0, 
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 127.9, 126.4, 126.0, 66.4, 49.2, 45.6, 39.0, 20.6; LRMS (EI, 70eV):  m/z 370; HRMS calcd for 
C26H26O2:  370.1933, found 370.1942. 
 
General Procedure for the Azide-Mediated Ring Opening of α, α-Disubstituted β-
Lactones:104  To a 50 °C solution of 0.015 mg of NaN3 (0.229 mmol) in 0.3 mL of DMSO was 
added 0.032 g of lactone 245b in 0.3 mL of DMSO followed by a 0.1 mL rinse.  The resulting 
clear, colorless solution was maintained for 3 h at 50 °C, then cooled to ambient temperature.  
After acidification with 1 M HCl (2 mL), the mixture was diluted with H2O (5 mL) and extracted 
with EtOAc (5 × 10 mL).  The combined organics were washed with H2O and brine, dried over 
Na2SO4, filtered, and concentrated.  The crude product was purified by flash chromatography 
(20% EtOAc/hexanes) to afford 0.035 g of β-azido acid 250b. 
 
(2S, 3R)-3-Azido-2-benzyl-2-methyl-5-phenylpentanoic acid (250b):  
Isolated as a pale yellow oil (95%):  [α]D = –35  (c  1.9, CHCl3); IR (thin 
film):  3063, 3028, 2929, 2099, 1705, 1603, 1545, 1496, 1454, 1275, 1213 cm-1; 1H NMR (300 
MHz, CDCl3): δ  7.43–7.19 (m, 10H), 3.70 (brd, J = 9.4 Hz, 1H), 3.09–3.00 (m, 1H), 2.98 (d, J = 
13 Hz, 1H), 2.79 (ddd, J = 7.9, 7.9, 16 Hz, 1H), 2.15-1.75 (m, 2H), 1.19 (s, 3H); 13C NMR (75 
MHz, CDCl3):  δ  180.1, 140.7, 136.7, 130.1, 128.5, 128.4, 128.1, 126.7, 126.2, 67.9, 53.2, 43.6, 
33.5, 33.1, 16.0; LRMS (EI, 70eV):  m/z 295 (M-N2); HRMS calcd for C19H21NO2 (M-N2):  
295.1572, found 295.1575. 
HO Ph
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104 A modified work-up procedure was performed for the isolation of the azido acid products compared to the 
original procedure described in ref. 81. 
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  (2S, 3R)-3-Azido-2-ethyl-2-methyl-5-phenylpentanoic acid (250a): 
Isolated as a pale yellow oil (98%):  [α]D = –39  (c  0.2, CHCl3); IR (thin 
film):  3028, 2931, 2099, 1702, 1456, 1386, 1254 cm-1; 1H NMR (300 
MHz, CDCl3): δ  7.33–7.28 (m, 2H), 7.24–7.19 (m, 3H), 3.60 (dd, J = 2.3, 11 Hz, 1H), 2.94 (ddd, 
J = 5.0, 9.7, 14 Hz, 1H), 2.69 (ddd, J = 7.3, 9.3, 14 Hz, 1H), 1.93–1.62 (m, 4H), 1.12 (s, 3H), 
0.91 (t, J = 7.4 Hz, 3H);   13C NMR (75 MHz, CDCl3):  δ  179.6, 140.7, 128.5, 128.4, 126.2, 67.9, 
51.9, 33.5, 33.1, 30.6, 15.4, 8.8; LRMS (EI, 70eV):  m/z 232 (M-N2); HRMS calcd for 
C14H18NO2 (M-N2): 232.1338, found 232.1335. 
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 (2S, 3R)-2-(1-Azido-3-phenyl-propyl)-2-methylhexanoic acid (250c):  
Isolated as a pale yellow oil (97%):  [α]D = –16 (c  1.0, CHCl3); IR (thin 
film): 3064, 3027, 2956, 2863, 2099, 1702, 1496, 1455, 1383, 1254, 1219, 1151 cm-1; 1H NMR 
(300 MHz, CDCl3): δ  7.33–7.27 (m, 2H), 7.24–7.19 (m, 3H), 3.59 (dd, J = 2.3, 11 Hz, 1H), 2.94 
(ddd, J = 4.8, 9.6, 14 Hz, 1H), 2.69 (ddd, J = 7.3, 9.2, 14 Hz, 1H), 1.13 (s, 3H), 0.90 (t, J = 6.8 
Hz, 3H);  13C NMR (75 MHz, CDCl3):  δ  174.5, 140.7, 128.5, 128.4, 126.2, 68.0, 51.7, 37.5, 
33.5, 33.0, 26.5, 23.1, 16.2, 13.8;  LRMS (EI, 70eV):  m/z 260 (M-N2); HRMS calcd for 
C16H22NO2 (M-N2):  260.1651, found 260.1650. 
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(2R, 3R)-3-Azido-2-benzyl-2-isopropyl-3-phenylpentanoic acid (250d):  
Isolated as a pale yellow residue (14%):    [α]D = –97 (c 0.4, CHCl3); IR (thin 
film):   3031, 2922, 2850, 2104, 1700, 1454, 1255, 702 cm-1; 1H NMR (300 MHz, CDCl3): 
δ 7.49–7.45 (m, 2H), 7.39–7.31 (m, 3H), 7.31–7.20 (m, 5H), 4.92 (s, 1H), 3.05 (d, J = 14 Hz, 
1H), 2.99 (d, J = 14 Hz, 1H), 2.38 (septet, J = 6.9 Hz, 1H), 1.11 (d, J = 6.9 Hz, 3H), 0.82 (d, J = 
HO Ph
O
Pr Bn
N3
i
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 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3):  δ 178.2, 137.3, 136.4, 130.3 (2C), 129.3 (2C), 128.4. 
128.3 (2C), 128.2 (2C), 126.7, 67.9, 58.2, 39.2, 30.5, 29.7, 19.7, 18.5; LRMS (EI, 70eV):  m/z 
295 [M-N2]+;  HRMS calcd for C19H21NO2:  295.1572, found 295.1569. 
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